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ABSTRACT 
 The development of reliable methods for the “on demand” de novo design of an 
enzymatic catalyst for an arbitrary chemical reaction has been an elusive goal of the 
computational protein design community.  Recent successful results of de novo 
computational enzyme design have been encouraging, but the activity of the enzymes 
produced so far is still well below that of natural enzymes and the generalizability of 
these methods has yet to be established. 
Presented in this thesis are methods that we have developed for the computational 
design of enzyme active sites as well as results from the evaluation of these methods 
through a test case, the Kemp elimination.  Initial Kemp elimination designs were 
shown to be inactive.  However, in the course of refining these design procedures, we 
carried out extensive theoretical and experimental evaluation of several of these 
inactive designs, which allowed us to identify the causes of the inactivity and led to 
adjustments of our design procedure.  These modified methods were then successfully 
used to design four distinct enzymes for this reaction in three inert scaffolds including 
the scaffold that housed the previously inactive designs.  In addition, we demonstrate 
that molecular dynamics simulations can accurately predict the activity of designed 
Kemp elimination enzymes and can be used as a reliable prescreening step, allowing 
us to focus our experimental efforts on designs that are most likely to be active. 
The work presented here demonstrates that the cyclic evaluation and redesign of 
both active and inactive enzymes was instrumental in the identification and resolution 
of deficiencies in our computational methods and directly resulted in de novo 
designed enzymes with novel and increased activity. 
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Chapter I 
 
 
Introduction 
 
 
Enzymes are awesome 
Enzymes are extremely efficient catalysts, accelerating chemical reaction rates up 
to 1019 times that of the uncatalyzed reaction.1  In addition to the large rate enhancements 
that can be observed, enzymes can also carry out reactions with extreme regio- and 
stereospecificity, eliminating the need for protecting groups and reliably producing a 
single product.2,3  In the face of concern over the environmental impact of chemical 
synthesis, enzymes have emerged as attractive alternatives to chemical catalysts because 
they work under mild, aqueous conditions, reducing the generation of hazardous wastes 
that are often associated with organic synthesis.2  The enzymes themselves are, of course, 
biodegradable and can usually be produced in large quantities via recombinant expression 
in bacteria or fungi. 
Despite their promise, significant challenges prevent the widespread use of 
enzymes as industrial catalysts.  The applicability of enzymes can be limited by their 
instability in conditions appropriate for industrial processes, including high temperatures, 
extreme pHs, and organic solvents.2  In addition, the scope of reactions that can be 
catalyzed by enzymes is limited to those found in natural metabolic pathways, although 
some enzymes, including lipases, have been shown to be somewhat promiscuous in their 
substrate specificity.4  Directed evolution has been used to improve stability, optimize 
efficiency, and modify the substrate specificity of many enzymes.5-7  However, this 
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method requires existing activity toward the reaction of interest, so it cannot be used to 
introduce truly novel chemistries.5  
Catalytic antibodies have shown promise in the catalysis of a wide variety of 
chemical transformations including stereoselective and novel reactions.8  However, the 
catalytic efficiencies of antibodies have traditionally been modest due in part to selections 
that are based on binding to a synthetic transition state analog instead of on enzymatic 
turnover.8,9  Reactive immunization has been used to overcome these limitations, 
producing catalytic antibodies with reaction rates approaching those of the wild-type 
enzyme, but this method can only be applied to reactions whose transition states are 
known and can be readily mimicked with a reactive transition state analog that is 
accessible by current synthetic methods.10,11  In addition, Xu et al. has suggested that the 
immunoglobulin scaffold itself may limit the scope of reactions amenable to catalysis 
with antibodies.8 
While directed evolution and catalytic antibodies have both been successfully 
used for enzyme engineering, both have features that keep them from being applied 
generally for the engineering of novel enzymatic activities.  In contrast, computational 
protein design does not suffer from these limitations, and can be envisioned as a solution 
to many complex synthetic organic chemistry problems. 
 
Computational protein design 
Computational protein design has shown great promise for developing novel 
functions in proteins.  The general approach to solving a computational design problem is 
cyclic (Figure 1-1).  Beginning with the backbone coordinates of a high-resolution 
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protein crystal structure, an optimization algorithm is used to search through 
combinations of side-chain identities and conformations for the sequence and geometries 
of amino acids that will best stabilize the protein fold.12,13  The extent to which a 
particular sequence might stabilize the desired fold is evaluated through a force field 
scoring function, which calculates an energy for the sequence that should correlate to the 
protein’s free energy of folding.  The sequence and conformation of amino acids that will 
best stabilize the backbone structure (i.e., fold into the desired conformation) is assumed 
to be the one with the lowest energy.  This global minimum energy conformation 
(GMEC) must then be experimentally validated by structural and/or thermodynamic 
comparison of the designed sequence to that of the native protein.12-14  Information 
gained from evaluating the deviations of theory from experiment can then be used to 
readjust the force field parameters, thus completing the design cycle.12 
For a small 59-residue protein, there are about 1077 possible sequences (assuming 
that all 20 amino acids are allowed at all positions).  If a single molecule of each of these 
sequences were to actually be synthesized, their combined mass would be approximately 
7.6 × 1056 g, which according to some estimates, approaches the mass of the observable 
universe.  When the conformational flexibility of the side chains is also taken into 
account, the number of possible solutions explodes even further.  To reduce the 
combinatorial complexity of the problem to a reasonable size, we limit our designs to use 
a library of discrete sidechain conformations called rotamers, which represent the 
statistically significant amino acid sidechain conformations found in protein crystal 
structures.15  In results described later in this text, we used rotamer libraries based on 
 4 
those developed by Dunbrack and Karplus,16 as well as sidechain conformer libraries 
developed in the Mayo lab.17 
The ORBIT (Optimization of Rotamers By Iterative Techniques) software suite is 
a computational protein design package developed in the Mayo lab.13  Standard 
implementations of ORBIT use a scoring function based on physical principles and apply 
the DREIDING force field,18 which incorporates four empirically based potential 
functions to calculate the total energy (Etotal) of a structure:  
   Etotal = Evdw + Eh-bond + Eelect + Eas  . 
(1) A van der Waals (VDW) interaction energy (Evdw) is calculated for each pair of 
rotamers using a Lennard-Jones 12-6 potential.18 
(2)  A hydrogen bond potential (Eh-bond) is used that is angle-, distance-, and 
hybridization-dependent.19 
(3) Electrostatic interactions (Eelect) are calculated based on Coulomb’s Law 
incorporating a distance-dependent dielectric of 40r, where r is the interatomic 
distance.19 
(4) A solvation term (Eas) is used that employs a solvation potential based either on 
the protein’s surface area or the occlusion of one atom by another.  Both of these 
solvation models give an energy benefit to buried nonpolar regions of the protein 
and penalize exposed nonpolar and buried polar regions.20,21 
The optimization algorithms provided by ORBIT apply a variety of methods to 
establish the optimal sequence or set of sequences to stabilize a given fold.  Algorithms 
based on the Dead-End Elimination theorem (DEE)22-25 are used to quickly identify and 
remove amino acid rotamers and pairs of rotamers that cannot exist in the GMEC.  
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ORBIT also supplies stochastic methods of sequence optimization such as those based on 
the Fast and Accurate Side-Chain Topology and Energy Refinement (FASTER) 
algorithm15 and Monte Carlo26,27 either alone or in combination with DEE to both 
decrease calculation time and to sample sequence space around the GMEC. 
ORBIT has been used to design proteins in a wide variety of systems.  Successful 
implementations include the full sequence design of a protein that adopts a zinc finger 
fold independent of zinc binding,28 the redesign of calmodulin to increase its binding 
specificity for a single target peptide,29 and the de novo design of a protein-protein 
interface.30 
 
Computational enzyme design 
Promisingly, ORBIT has also been used to design an enzyme with modest 
catalytic activity.31  This “protozyme” with p-nitrophenol acetate hydrolysis activity with 
a kcat/kuncat of 102 was one of the first examples of a de novo computationally designed 
enzyme.  Other labs have also employed computational tools to design enzymes, 
including transplanting reactive metalloenzyme active sites into inert proteins.32,33  In 
addition, computational enzyme design methodologies have been used to switch the 
specificity of existing enzymes.34,35  More recent dramatic successes from one of these 
labs include the de novo design of retroaldolases as well as enzymes that catalyze the 
Kemp elimination, a reaction for which no natural enzyme exists.36,37 
The promise of computational enzyme design has been clearly established.  
However, the generalizability of these methods for other chemical transformations has 
not yet been demonstrated.  In addition, while some of the enzymes designed so far have 
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had impressive catalytic activity, the computational design of enzymes with true native-
like efficiency still presents a challenge.36,37  The goal of engineering “designer enzymes” 
for any reaction remains extremely attractive as it will allow the scope of enzymatic 
reactions to extend beyond the limits of natural cellular metabolism, broadening the range 
of possible substrates and products, especially those with stereogenic centers.  Once this 
challenge has been met and the generality of computational protein design techniques has 
been established, rapid, on-demand engineering of enzymes will be possible for many 
important chemical reactions. 
Towards this goal, my work has focused on the introduction and evaluation of 
new enzyme design capabilities both in ORBIT and in a related program, Phoenix.  Force 
field parameterization in protein design has historically been carried out with respect to 
protein stability and overall fold without regard to specific function.  In the case of 
ORBIT, parameters for the DREIDING force field were optimized through the sequence 
design of a small protein and the subsequent experimental evaluation of changes in 
overall thermodynamic stability.12,38  The resulting parameters were weighted to 
emphasize VDW contacts and buried hydrophobic surface area.  While these parameters 
were successfully used to design many hyperstable proteins, they are not necessarily well 
suited for designing enzymes because most natural enzymes are not evolved for optimum 
stability.39,40 
According to the transition state theory, enzymes achieve such large rate 
enhancements through specific tight binding and stabilization of the reaction transition 
state (TS).41  Computational simulations of enzyme active sites have suggested that polar 
and nonpolar residues that contact the TS but are not directly involved in the reaction 
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chemistry can provide additional stabilization to the TS through electrostatics and VDW 
interactions, thus promoting catalysis.42  To design an effective enzyme de novo, we must 
first determine the nature of the interactions between the protein and the rate limiting TS 
that promote catalysis; information about these interactions (e.g., sidechain functional 
groups and contact geometries) can be gained from ab initio calculations, analogy to 
existing enzymes, or chemical intuition.17,43  These protein-TS contacts can then be 
incorporated into the scoring function.17,44 
The major changes made to ORBIT to accommodate enzyme design include the 
introduction of a geometry biasing term that allows an energetic benefit to be added to 
those sequences that can make specified stabilizing contacts to a TS model present in the 
active site.  In addition, we have implemented various methods for the creation of 
libraries of transition state poses within the active site that can be sampled during the 
sequence search.17 
Chapter II of this thesis is a journal article that I co-authored describing our 
computational enzyme design methodology in detail.  Here, our methods were evaluated 
through recapitulation of the active site configurations of three natural enzymatic/binding 
protein systems: Escherichia coli chorismate mutase, Saccharomyces cerevisiae 
triosephosphate isomerase, and Streptomyces avidinii streptavadin.  
As a result of our previous de novo design experience, we chose to focus on a 
well-studied chemical system: the general base-catalyzed Kemp elimination (KE) of 5-
nitrobenzisoxazole (Figure 1-2). The KE has been used since the 1970s as a physical 
organic model for proton transfer from carbon45,46 and more recently as a model system 
for enzymatic proton transfer reactions.47-49  Other attractive features of this reaction are 
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that it is irreversible with a single transition state and that it has a product that can be 
observed spectrophotometrically (λmax = 405 nm).45  In addition, multiple catalytic 
antibodies have been created that can catalyze this reaction with rate accelerations up to 
106 times faster than the background reaction.50,51  The crystal structure of one of these 
antibodies has given us clues as to how transition state stabilization can be achieved for 
this reaction (Figure 1-3).52  In this catalytic antibody, stabilization occurs through a 
combination of a carboxylate general base, extensive π-stacking above and below the 
plane of the ring system, and hydrogen bond contacts to the base.  In addition, there is 
precedent for the amenability of this reaction to computational enzyme design 
methodologies, as Röthlisberger et al. were able to computationally introduce catalytic 
activity for the KE into three separate inert scaffolds, creating multiple active enzymes.37  
In Chapter III, the computational and experimental details of this system are 
described and one of the resulting inactive designs is discussed.  In the protein design 
cycle (Figure 1-1), the design procedure cannot be adjusted without some information 
from the initial inactive design indicating the possible cause of inactivity.  To complete 
the design cycle, we first had to determine why this initial design was inactive.  This 
chapter also includes details of crystallographic analysis carried out in collaboration with 
the Molecular Observatory at Caltech and molecular dynamic (MD) simulation studies 
carried out in collaboration with Ken Houk’s lab at the University of California, Los 
Angeles that were used to analyze the inactive design.  The X-ray crystal structure of this 
inactive design confirmed that the actual active site of the design was very similar to the 
predicted structure.  Thus, the inactivity was not due to gross misplacement of the active 
site residues or disruption of the overall protein fold.  MD analysis of the design helped 
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us to determine possible causes of the inactivity including an active site that was too 
flexible and solvent exposed. 
The lessons learned from our first KE designs pointed us in the direction of more 
buried, less polar active sites.  Using the same scaffold as the initial design, we moved 
the active site away from the natural, solvent-exposed active site and located it farther 
into the barrel of the protein.  In Chapter IV, I discuss this new design, HG-2, which was 
predicted to have activity by the blind MD simulations due to the drier, less flexible 
active site.  This activity was confirmed by experimental characterization of this enzyme, 
also discussed in Chapter IV. 
Because of the expense and time associated with experimental evaluation of 
designed enzymes, strategies for the a priori differentiation of active designs from 
inactive ones are needed to make the process of enzyme design more efficient.  In 
Chapter IV, additional designs are described which were carried out using two scaffolds 
that have been used to produce successful KE designs in David Baker’s lab at the 
University of Washington.37  Of the six enzymes synthesized, four showed activity and 
three of these resulted from the evaluation our enzyme design methods through 
redesigning the active site of scaffolds used in the active KE designs from the Baker lab.  
The fourth active design is unique.  In most cases, blind MD analysis of these designs 
was successful in distinguishing active designs from inactive ones.  MD analysis could 
thus serve as an important tool in the computational design procedure, providing an initial 
screen of sequences predicted by the design procedure to help us determine the designs 
on which to focus our experimental efforts. 
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Appendix A describes an early attempt at de novo design of enzymatic activity.  
Here, our goal was to design an enantioselective enzyme for the kinetic resolution of of 
N-benzoyl-L-phenylalanine through the selective hydrolysis of L-2-phenyl-4-
benzylphenyloxazolin-5-one (FOX).  Lessons learned from this first unsuccessful attempt 
at enzyme design led us to focus on less flexible scaffolds and chemical systems that 
have a smaller background reaction rate.  In addition to the de novo enzyme design 
project that has spanned my entire graduate career, I have had the opportunity to work on 
other computational design projects related to enzymes and binding proteins.  In 
Appendix B, I discuss our ongoing efforts to alter the specificity of an existing 
thermophilic xylanase.  Appendix C presents computational efforts toward changing the 
specificity of an androgen receptor as part of a collaboration with the Fletterick lab at the 
University of California, San Francisco.  Appendix D is the first description of the 
recombinant over-expression and purification of a thermophilic xylanase from 
Thermoascus aurantiacus (TAX).  A recombinant version of this enzyme was necessary 
to allow genetic manipulation in the creation of new designs and TAX was used as the 
scaffold for the initial inactive KE design and one of the subsequent active designs.  
Because of its ease of expression, thermostability, and ability to tolerate multiple 
mutations, this enzyme proved to be a useful scaffold for computational design.   
In sum, the work presented in this thesis shows that by iterative structural and 
theoretical evaluation of active and inactive designs, adjustment of our enzyme design 
procedure, and subsequent redesign, we can identify and address deficiencies in our 
design methodology, resulting in de novo designed enzymes with significant activity for 
the reaction of interest.  The field of de novo computational enzyme design is extremely 
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promising and the work presented here is a significant step towards the goal of a general 
method for the computational design as enzymes in the Mayo lab.  This work will serve 
as the foundation for future studies, which will be undertaken to obtain reaction rate 
accelerations and efficiencies comparable to those of natural enzymes and to generalize 
these methods for a wide variety of chemistries. 
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Figure 1-1.  The protein design cycle.  After design, the sequences predicted by the 
algorithm are synthesized and experimentally evaluated for their desired characteristics.  
The correlation of experiment and theory is used to adjust the design procedure for future 
designs.  Adapted from Dahiyat et al. 1996.12 
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Figure 1-2.  The Kemp elimination of 5-nitrobenzisoxazole. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-3.  Kemp elimination catalytic antibody 34E4.52   The co-crystallized hapten 
is shown in pink, the general base is shown in cyan along with two supporting contacts.  
Hydrogen bonds are indicated with dotted lines. 
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Combinatorial methods for small molecule placement in 
computational enzyme design 
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Abstract 
 The incorporation of small molecule transition state structures into protein design 
calculations poses special challenges because of the need to represent the added 
translational, rotational, and conformational freedoms within an already difficult 
optimization problem.  Successful approaches to computational enzyme design have 
focused on catalytic sidechain contacts to guide placement of small molecules in active 
sites.  We describe a process for modeling small molecules in enzyme design calculations 
that extends previously described methods, allowing favorable small molecule positions 
and conformations to be explored simultaneously with sequence optimization.  Because 
all current computational enzyme design methods rely heavily on sampling of possible 
active site geometries from discrete conformational states, we tested the effects of 
discretization parameters on calculation results.  Rotational and translational step sizes as 
well as sidechain library types were varied in a series of computational tests designed to 
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identify native-like binding contacts in three natural systems.  We find that 
conformational parameters, especially the type of rotamer library used, significantly 
affect the ability of design calculations to recover native binding-site geometries.  We 
describe the construction and use of a crystallographic conformer library, and find that it 
more reliably captures active-site geometries than traditional rotamer libraries in the 
systems tested. 
 
Introduction   
 As catalysts, enzymes offer advantageous properties including dramatic rate 
enhancements, complete control over absolute stereochemistry, and nontoxic 
biodegradation.  Yet a fundamental limiting factor in the use of enzymes for chemical 
synthesis, bioremediation, therapeutics, and other applications is the availability of 
enzymes with the required activities, specificities, and tolerances to reaction conditions.  
It is therefore a major goal of computational protein design to be able to reliably create 
completely new protein catalysts with specific properties on demand.   
 A catalyst by definition must reduce the energy barrier for formation of the 
transition state.  To design transition-state-stabilizing interactions, computational protein 
design groups have incorporated transition-state or high-energy intermediate state 
structures into design calculations.  These efforts have yielded experimentally verified 
new catalytic proteins.1,2  However, substantial challenges still prevent routine or reliable 
design of enzymes.  One major challenge is in finding energy functions that are fast 
enough for large calculations but that still provide informative approximations of 
electrostatic and desolvation effects in the protein environment.3,4   This paper focuses on 
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another fundamental challenge, the need to represent the large translational, rotational, 
and conformational freedoms of a small molecule within already astronomically large 
sequence design calculations. 
 Here we define protein design as the selection of amino acid sequences such that 
the resulting protein occupies a given three-dimensional fold and has desired functional 
properties.  Earlier experiments sought to redesign full protein sequences or confer 
increased thermostability,5,6 but newer work has successfully introduced other properties, 
including catalytic activity, conformational specificity, ligand affinity, and even novel 
protein folds.1,2,7-9   In these examples, sidechain placement algorithms were used to select 
from a set of discrete, probable sidechain rotamers using energy functions tuned to 
produce thermostable proteins.  These calculations represent difficult optimization 
problems10 and they can also be large—a sample calculation performed on a typical 
enzyme active site yields more than 1065 possible sequence combinations, even when 
excluding movements of the small molecule. 
 The computational demands of sequence selection prevent ligand positioning 
using standard docking procedures, which often approximate or neglect sidechain 
flexibility.11 Approaches developed specifically for the purpose of enzyme and binding 
site design have introduced other schemes to limit the calculation size.  Looger et al. used 
stationary, inflexible ligand poses in a large number of individual protein design 
calculations and demonstrated experimentally that several of the resulting proteins had 
high ligand affinity.8  Lilien et al. reported and experimentally validated an ensemble-
based method that allows ligand translation and rotation simultaneously with sidechain 
optimization but only permits mutation of two or three amino acid positions at a time.12  
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Chakrabarti et al. described a method for sequence design that neglects conformational 
and positional ligand flexibility and has not been experimentally tested.13,14    
 To design new enzyme active sites, a ligand placement method must be able to 
select side chains in many positions and must consider rotational, translational, and 
conformational freedom of the small molecule.  The new catalytic proteins of Bolon and 
Mayo1 and Dwyer et al2 (this article, by Dwyer et al. has been retracted since the 
publication of this manuscript40) were designed by treating high-energy-state structures of 
the reacting molecules as extensions of contacting amino acid sidechain rotamers.  In the 
latter case, a two-step procedure was utilized, where ligands, anchoring side chains, and 
other catalytic side chains were placed through a geometric screening procedure and 
surrounding side chains were designed in a second step.2,15  We have developed a process 
for ligand placement in computational protein design calculations that expands upon 
previous work and that allows ligand rotation, translation, and conformational freedom to 
be explored combinatorially within the sequence design calculation itself.  The 
implementation of ligand placement procedures within the context of the pairwise-
decomposable protein design framework makes it possible to use a single energy function 
that can be parameterized as needed to reproduce experimental data. 
 We tested both a simple rotational and translational process for ligand placement 
as well as the previously used targeted ligand placement approach.  A contact-based 
screening method is described that allows selection of ligand positions and confomations 
compatible with catalytic contacts.  Test calculations in three systems, E. coli chorismate 
mutase, S. cerevisiae triosephosphate isomerase, and S. avidinii streptavidin, suggest that 
the success of ligand placement procedures can be quite sensitive to conformational 
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sampling parameters, including rotational and translational step sizes and the types of 
rotamer libraries used.  We evaluated the efficacy of two standard rotamer libraries and 
two crystallographic conformer libraries.  Traditional rotamers are constructed from 
canonical χ angles determined by statistical analysis of the Protein Data Bank,16-18 
whereas conformers have Cartesian coordinates taken directly from high-resolution 
structures.  Conformer libraries may allow more accurate modeling because they are not 
limited to ideal geometries and their sizes can be tuned more easily and naturally.19,20  In 
our tests, a backbone-independent conformer library recovered wild-type-like active site 
geometries more successfully than the other libraries, despite smaller size.  
 
Results and Discussion 
 We have implemented and tested a process for incorporation of small molecules 
into computational protein design calculations.  The procedure is general and may be 
used to place ground-state ligands or transition-state structures.  It is also amenable to 
multistate design methods that seek to explicitly reflect the energy difference between 
reactant and transition states or between alternative ligands. 
 
General Calculation Procedure 
 Each ligand placement calculation comprised five steps.  In the first step, a large 
number of discrete variations of ligand coordinates was created. Initial sets of 
orientations were created by one of two methods, either simple rotation and translation or 
a targeted placement approach, both of which are discussed in more detail in subsequent 
sections.   In the tests described here, each set of ligand variations contained 106-109 
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members, reflecting rotational and translational movement as well as internal 
conformational flexibility. 
 Next, the large number of substrate orientations was reduced to a manageable 
number (< ~ 20,000) using both a simple hard-sphere steric potential to check for 
backbone clashes and a set of user-defined geometric criteria for sidechain/ligand 
contacts.  In this work, geometric criteria were defined to reflect the distances, angles, 
and torsions characteristic of important catalytic contacts observed in the crystal 
structures (Figure 2-1).  In designing an enzyme with no naturally existing precedent, 
ideal contact geometries would be based on chemical intuition and/or quantum 
mechanical calculations.  The geometric criteria were applied as follows.  For every 
ligand variation, each of the geometric criteria was tested for satisfaction by contacts 
from any possible amino acid sidechain conformation in all designed protein positions.  If 
a ligand variation was not able to make at least one of each type of user-specified contact, 
that ligand variation was discarded from the set.   After geometric and steric pruning, the 
ligand variations remaining were only those theoretically capable of making each of the 
user-specified contacts.  
 In the third step, pairwise energies for all sidechain/sidechain, 
sidechain/backbone, backbone/ligand, and sidechain/ligand interactions were calculated 
using the full force field.  In our work, this normally includes a scaled van der Waals 
term,21 hydrogen-bonding and electrostatic terms,22 and a solvation potential.23,24 
 The fourth step is an optional energy biasing that favors sidechain/ligand contacts 
deemed necessary for catalysis or binding.  This energy biasing step helps to overcome 
the shortcomings of molecular mechanics energy functions, as well as the inherent 
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limitation of treating a multi-state design problem—differential stabilization of transition 
state relative to substrate in protein versus solution—using single-state design algorithms.  
As methods for modeling electrostatics and solvation and for designing over multiple 
states improve, the need for this biasing step should be reduced.  Previous work utilized 
selective application of solvation energy1 or an additional search algorithm step8 for the 
same purpose.  We favor the use of adjustable bias energies that can be tailored for 
specific purposes and investigated as a design variable.   
 To implement the bias, user-specified energies were added or subtracted from 
pairwise sidechain/ligand interaction energies.  We use the energy bias under two 
regimes, one for normal design calculations and another for rapid assessment of catalytic 
residue arrangements within a protein scaffold.  In normal design calculations, a small 
energy benefit is simply applied to favor specified types of sidechain/ligand contacts.  
Alternatively, to quickly identify potential catalytic residues, exaggerated energetic 
benefits and penalties are applied together.  A very large energy benefit is given for 
desired types of pairwise interactions (100 kcal/mol was used in the test cases reported 
here).  An even larger energy penalty (10,000 kcal/mol here) is applied to all other 
pairwise sidechain/ligand interactions, except when the side chain is alanine or glycine.  
In other words, the energy penalty forces all designed side chains to alanine or glycine 
unless they participate in user-specified catalytic contacts with the ligand.  Although this 
process clearly does not yield physically relevant energetics, it offers a useful tool to 
investigate the catalytic conformational space within a binding pocket.  The tests 
performed here to study the effect of sampling parameters on calculation results took 
advantage of this second approach.  Calculations performed to demonstrate sequence 
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selection utilized the normal design approach of applying a simple energy benefit to 
catalytic contacts. 
 Finally, in the fifth step, optimal sequences were identified using the FASTER25,26 
or HERO27 search methods.  In the test cases described here, the result reported is the 
lowest-energy sequence with the maximal number of specified contacts.   
 
Rotation-Translation Search  
 Simple rotation and translation can be used to fill the active site with an initial set 
of ligand variations in the first step of the process described.  Because discrete steps must 
be used to rotate and translate the ligand, we evaluated the sensitivity of the calculation 
results to rotational and translational step sizes.  A series of calculations was performed 
using an alanine-containing active-site background, as discussed in step 4 above.  We 
first tested different rotational step sizes using the crystallographic translational starting 
position with three initial random rotations. Backbone-dependent and backbone-
independent rotamer and conformer libraries were tested.   Each sidechain library was 
tested with and without inclusion of the specific crystallographic sidechain rotamers from 
the structure under examination.   
As seen in Table 2-1, the results of these calculations (in terms of both RMSD 
relative to crystallographic position and number of wild-type contacts) were strongly 
dependent on the both the rotational step size and the rotamer library used.   In the case of 
chorismate mutase, only the backbone-independent conformer library was able to find 
nativelike geometry and contacts.  Figure 2-2 shows results from this library with the 5° 
step size.  When the crystallographic rotamers were included in the calculation, however, 
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all four libraries returned native-like results.  It should be noted that none of the three test 
case structures were included in the set of structures used to create the conformer 
libraries.  The backbone-independent conformer library appeared the most consistently 
successful with the other two test cases as well, although it showed strong dependence on 
rotational step size in streptavidin. 
 Next, we tested various combinations of rotational and translational step sizes 
starting from random initial ligand positions and using only the backbone-independent 
conformer library (Figure 2-3; Table 2-2).  The crystallographic rotamers from the 
structures under investigation were not included in these calculations.  The results show 
that, subject to the constraints imposed by the geometries defined in the pruning step and 
the biasing step, more than one combination of rotational and translational step size is 
viable for each test case and the sensitivity of the result to step size varies among the test 
cases.  
 The rotation/translation tests were performed using three initial random starting 
positions for each system.  The starting positions were created by randomly rotating and 
translating the ligand within a 1 Å3 box around the ligand centroid (or the centroid of the 
bicyclic ring system in biotin).  Using the same atom comparisons as described in the 
tables, the nine initial positions had RMSDs relative to crystallographic positions of 
between 2.1 Å and 4.5 Å, with an average of 3.2 Å.  These tests do not provide full, 
unbiased searches of the active sites.   Full active site searches could be conducted using 
this method by performing separate calculations for grid points distributed evenly 
through the active site.  Given the time required to perform these smaller calculations 
(Table 2-2), searching an entire active site using rotational and translational perturbations 
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would be computationally expensive.   For example, examining a 3.6 x 3.6 x 3.6 Å grid 
using the 10° and 0.3 Å step sizes would require an estimated 324 hours on a 16-
processor cluster for placement of ligands and catalytic side chains in the chorismate 
mutase active site.  Thus, for initial positioning of a ligand within an active site, rotational 
and translational placement is inefficient.  However, the ability to adjust small molecule 
position and conformation simultaneously with sidechain optimization should be 
extremely valuable for refining an initial position identified from a coarser search 
method. 
 
Targeted Ligand Placement 
 A second approach places the small molecule with reference to a contacting side 
chain (Figure 2-4).   In this approach, one or more small molecule variations are placed 
for every rotamer of the selected contacting side chain in every putative active-site 
position.  This process has the advantage that ligand poses are targeted more efficiently to 
orientations that are able to make productive sidechain contacts.  Previous computational 
enzyme design work utilized similar approaches.1,2  In contrast to previous methods, 
however, our procedure does not maintain any association between the targeting rotamer 
and the small molecule—once the set of ligand conformations and orientations is 
constructed in step 1, the ligand variations are all subjected to pruning, pairwise energy 
calculations, and optimization as independent entities in the calculation.  An implication 
of this procedure is that a ligand may engage in a catalytic contact with a rotamer, amino 
acid, or protein position that differs from those of the sidechain rotamer that was 
originally used to place that ligand. 
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 We tested the effect of four types of sidechain libraries on the ability of a targeted 
placement process to find wild-type-like ligand positions and contacts.  For the three test 
cases, the following sidechain contacts were used to anchor the ligand:  chorismate 
mutase, C11 carboxylate to arginine; streptavidin, N1 to aspartate; triosephosphate 
isomerase, O2 and O3 to histidine.   For each contact type, variations were allowed in the 
geometry of the contact, including the contacting atoms (NH1-NH2 versus NE-NH1 for 
arginine) and variations in defined distances, angles, and dihedrals of the contact.   
  As with the rotational and translational search, success in achieving native active-
site conformations was highly dependent on the sidechain library used (Table 2-3).  Only 
the backbone-independent conformer library yielded results for all three test cases that 
were comparable to those with crystallographic rotamers included.   Using that library, all 
three systems returned all wild-type contacts with low ligand RMSD relative to the 
crystallographic position.  As with the rotation/translation search, the chorismate mutase 
case showed the strongest sensitivity to rotamer library.   Inspection of the structures 
revealed that an arginine side chain (Arg 28) occupies a conformation in the inhibitor-
bound, active enzyme structure that was not well approximated in the other rotamer 
libraries.   
 The targeted placement approach allowed a thorough and directed search of 
active-site conformational space, including between 106 and 109 small molecule 
orientations and conformations spread throughout the active site.  In contrast to the 
rotation/translation method, a full active-site search took between one and eighteen hours 
to complete using the backbone-independent conformer library and no initial starting 
position was required.   This method offers an efficient first step for defining active-site 
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geometry in a new protein scaffold.   One shortcoming is that it may be difficult to 
sample the many geometrical variations of a flexible hydrogen-bonding interaction.  For 
example, the 972 variations in guanidino-carboxylate contact geometry sampled in the 
chorismate mutase case are probably adequate to reflect flexibility in this relatively rigid 
dual hydrogen-bonding interaction.  A less-restrained interaction, however, such as a 
serine hydrogen bonding with a sterically unrestricted ligand carbonyl oxygen, results in 
a compromise between maintaining a manageable calculation size and modeling contact 
flexibility.  One solution is to use a targeted method to find an initial ligand position 
within the binding site and then, in a second calculation, optimize both active-site 
packing and fine rotational and translational placement of the ligand.  
  
Sequence Design 
 The computational tests described in the previous sections were designed to 
evaluate the effects of calculation parameters on recovery of native enzyme geometries, 
and the design of active-site residues was limited to catalytic side chains.  However, the 
general procedure described here is equally amenable to full active-site design 
calculations.   
 In previously published work, 18 active site residues of E. coli chorismate mutase 
were redesigned simultaneously with rotational and translational relaxation of the 
transition-state structure from the starting crystallographic position.28  The six predicted 
mutations were experimentally investigated and some were found to confer increased 
catalytic efficiency28 or thermostability. A detrimental mutation predicted in the study 
underscored the importance of continued work on energy functions.  In the calculation 
that motivated this experimental work, the initial starting position of the small molecule 
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was taken from the crystal structure and a limited degree of rotational and translational 
optimization was employed.   
 We performed a test calculation to demonstrate that small molecules can be 
placed simultaneously with full active-site sidechain optimization, without reference to 
any known starting position.  In a sample calculation using E. coli chorismate mutase, the 
targeted placement method was used to identify 107 small molecule variations.  In this 
example, after the geometric pruning step and elimination of variants with backbone 
steric clashes, 155 small molecule variations remained.  These variants were evaluated 
combinatorially with ten different side chain identities in twelve active-site positions.   
Using FASTER for optimization, the calculation took approximately 9 hours to complete 
on a 16-processor cluster with about 70% of the total calculation time consumed in 
calculating a surface-area-based solvation term.    
 
Conclusions 
 The described procedures allow the incorporation of small molecule placement 
directly into sequence design calculations.  The test calculations performed suggest that 
the results of computational enzyme design processes can be quite sensitive to calculation 
parameters including the rotamer library used and the coarseness of ligand positioning.  
These results emphasize that the conformational space of a calculation must be explored 
before meaningful conclusions can be reached about energy functions.      
 Given that we still have much to learn about the complex relationship between 
protein structure and catalytic activity,29,30 luck and choice of system may continue to 
play a role in the success of de novo computational enzyme design efforts for some time.  
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However, the power of computational enzyme design to stringently evaluate our 
understanding of the energetics of catalysis should not be overlooked.  Experimental 
feedback gained from both successful and unsuccessful designs will make it possible to 
critically examine energy functions for modeling active sites.  Employing quality 
transition-state structures derived from ab initio calculations and experimental evidence 
will help computational design experiments to provide more meaningful information 
about the effectiveness of energy functions.  The use of large sidechain structural libraries 
and fine movements of transition-state structures will help to reduce errors from 
conformational sampling.  Backbone relaxation and multi-state design will offer other 
important tools to improve the value of design calculations.  Finally, the construction of 
gene libraries or large numbers of computationally designed variants has great potential 
for overcoming the shortcomings of enzyme design models,31 but results from these 
experiments will be most useful for furthering our understanding of catalysis and design 
if both active and inactive variants are reported.  By critically evaluating current methods 
for computational enzyme design, we will move closer to a deeper and more practically 
useful understanding of the sequence determinants of enzyme activity in the future. 
 
 
 
 
 
 
Methods 
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Structures and charges 
 PDB files were used without minimization (E. coli chorismate mutase,32 1ecm; S. 
avidinii streptavidin,33 1mk5; S. cerevisiae triosephosphate isomerase,34 1ney).  
Hydrogens were added with REDUCE.35 
 A library of ligand internal conformations was created for each system as follows.  
Chorismate mutase:  An HF/6-31G* ab initio transition-state structure36 was used with 
only one variation—the O4 hydroxyl proton was allowed to occupy three positions, 60°, 
180°, and -35°, defined by the H-C-O-H dihedral angle.  The minima in a torsional 
profile at the HF/6-31G* level were at approximately 180° and -35°, and 60° was 
included as an option because hydrogen-bonding patterns in chorismate mutases from 
other species suggested population of that region of torsional space.  Streptavidin:  Four 
rotatable bonds in biotin were allowed to occupy three positions each (60°, -60°, 180° for 
sp3-sp3 bonds and 30°, 90°, 150° for the symmetric carboxylate group).  Thirty-four 
conformations were excluded because of high internal energy calculated using the van 
der Waals component of the DREIDING force field.37  Triosephosphate isomerase:  The 
pdb structure used was the Michaelis complex with the substrate dihydroxyacetone 
phosphate.  In ground-state dihydroxyacetone phosphate, two rotatable bonds (defined by 
the P-O-C-C and C-C-O-H dihedral angle) were allowed to occupy three positions each 
(60°, -60°, 180°).  Three conformations were excluded because of high internal 
DREIDING van der Waals energy.  
 Ligand atomic charges were obtained by fitting charges to electrostatic potential 
from HF/6-31G* single-point energy calculations using the transition-state structure 
(chorismate mutase) or crystallographic ground-state structure (biotin, dihydroxyacetone 
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phosphate).   Ab initio calculations and charge determinations were performed using 
Spartan (Wavefunction, Inc.) or Jaguar (Schrödinger, Inc.). 
 
Sidechain rotamer libraries 
 Standard backbone-dependent and backbone-independent rotamer libraries were 
used with expansion by one standard deviation about χ1 and χ2.17 
 Crystallographic conformer libraries were prepared using coordinates from 
149,813 side chains selected from 1,011 unique structures.  A clustering algorithm was 
developed based on ideas described by Shetty et al20 and is described briefly here. Every 
sidechain conformation from the raw data set is assigned to exactly one cluster.  Each 
cluster is represented by the centroid, which is the member with coordinates closest to the 
average coordinates of all cluster members.  A conformer library consists of a list of all 
of the cluster representatives and their coordinates. In our clustering algorithm, clusters  
are assigned through discrete clustering moves:  Switch allows a single raw conformer to 
leave one cluster and join another; Merge combines two clusters into one; Split allows a 
raw conformer to start a new cluster on its own.  These moves are depicted in Figure 2-5.   
 RMSDs between pairs of conformers are compared to determine whether or not to 
apply a particular move. Switch is applied so that each raw conformer is a member of the 
cluster whose centroid is closest to it.  Merge and Split are applied based on the value of 
the clustering parameter p: two clusters are merged if their centroids are within p of each 
other, whereas a conformer splits off and starts a new cluster if the closest centroid of any 
existing cluster is farther than p from it. The clustering moves are applied as follows until 
the number of clusters converges: 
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1. Start with a small number of clusters (1 was used in this work), and randomly 
assign a single raw conformer to each as the sole member and cluster 
representative.  
2. Assign each raw conformer in the data set to the cluster whose centroid is closest. 
3. While the number of clusters is not converged: 
a. Iteratively attempt to Merge pairs of clusters until no cluster can be further 
merged.   
b. For each conformer C: 
i. Measure the distance d between C and the centroid of every 
existing cluster. 
ii. If the distance d to the closest cluster centroid is greater than p, 
Split C off as its own cluster. 
iii. Else, Switch C to the closest cluster. 
iv. Recompute the centroid for every cluster that has changed 
membership. 
 
 
 The algorithm allows the construction of both backbone-dependent and backbone-
independent libraries to custom sizes by using clustering factor p to define the desired 
degree of similarity between independent conformers.  In this work, clustering factors of 
0.3 Å and 1.0 Å were used for backbone-dependent and backbone-independent rotamer 
libraries, respectively.   
 For all calculation types, conformer libraries were smaller than the standard 
rotamer libraries.  As an example, the number of sidechain conformations for the 
chorismate mutase calculations described in Table 2-3 were as follows:  backbone-
independent rotamer, 14229; backbone-independent conformer, 5955; backbone-
dependent rotamer, 7945; and backbone-dependent conformer, 5539.  
 
Calculation parameters 
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 All non-Gly, non-Pro residues reasonably within the natural active sites were 
included in calculations.  Residues with any atom within a 5 Å radius from any atom in 
the crystallographic ligands were included, less those residues separated from the natural 
ligand by backbone elements and plus a few adjacent residues not within the 5 Å cutoff.  
The positions designed were (all in chain A unless otherwise designated): chorismate 
mutase, 28, 32, 35, 39, 46, 47, 48, 51, 52, 55, 81, 84, 85, 88, 7B, 11B, 14B, 18B; 
streptavidin, 23, 24, 25, 27, 43, 45, 46, 47, 49, 50, 79, 86, 88, 90, 92, 108, 110, 112, 128, 
130; and triosephosphate isomerase, 10, 12, 95, 97, 165, 170, 211, 230. 
 In ligand placement test cases, designed residues were restricted to ligand-
contacting residues or alanine as follows: Arg, Lys, Gln, Glu, or Ala in chorismate 
mutase; Ser, Asn, Tyr, Asp, or Ala in streptavidin, and Glu, His, Lys, or Ala in 
triosephosphate isomerase.  Four calculations on triosephosphate isomerase were run as 
smaller component calculations, as indicated in Table 2-2, because of prohibitive size as 
a single calculation.    
 
Energy functions and optimization 
 Energy functions included scaled van der Waals,21 hydrogen-bonding, and 
electrostatic terms.22 A surface-area-based solvation potential23 was used in sequence 
design calculations but not for ligand placement, where solvation energy would have 
been heavily outweighed by geometric considerations.  Sequences were optimized with 
respect to the energy function using FASTER25,26 or HERO.27  On occasion, a top-ranked 
sequence contained more than one instance of a given specified geometric contact, owing 
to the energy benefit applied for these contacts.  In these cases, Monte Carlo38,39 was used 
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to sample around the global minimum energy sequence and the top-ranked sequence with 
a single instance of each geometric contact was reported. 
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Table 2-1.  RMSD and number of wild-type contacts as a function of rotational step 
size and rotamer librarya,b 
 
Chorismate Mutase     
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - - 0.61 ± 0.03 (4.0) 0.55 ± 0.05 (4.0) 0.47 ± 0.04 (4.7) 
   with xtal rotamers - - 0.61 ± 0.03 (4.0) 0.55 ± 0.05 (4.0) 0.47 ± 0.04 (4.7) 
Rotamer: bb-ind - - 3.88 ± 0.37 (0.0) 2.88 ± 1.44 (0.0) 3.01 ± 1.61 (0.0) 
   with xtal rotamers - - 1.57 ± 1.70 (2.7) 0.51 ± 0.00 (4.0) 0.52 ± 0.01 (4.0) 
Conformer: bb-dep - - 3.66 ± 0.11 (1.0) 3.59 ± 0.08 (1.0) 3.60 ± 0.09 (1.0) 
   with xtal rotamers - 1.67 ± 1.78 (3.3) 1.57 ± 1.83 (3.7) 0.60 ± 0.08 (4.3) 0.54 ± 0.06 (5.0) 
Rotamer: bb-dep - - - - - 
   with xtal rotamers - - - 0.49 ± 0.04 (4.3) 0.52 ± 0.01 (4.0) 
      
Streptavidin-Biotin      
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - - - - 0.27 ± 0.09 (5.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.20 ± 0.13 (5.0) 
Rotamer: bb-ind - - 0.77 ± 0.42 (2.3) 0.60 ± 0.14 (3.0) 0.60 ± 0.05 (2.7) 
   with xtal rotamers 0.37 ± 0.17 (5.0) 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.30 ± 0.17 (5.0) 
Conformer: bb-dep - - - 0.25 ± 0.12 (5.0) 0.20 ± 0.07 (5.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.22 ± 0.03 (5.0) 0.29 ± 0.09 (4.0) 
Rotamer: bb-dep - - - 0.82 ± 0.28 (2.3) 0.66 ± 0.02 (3.0) 
   with xtal rotamers - 0.24 ± 0.09 (5.0) 0.24 ± 0.07 (5.0) 0.26 ± 0.06 (5.0) 0.16 ± 0.06 (5.0) 
      
Triosephosphate Isomerase     
    Rotational step size   
Rotamer Libraryc 30° 20° 15° 10° 5° 
Conformer: bb-ind - 1.87 ± 1.07 (0.7) 3.59 ± 2.28 (1.0) 0.28 ± 0.07 (3.0) 0.24 ± 0.05 (3.0) 
   with xtal rotamers - 1.31 ± 0.29 (1.0) 1.95 ± 2.28 (1.3) 0.27 ± 0.06 (3.0) 0.15 ± 0.02 (3.0) 
Rotamer: bb-ind 5.09 ± 0.05 (0.3) 0.60 ± 0.12 (1.7) 0.55 ± 0.25 (2.3) 0.34 ± 0.04 (2.3) 0.25 ± 0.08 (3.0) 
   with xtal rotamers 5.06 ± 0.05 (0.3) 0.60 ± 0.12 (2.0) 0.37 ± 0.04 (3.0) 0.25 ± 0.04 (3.0) 0.15 ± 0.02 (3.0) 
Conformer: bb-dep - - - - - 
   with xtal rotamers - - - - 0.15 ± 0.02 (3.0) 
Rotamer: bb-dep 3.28 ± 0.73 (1.7) 0.60 ± 0.12 (1.7) 0.37 ± 0.05 (2.3) 0.31 ± 0.04 (2.3) 0.25 ± 0.08 (3.0) 
   with xtal rotamers 3.28 ± 0.73 (2.3) 0.60 ± 0.12 (2.3) 0.37 ± 0.05 (3.0) 0.29 ± 0.03 (3.0) 0.15 ± 0.02 (3.0) 
 
a  Dashes indicate that required contacts were not satisfied in at least one of three trials. 
b  Values are non-hydrogen-atom RMSD in Ångstroms relative to crystallographic ligands or bicyclic ring 
atom RMSD relative to crystallographic ligand for biotin (i.e., the pentanoic acid moiety was not 
considered in biotin RMSDs).  Averages and standard deviations from three random initial positions are 
reported.  Numbers in parentheses are the number of contacts where the amino acid position was the same 
as in the wild-type structure, averaged over the three trials.  Maximum possible number of wild-type 
contacts:  chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.   
c  bb-ind: backbone-independent, bb-dep: backbone-dependent.
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Table 2-2. RMSD and number of wild-type contacts as a function of rotational and 
translational step sizesa,b 
 
Chorismate mutase      
 Rotational step size  Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 1.69 ± 1.54 (2.3) 2.61 ± 1.67 (1.3) 0.77 ± 0.10 (4.3) 0.73 ± 0.02 (4.0) 0.61 ± 0.06 (4.7) 3 
0.5 0.91 ± 0.20 (3.7) 0.72 ± 0.07 (4.0) 0.83 ± 0.06 (3.3) 0.74 ± 0.05 (4.0) 0.60 ± 0.13 (4.3) 10 
0.4 2.02 ± 1.99 (2.3) 0.60 ± 0.04 (4.7) 0.59 ± 0.13 (4.0) 0.57 ± 0.12 (4.3) 0.53 ± 0.13 (4.3) 11 
0.3 1.73 ± 1.51 (2.3) 0.61 ± 0.07 (4.3) 0.62 ± 0.15 (4.3) 0.58 ± 0.07 (4.0) 0.65 ± 0.04 (4.0) 12 
0.2 1.71 ± 1.53 (2.3) 0.62 ± 0.10 (4.0) 0.60 ± 0.09 (4.0) 0.54 ± 0.07 (4.0) 0.56 ± 0.05 (4.0) 33 
       
Streptavidin-biotin      
 Rotational step size  Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 - 1.16 ± 0.60 (3.7) 1.67 ± 1.02 (3.7) 0.88 ± 0.44 (4.3) 0.84 ± 0.48 (4.3) 5 
0.5 2.05 ± 0.59 (1.7) 0.91 ± 0.44 (5.0) 0.84 ± 0.61 (5.0) 0.99 ± 0.91 (3.7) - 18 
0.4 1.32 ± 1.39 (3.7) 0.80 ± 0.09 (5.0) 0.67 ± 0.28 (5.0) 0.96 ± 0.72 (3.7) - 19 
0.3 0.63 ± 0.16 (5.0) 1.08 ± 0.49 (5.0) 0.57 ± 0.21 (5.0) 1.03 ± 0.48 (4.3) - 18 
0.2 0.60 ± 0.32 (5.0) 0.70 ± 0.34 (5.0) 0.80 ± 0.24 (5.0) - - - 
       
Triosephosphate isomerase      
 Rotational step size  Translational 
step size (Å) 30° 20° 15° 10° 5° 
Time 
(10°, 
hours)c 
0.6 3.80 ± 2.14 (0.3) 5.22 ± 0.32 (0.0) 1.29 ± 0.91 (1.3) 2.39 ± 2.54 (1.7) 2.40 ± 2.58 (2.0) 0.4 
0.5 3.92 ± 1.94 (0.0) 5.64 ± 0.45 (0.3) 4.47 ± 1.45 (0.0) 1.33 ± 1.01 (1.7) - 2 
0.4 3.13 ± 1.77 (0.3) 1.96 ± 1.05 (2.0) 0.47 ± 0.24 (1.7) 0.78 ± 0.66 (3.0) - 2 
0.3 3.44 ± 1.96 (0.3) 0.59 ± 0.18 (2.0) 0.60 ± 0.29 (2.3) 0.46 ± 0.11 (3.0) - 2 
0.2 2.33 ± 1.80 (0.7) 0.68 ± 0.10 (2.3) 0.49 ± 0.12 (3.0) 0.44 ± 0.11 (3.0) - 5 
 
a  Dashes indicate that required contacts were not satisfied in at least one of three trials or that the 
calculation was too large to complete. 
b  Values are non-hydrogen atom RMSD in Ångstroms relative to crystallographic ligands or bicyclic atom 
RMSD relative to crystallographic ligand for biotin (i.e. the pentanoic acid moiety was not considered in 
biotin RMSDs).  Averages and standard deviations from three random initial positions are reported.  
Numbers in parentheses are the number of contacts where the amino acid position was the same as in the 
wild-type structure, averaged over the three trials.  Maximum possible number of wild-type contacts:  
chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.  
c Wall clock time; calculations performed on a 16-processor cluster. 
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Table 2-3.  Results from targeted placement procedure as a function of rotamer 
library. 
 
Chorismate mutase    
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.88 0.60 (5) 16 
   with xtal rotamers 7.88 0.68 (3) 18 
Rotamer: bb-ind 8.18 3.61 (0) 51 
   with xtal rotamers 8.18 0.66 (4) 62 
Conformer: bb-dep 7.64 3.62 (1) 8 
   with xtal rotamers 7.64 0.68 (4) 9 
Rotamer: bb-dep 7.76 2.31 (1) 14 
   with xtal rotamers 7.76 0.66 (4) 16 
    
Streptavidin-biotin    
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.07 0.64 (5) 1.4 
   with xtal rotamers 7.07 0.64 (5) 1.4 
Rotamer: bb-ind 7.20 0.54 (4) 3.5 
   with xtal rotamers 7.20 0.34 (4) 3.4 
Conformer: bb-dep 6.35 0.37 (5) 0.2 
   with xtal rotamers 6.35 0.54 (4) 0.2 
Rotamer: bb-dep 7.17 3.50 (0) 2.6 
   with xtal rotamers 7.17 0.19 (5) 2.8 
    
Triosephosphate isomerase   
Rotamer librarya 
log(initial ligand 
variations) 
RMSD (Å)b 
(WT contacts) 
Time 
(hours)c 
Conformer: bb-ind 7.31 0.49 (3) 1.3 
   with xtal rotamers 7.31 0.49 (3) 1.3 
Rotamer: bb-ind 7.78 0.46 (3) 8.7d 
   with xtal rotamers 7.78 0.46 (3) 8.7d 
Conformer: bb-dep 6.82 7.51 (0) 0.3 
   with xtal rotamers 6.82 0.78 (3) 0.3 
Rotamer: bb-dep 7.58 0.51 (3) 4.3d 
   with xtal rotamers 7.58 0.51 (3) 4.9d 
a  bb-ind, backbone-independent; bb-dep, backbone-dependent. 
b  RMSDs calculated as described in Table 2-1.  Maximum possible number of wild-type contacts:  
chorismate mutase, 5; streptavidin, 5; triosephosphate isomerase, 3.  
c  Wall clock time; calculations performed on a 16-processor cluster. 
d  Calculation was performed as a series of smaller calculations. 
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Figure 2-2.  Sample results from test calculations presented in Table 2-1.  
Crystallographic side chains and ligands are shown in gray.  Results from three trials 
using different initial random rotational positions are shown in red, teal, and orange.  In 
cases where three colors are not visible, the selected rotamers from two or more 
calculations were identical.  Results are shown from calculations with 5° rotation and the 
backbone-independent conformer library. (A) Chorismate mutase.  An alternate backbone 
position was chosen for a glutamate-hydroxyl contact in one trial (red side chain, lower 
left). (B) Biotin in streptavidin.  Note that the biotin pentanoic acid moiety samples 
different conformations in the calculation and the surrounding side chains were not 
designed. (C) Triosephosphate isomerase. 
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Figure 2-3.  Effect of rotational and translational step sizes.  Each spot represents the 
average of three trials with initial random starting positions.  Missing points indicate that 
one or more trials could not identify wild-type-like contacts or else that the calculation 
was prohibitively large; no calculations were performed using a 25° rotational step size.  
Colors indicate non-hydrogen atom RMSD as described in the tables.  (A) Chorismate 
mutase (min., 0.53 Å; max., 2.61 Å),  (B) Streptavidin-biotin (min., 0.57 Å; max., 2.05 
Å), (C) triosephosphate isomerase (min., 0.44 Å; max., 5.64 Å). 
 
 
 
 
 
 
Figure 2-4.  Targeted placement procedure.  For a given side chain rotamer, small 
molecule ligands are placed such that they are able to meet specified geometric criteria.  
This is repeated for every possible conformation of the amino acid at every designed 
position.  Shown is a subset of orientations of a chorismate mutase transition-state 
structure in contact with one conformation of arginine. 
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Figure 2-5.  The three clustering moves are illustrated by showing the state of a 
sample system before and after the move is performed.  Each dot represents a single 
sidechain conformation taken from the PDB.  Distances represent sidechain RMSDs 
between pairs of conformers. Dots sequestered together by a dashed line and colored the 
same are members of the same cluster.  Darker-colored dots denote cluster 
representatives.   
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Chapter III 
 
 
Towards the computational design of a Kemp elimination enzyme 
and investigation of an inactive design  
 
 
A majority of the experimental work described in this chapter was performed in the Mayo 
laboratory.  Dr. Leonard Thomas of the Caltech Molecular Observatory solved and 
refined the crystal structure of HG-1 and Gert Kiss of the Houk lab (UCLA) carried out 
the molecular dynamics simulations. 
 
 
 
Abstract   
A general method for the de novo design of enzymatic activity has long been a 
major goal in computational protein design.  Previous de novo enzyme design efforts 
placed little, if any, emphasis on the analysis of inactive designs, and the highly active 
designed enzymes that were recently reported were identified through the synthesis and 
screening of a large number of designs.  Here, we describe an iterative method for the 
computational design of enzymes that combines computational enzyme design techniques 
with molecular dynamics simulations and crystallographic analysis of inactive designs.  
We used these methods to design and analyze an inactive design for the catalysis of the 
Kemp elimination, which helped us to understand the causes of our design’s inactivity, 
including excessive solvent exposure and active site flexibility.  We then applied this 
information to adjust our design procedure for future rounds of design. 
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Introduction 
In early incarnations of computational protein design methodology, the strategy 
for software development was put forth in terms of the so called “protein design cycle” 
(Figure 1-1) where the experimental evaluation of an initial design is used to inform the 
adjustment of the design process for further rounds of designs.1,2  These steps would 
ideally be continued iteratively until the protein sequences predicted by the algorithm 
have the desired characteristics.  However, there is little evidence that this strategy has 
actually been used outside of force-field parameterization purposes,1,3-5 and most inactive 
proteins from subsequent design efforts were likely discarded without comment or further 
investigation into the cause of the inactivity.  This is unfortunate because little 
information can be gained from such an approach to protein design.  Without detailed 
analysis of failed designs, flaws in the design procedure cannot be identified and adjusted 
to produce designed proteins with the desired characteristics. 
Despite the lack of the type of systematic approach described above, the field of 
computational enzyme design has seen some success in the past ten years.  The first 
successful computational introduction of de novo enzymatic activity into an inert scaffold 
was a protozyme, which catalyzed the hydrolysis of an activated ester with a very small 
rate enhancement (kcat/kuncat of about 102).6  Additional incremental advances were made 
with the design of metalloenzymes and computationally designed changes in enzyme 
specificity.7-9  In 2008, a breakthrough in de novo computational enzyme design came 
when the Rosetta protein design software was used to introduce catalytic activity for two 
distinct chemical reactions into a variety of inert scaffolds.10,11  The reaction rates of 
these designed enzymes are impressive, but still well below those of natural enzymes.  
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Directed evolution was subsequently used to substantially increase the kcat/Km and the rate 
enhancement of one of the active designs.11 
The synthesis and experimental evaluation of each potential enzyme is expensive 
both in terms of time and money.  In the case of the enzymes designed by Röthlisberger 
et al., over 70 individual designs, which were predicted to be active by their protein 
design methodology, were screened in order to identify 8 active enzymes.11  While their 
methodology was successful in terms of producing active enzymes, the necessity of a 
“shotgun” approach suggests an incomplete understanding of some details of the 
enzymatic system and/or inaccurate modeling by the protein design algorithm.  
Here, we focused on the development of a single design to rigorously test our 
understanding of enzymatic catalysis and the applicability of the protein design cycle to 
de novo enzyme design problems.  To this end, we used our protein design software, 
ORBIT, in an attempt to design a catalyst for a model chemical system, the Kemp 
elimination (Figure 1-2).  These methods resulted in a design called HG-1, which showed 
no Kemp elimination activity.  In collaboration with the Houk lab at UCLA and the 
Molecular Observatory at Caltech, molecular dynamics simulations and crystallographic 
techniques were used to identify the possible sources of the inactivity, and a plan for 
future redesigns of the protein to create an active Kemp elimination enzyme was outlined. 
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Materials and Methods 
Transitions state (TS) structure 
Our TS structure was previously calculated ab initio12 using the partial atomic 
charges used listed in Table 3-1.  To assist with defining geometric constraints in the 
calculations, a pseudoatom named PSA with no charge and a negligible radius was added 
0.01 Å from H3 in the plane of the TS.  The final TS structure is shown in Figure 3-1 
along with the atom names. 
 
Scaffold selection 
For the initial design, the xylanase from the thermophilic fungus T. aurantiacus 
(TAX) was chosen as the scaffold.  TAX has a (α/β)8-barrel fold with a large, solvent-
exposed active site.  The crystal structure (PDB code: 1GOR) is 1.7 Å resolution with 
xylobiose bound in the active site.13  The structure from the PDB was used without 
minimization and hydrogens were added with Molprobity.14 
 
Active site search  
All non-Pro positions within 5 Å of xylobiose in 1GOR were designated as design 
positions (residues 50, 83, 84, 87, 90, 130, 172, 207, 209, 267, and 275).  Catalytic 
positions were defined as all of the carboxylate residues within 5 Å of xylobiose in 
1GOR (E46, E131, and E237).  All design positions were allowed to sample all 
conformations of Gly, His, Phe, Trp, Ser, Thr, and Tyr.  Catalytic positions were allowed 
to sample all conformations of Glu and Asp.  A backbone-independent conformer library 
was used to approximate sidechain flexibility.15  As described in Chapter II, a library of 
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TS poses was generated in the active site by targeted ligand placement in which a defined 
set of ligand structures is built with respect to each conformation of the general base 
(Asp/Glu) at each catalytic position.  The contact geometries that represent this set of 
ligand poses are listed in Table 3-2.  After the generation of ligand poses, interaction 
energies were calculated, and TS-sidechain interaction energies were then biased to favor 
interactions that satisfy the geometric constraints in Table 3-3.  An additional energy-
biasing step was carried out to favor the hydrogen bond interactions to the base that were 
required (Table 3-4).  The energy calculation and energy biasing steps are described in 
detail in Chapter II. 
 
Active site repacking 
 For the repacking calculation, the initial TS position was taken from the results of 
the active site search.  From this initial position, the TS structure was translated ± 0.2 Å 
in x, y, and z in 0.1 Å steps and rotated 5° in each direction in 2.5° steps.  The geometric 
constraints from Tables 3-3 and 3-4 were applied to enforce the contacts between the TS 
and each of the three catalytic residues identified in the active site search (Y90, E237, 
and W275) as well as between E237, and H209.  Positions 83 and 239, which are 
positioned such that they could be members of a potential hydrogen bond network with 
E237 were allowed to sample all conformations of all residues except for Cys and Pro.  
All other positions that clashed with the TS or catalytic residues including 21, 46, 87, 89, 
and 267 were allowed to sample all conformations of any non-polar residue. 
Lazaridis-Karplus occlusion-based solvation16 was applied with a scale factor of 
1.0 for nonpolar burial and nonpolar exposure and a scale factor of 0.6 for polar burial.  
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Other standard ORBIT parameters were applied as in Lassila et al., and a backbone-
independent conformer library was used to represent sidechain flexibility.15  As in the 
active site search, sidechain-TS interaction energies were biased to favor those contacts 
that satisfy the geometries in Tables 3-3 and 3-4.  Sequence optimization was carried out 
with FASTER,17,18 and a Monte Carlo-based algorithm19,20 was used to sample sequences 
around the minimum energy conformation identified by FASTER (FMEC). 
 
Hydrophobic active site repacking 
This repacking calculation was similar to the previous active site repacking 
described above.  All polar residues within the active site that were not directly 
contacting the base were designed and restricted to sampling conformations of 
hydrophobic residues only (Ala, Val, Leu, Ile, Phe, Tyr, Trp, and Met).  Residues 46, 47, 
84, 87, 89, 130, 131, 207, and 267 were allowed to sample all conformations of Ala, Val, 
Leu, Ile, Phe, Tyr, and Trp.  In addition, residues 83, 21, and 50 were also allowed to 
sample conformations of Met.   
 
Gene synthesis and cloning 
The gene for TAX was back-translated from the protein sequence using the codon 
usage bias of E. coli in DNA 2.0.21  The DNA sequence for a Factor Xa cleavage site and 
six-histidine purification tag were added to the 3′ end of the gene.  Overlapping 
oligonucleotides spanning the gene sequence and flanking primers were designed using 
the Assembly PCR Oligo Maker web server.22  The basic melting temperature calculation 
method was used along with a 50 mM cation concentration, a DNA concentration of 0.5 
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µM, maximum oligo length of 40, a 55°C annealing temperature, and a 40°C acceptable 
overlap Tm.  The resulting oligonucleotides were 31-41 base pairs in length and the full-
length gene was constructed by recursive PCR of the overlapping oligonucleotides using 
a method based on the one described by Stemmer et al.23 
A primer mix was made by combining 2 µL each of the oligonucleotide primers, 
which had been diluted to 10 µM in H2O.  The 50 µL gene assembly reactions contained 
5 µL 10x KOD buffer (Applied Biosystems), 1 mM MgCl2 (Applied Biosystems), 0.2 
mM dNTP mix (Novagen), 2.5 U KOD hot start (Applied Biosystems), and 10 µL of the 
primer mix.  Gene amplification was carried out in 50 µL reactions containing 1 µL of 
the assembly reaction, 5 µL 10x KOD buffer (Applied Biosystems), 1 mM MgCl2 
(Applied Biosystems), 0.2 mM dNTP mix (Novagen), 2.5 U KOD hot start (Applied 
Biosystems), and 1 µM of the forward and reverse flanking primers.  The reactions were 
carried out on Mastercycler Personal Thermocycler (Eppendorf) using the temperature 
program described in Table 3-5. 
 After amplification, the reactions were purified with a QIAquik PCR Purification 
Kit (Qiagen) then digested with BamHI and NdeI (New England Biolabs).  The digested 
genes were then run on a 1% agarose gel, extracted and purified using a QIAquik Gel 
Extraction Kit (Qiagen), and ligated into similarly digested pET11a vector (Novagen). 
 
Site-directed mutagenesis 
Mutagenesis primers were designed using the rules outlined in the Site-Directed 
Mutagenesis Kit (Stratagene).  Primer melting temperatures were calculated using 
Equation 3-1: 
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! 
Tm = 81.5 + 0.41(%GC) "
675
N
"%mismatch  .         [Equation 3-1] 
Mutagenesis primers were phosphorylated in 50 µL reactions containing 5 µL 10x T4-
ligase buffer (New England Biolabs), 4 µg primer, and 10 units T4-polynucleotide kinase 
(New England Biolabs).  Phosphorylation reactions were incubated at 37°C for 2 hours.  
Mutants were created using a protocol modified from the QuickChange Multi Site-
Directed Mutagenesis Kit (Stratagene).  Each 50 µL site-directed mutagenesis reactions 
contained 50 ng template, 120 ng of each phosphorylated mutagenesis primer, 3 µL each 
10x Pfu Turbo buffer, 3 µL 10 x Taq ligase buffer (New England Biolabs), 2 mM dNTP 
mix (Stratagene), 2.5 U Pfu Turbo (Stratagene), and 40 U Taq DNA ligase (New England 
Biolabs).  PCR was carried out on Mastercycler Personal Thermocycler (Eppendorf) 
using the temperature program described in Table 3-5. 
 
Protein expression and purification 
TAX and HG-1 were expressed in BL-21 (DE3) E. coli cells in LB with 
ampicillin.  30 mL starter cultures were grown overnight at 37°C and then used to 
innoculate 1L cultures.  The cells were grown with shaking at 37°C until OD600 ~ 0.3 and 
were then grown at 25°C until OD600 ~ 0.6.  Expression was induced with 1 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) and carried out at 25°C for 12-18 hours.  
Cells were harvested by centrifugation and were resuspended in 30 mL buffer 1 (20 mM 
Tris pH 7.4, 300 mM NaCl, 10 mM imidazole).  10 mM MgCl2, ribonuclease A, and 
deoxyribonuclease I (Stratagene) and the cells were lysed mechanically with an 
Emulsiflex-C5 (Avestin).  The soluble fraction was incubated for ~ 1 hour with 3 mL Ni-
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NTA resin (Qiagen) that had been equilibrated with 10 bed volumes of buffer 1.  The 
resin was washed in a gravity column with 10 bed volumes of buffer 2 (20 mM Tris pH 
7.4, 300 mM NaCl, 20 mM imidazole) and HG-1 was eluted with 3 bed volumes of 
buffer 3 (20 mM Tris pH 7.4, 300 mM NaCl, 250 mM imidazole).  The eluate was 
concentrated using Amicon 10,000 MWCO centrifugal concentrators (Millipore) and the 
buffer was exchanged to 50 mM sodium citrate, 150 mM NaCl pH 5.5 using PD-10 
desalting columns (GE). 
 
Protein characterization 
The molecular weights of all proteins were confirmed by electrospray mass 
spectrometry at the Protein/Peptide MicroAnalytical Laboratory (PPMAL) at Caltech.  
The secondary structure and stability of the proteins were characterized by circular 
dichrosim (CD) spectroscopy with an Aviv 62DS spectrometer equipped with a 
thermoelectric temperature controller.  All CD experiments were carried out in a 1 mm 
cuvette with 10 µM protein in 50 mM MES pH 5.5, 100 mM NaCl, or 50 mM potassium 
phosphate, 100 mM NaCl pH 7.5.  Wavelength scans were performed at 25°C with 3 sec 
of averaging at each point.  Thermal denaturation was monitored at 222 nm from 4°C to 
98°C with 1°C temperature steps, 2 min of temperature equilibration time, and 30 sec of 
averaging.  Apparent midpoints of thermal denaturation (Tm) were obtained using the 
equation of Minor and Kim.24  Tm values should be considered approximate and not 
actual thermodynamic parameters, as the denaturation was not reversible in any case 
tested.  
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Substrate synthesis and purification 
 5-nitrobenzisoxazole was synthesized as described.25  Briefly, 3.5 g benzisoxazole 
(Alfa Aesar) was added to 15 mL concentrated H2SO4 cooled in an ice water bath.  2 mL 
of concentrated HNO3 was added dropwise to the mixture.  Nitrification was carried out 
for 30 min with stirring at 0°C.  The reaction mixture was poured into 100 mL ice water 
and the yellow precipitate was filtered.  The solid was recrystalized three times from 60 
mL of warm absolute ethanol yielding long, colorless needles.  m.p.: 126 °C (lit.25 m.p. 
126-127°C). 
IR (CDCl3): ν =1620 (arom);1520, 1352 (NO2) cm-1 
1H-NMR (CDCl3): δ = 7.75 (d, 1H); 8.5 (dd, 1H); 8.75 (d, 1H); 8.9 (d, 1H) ppm 
MS: m/z = 163.1 (100%, M-), 133.0 (47%, M- - NO), 117.9 (7%. M- - NO2) 
 
Nuclear magnetic resonance (NMR) analysis was performed on a Varian Mercury 300 
MHz machine and IR spectra were recorded using a Perkin-Elmer Spectrum BX 
spectrometer.  Electrospray mass spectrometry was performed at PPMAL (Caltech). 
 
Kinetic measurements 
The production of the phenolate product (Figure 1-2) was monitored at 405 nm 
using a Shimadzu UV-1601 spectrophotometer equipped with a temperature-controlled 
cell holder.  A 40 mM stock of 5-nitrobensoxazole was made in acetonitrile and stored at  
-20°C.  Assays were carried out with 250 µM protein in 40 mM buffer, 100 mM NaCl at 
20°C and 37°C. 
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Crystallization conditions 
Crystallization conditions were set up by hand in 24-well hanging drop plates 
using 2.0 × 2.0 µL drops and Index, Crystal 1, and Crystal 2 screens (Hampton Research) 
as well as a variety of custom screens using conditions similar to the crystallization 
conditions for 1GOR.13  The protein sample contained 10 mg/mL HG-1 in 50 mM 
sodium citrate pH 5.5, 100 mM NaCl.  A single large crystal (~ 0.5 mm) with multiple 
protrusions was found in buffer containing 0.8 M posassium-sodium tartrate, 0.1 M Tris 
pH 8.5, 0.5% PEG-MME 5000.  A smaller single crystal (~ 0.1 mm) was identified in 
100 mM sodium phosphate pH 6.5, 12% PEG-600. 
 
X-ray diffraction data collection and refinement 
The spikes projecting off the 0.5 mm crystal were broken off for diffraction 
screening.  The best diffraction was obtained from a crystal cryoprotected in the reservoir 
solution (0.8 M posassium-sodium tartrate, 0.1 M Tris pH 8.5, 0.5% PEG-MME 5000) 
with 15% ethylene glycol. 
Data were collected using a MicroMax-007HF X-ray generator with a RAXIS 
IV++ detector (Rigaku Corp.)  All data were processed using CrystalClear (Rigaku 
Corp.) and Mosflm.26  The indexed and scaled data were further evaluated using CCP4.27  
Molecular replacement was carried out using Phaser version 1.3.328 and 1GOR as the 
starting model.13  Further refinement was performed with Coot29 and Refmac.30 
 
Molecular dynamics (MD) simulations 
 MD simulations were carried out for 20 ns for each enzyme-substrate complex at 
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NPT conditions (constant number of particles, pressure, and temperature) with a pressure 
of 1 bar and temperature of 300 K.  The TIP3P explicit solvent model31 was used to 
solvate the protein in an octahedral-shaped volume, ensuring a solvent layer of at least 10 
Å from any point of the protein surface.  Each face of the octahedral box is connected to 
a mirror image of itself, which allows the system to be treated with periodic boundary 
conditions: when a water molecule “escapes” the original octahedral box, it re-enters 
from the opposite face of that same box.  This ensures equilibration through diffusion, 
while the number of particles is kept constant.  The temperature is regulated and evenly 
distributed through a Langevin equilibration scheme.  The benzisoxazole substrate was 
parameterized from quantum mechanical calculations in order to be treated correctly by 
the AMBER force field.32  Prior to production MD, the geometry of the X-ray-based 
structure was optimized and slowly heated to 300 K over a time period of 300 ps at NVT 
conditions, and then equilibrated at NPT conditions for 2 ns. 
 
 
Results and Discussion 
Design procedure 
TS theory suggests that natural enzymes achieve their large rate accelerations 
through preferential stabilization of the TS.33  Thus, our computational enzyme design 
strategy is based on a TS or high-energy intermediate structure and the active site 
residues are chosen for their ability to stabilize the TS as well as participate in the 
reaction chemistry.15 
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As mentioned in Chapter I, our computational protein design software was 
optimized for stabilizing small proteins and required adaptation to the unique 
requirements of enzymatic catalysis.15  Specifically, the interactions that are predicted to 
stabilize the TS were to be enforced through geometric requirements and the positioning 
of the TS was varied systematically within the binding pocket during the sequence 
optimization.  The details of this design methodology are described in Chapter II. 
 The catalytic contacts that were predicted to stabilize the Kemp elimination (KE) 
TS are shown in Figure 3-2.  These contacts were inspired by the catalytic residues 
observed in the catalytic antibody 34E4 (Figure 1-3).  A carboxylate-containing residue 
was chosen as a general base in analogy to the Glu that was determined to be the general 
base in the catalytic antibody 34E4.34  In addition, a carboxylate base avoids problems 
with the protonation state variations of His and the large number of rotameric states of 
Lys.  A π-stacking residue was required to facilitate electron delocalization within the 
TS.  A hydroxyl group was added to stabilize the negative charge that develops on the 
benzisoxazole oxygen in the TS.12  No analogous hydrogen bond donor is observed in the 
catalytic antibody, although water is postulated to fill this role.34  During the course of 
this study, a similar active site arrangement was used by Röthlisberger et al. to obtain 
active KE enzymes.11 
In addition to the direct contacts to the TS, a supporting contact to the general 
base was also required to stabilize its conformation.  As shown in Figure 3-3, this contact 
is a hydrogen bond to the general base from a His (Hie and Hid are His residues, which 
are protonated at Nε or Nδ, respectively), Glu, or Asp residue.  This contact was required 
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through a second, separate geometry-biasing step.  The geometric definitions for the three 
catalytic contacts and the additional base contact are shown in Table 3-2. 
 
Active site search 
The active site search resulted in multiple possible active site configurations that 
satisfied all four of the required contacts.  The active sites were assessed visually and 
active site 1-2 was chosen for repacking (Figure 3-4A).  In 1-2, the general base is a wild-
type Glu at position 237 that is in a conformation similar to that seen in the crystal 
structure.  The base is held in place by a wild-type His at position 209 that preserves a 
contact seen in the crystal structure of the wild-type TAX.  A wild-type Trp at position 
275 makes a stacking contact to the TS and is in its crystallographic conformation.  
Finally, the hydrogen bond contact is fulfilled by a Tyr at position 90. 
 
Active site repacking 
 The active site repacking calculation resulted in a seven-fold mutant called HG-1 
(Figure 3-4B).  This design features an extensive hydrogen bond network supporting the 
conformation of the base, E237, which is similar to the hydrogen bond network 
surrounding E237 in the wild-type protein.  In the crystal structure of TAX, His209 
makes a bridging contact between Glu237 and Asp239, indicating that it is in its fully 
protonated state which would also serve to stabilize the negative charge on both 
carboxylates.  As a result, the pKa of Glu237 is probably quite low.  This bridging 
contact is part of a larger hydrogen bond network that includes the indole of Trp275.  
One difference between the hydrogen bond network in the design and the one in TAX is 
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the D127N mutation, which should help to ensure that H209 is not positively charged, 
thus stabilizing the protonated form of E237 and increasing its pKa.  The pKa of E237 
was predicted to be 7.1 by PROPKA,35 which may be sufficient for proton abstraction 
from the substrate. 
Other mutations in the active site include W267A, W87G, A21M, E46M, and 
S89F (Figure 3-4B), which were introduced to make room in the pocket for substrate 
binding and to pack tightly around the substrate once it is bound. 
 
HG-1 activity assays 
HG-1 showed no KE activity over background under any of the conditions tested 
(pH 5.0-9.0, 20-37°C) (Figure 3-5).  Analysis by circular dichroism (CD) spectroscopy 
showed that the protein had similar secondary structure as the wild-type scaffold, 
indicating that the inactivity was not due to global unfolding or misfolding of the protein 
(Figure 3-6A).  The Tm for HG-1, also determined by CD, was about 10°C lower than the 
wild-type scaffold at pH 5.5 (Figure 3-6B).  At pH 7.5, an additional 10°C decrease in 
melting temperature was seen compared to wild-type TAX at pH 5.5.  However, the HG-
1 was fully folded at all of the temperatures and pHs tested at which KE activity was 
assayed.  Single and double mutants of HG-1 were also tested including N239D, 
N239D/M46A, and M46A.  No rate acceleration was seen for any of these variants above 
the scaffold-catalyzed reaction. 
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HG-1 crystal structure 
In an effort to understand the source of the inactivity of HG-1, we crystallized and 
solved the crystal structure of HG-1 to a resolution of 2.0 Å in collaboration with the 
Molecular Observatory at Caltech (Table 3-6).  The overall RMSD of HG-1 with respect 
to the scaffold is 0.36 Å, confirming that the overall fold has been maintained (Figure 3-
7A). 
The structure fits well to the electron density as shown in Figure 3-7B.  One 
concern with using molecular replacement (MR) to calculate the phases is potential bias 
from the template structure 1GOR.  As shown in Figure 3-8, the electron density around 
the mutated positions is well-defined and shows no signs of the wild-type amino acid, 
indicating little bias. 
The active site residues of HG-1, including the base, the hydrogen bond donor, 
and most of the hydrogen bond network, overlay well with the conformations predicted 
by ORBIT (Figure 3-9).  The largest deviations of the active site residues from the design 
are in the π-stacking residue (W275), the associated Arg (R276) and N172, which acts as 
a hydrogen bond bridge between the indole of W275 and H209 (Figure 3-9B).  W275 and 
R276 are both rotated out of the active site with respect to the design, removing potential 
binding interactions with the substrate and exposing the active site to solvent.  In 
addition, N172 is rotated 90° from the predicted conformation, but it is unclear if this 
deviation is the cause for the conformation of W275. 
The crystal structure revealed the presence of six ordered water molecules in the 
active site of HG-1 (Figure 3-10), five of which must be displaced before substrate 
binding could occur.  The presence of these waters could result in a large desolvation 
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penalty, which could prevent substrate binding as well as a reduction the pKa of the base 
through stabilization of the anionic form. 
Overall, the crystal structure indicates that the active site configuration predicted 
by ORBIT is correct with the exception of N172, W275, and R276.  The flexibility of the 
active site, indicated by the deviation of W275 and the associated R276, could result in 
the loss of favorable binding interactions.  The movement of these residues could also 
expose the active site to solvent, further decreasing the energetic benefit of substrate 
binding.  Unfortunately, the crystal structure could not unambiguously identify the cause 
of the protein’s inactivity, but these two factors could be significant impediments to 
activity. 
 
MD simulations 
The hypothesis of active site flexibility and solvent exposure being the cause of 
the inactivity was supported by MD simulations carried out by Gert Kiss in the Houk lab 
at UCLA.  The design model of HG-1 with the substrate bound in the active site was used 
as the starting structure of the simulations.  Figure 3-11 shows that the substrate-protein 
complex exists predominantly in two states.  In state 1, the substrate is stably bound and 
maintains a substrate-base distance of about 3 Å.  In state 2, a major reorientation of the 
substrate occurs and the substrate exits the active site.  Closer analysis of the active site 
residues during the transition between state 1 and state 2 indicates that within 2 ns, R276 
flips away from the active site, followed by W275 at 5 ns.  The loss of these binding 
interactions seems to directly contribute to the reorientation and subsequent expulsion of 
the substrate from the active site around 7 ns.  In addition, solvent molecules moving 
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rapidly into and out of the active site preferentially interact with the base and other polar 
residues causing significant destabilization of the bound substrate, actually pushing it 
from the active site.  These results suggesting that the active site is very flexible near 
W275 and R276 and is occupied by a large number of solvent molecules agree with 
findings from the crystal structure of HG-1. 
 
Design of a more hydrophobic active site 
 The more hydrophobic design of HG-1 resulted in the sequence HG-1h, an eight-
fold mutant with respect to HG-1 (N47F, K50M, M64A, H83V, T84F, F89L, N130F, and 
E131A).  Figure 3-12 shows that the overall conformation of the active site in HG-1h, 
including the TS and catalytic residues, is very similar to that in HG-1.  The pKa of E239 
in HG-1h was predicted to be about 1.0 pH unit higher than in HG-1.  MD analysis of this 
design shows that as in HG-1, the active site is very flexible and allows the substrate to 
exit the active site during the simulation.  The active site is still very solvent exposed, and 
solvent molecules still enter the active site over the course of the simulation to interact 
with the remaining polar residues and crowd the substrate out of the active site.  Figure 3-
13A shows representative configurations of HG-1h before and after the MD simulation.  
In the final configuration, the substrate-base distance is over 10 Å and the substrate-base 
distances shown in Figure 3-13B and 3-13C indicate that the contact is not maintained for 
any significant length of time.  These results suggest that our redesign is not likely to be 
active for many of the same reasons as HG-1. 
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Conclusions 
 While we were unsuccessful in designing an active KE enzyme, we were able to 
solve the crystal structure of one of our inactive designs, allowing us to gain further 
insight into the cause of the inactivity.  Unfortunately, neither the crystal structure nor the 
MD simulations of HG-1 were able to unambiguously determine the cause of HG-1’s 
inactivity.  However, both analyses indicated that the active site is very solvent exposed, 
flexible, and occupied by a large number of water molecules.  While it is not certain that 
these factors are the cause of the inactivity, any one of them could have a negative effect 
on substrate binding as well as on the base pKa and all three issues could be addressed by 
choosing an active site that is more deeply buried within a protein scaffold.  The natural 
active site of TAX, which was the focus of the designs presented here, was too solvent 
exposed and flexible to be amenable to this reaction.  Future redesigns of this scaffold 
must locate the active site away from the natural binding pocket in a location that is more 
deeply buried, perhaps in the barrel of the scaffold.  Other scaffolds with less solvent-
exposed active sites should also be explored.  A more deeply buried active site could 
effectively reduce the flexibility of the binding residues and shield the active site from 
solvent, though it remains to be seen if the resolution of these factors alone will result in 
an active KE enzyme. 
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Table 3-1.  Partial atomic charges for 5-nitrobenzisoxazole (5-NBZ). 
 
 
atom name charge
O1 -0.586
N2 -0.212
C3 0.041
C4 -0.252
C5 -0.148
C6 0.099
N6 0.517
O61 -0.484
O62 -0.506
C7 -0.168
C8 -0.269
C9 0.516
H3 0.490
H5 0.275
H7 0.251
H8 0.212  
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Table 3-2.  Variation of contact geometry for targeted ligand placement.  The TS was 
placed at every indicated geometry for every rotamer of Asp or Glu in the design 
calculation.  Because Asp and Glu both have two equivalent, but distinctly named, 
oxygens in their sidechains, a separate set of geometries is described for each oxygen. 
 
Placement: H3 from Aspartate (OD1)
type atom1 atom2 atom3 atom4 min max step
DISTANCE OD1 H3 1.1 1.5 0.2
ANGLE OD2 OD1 H3 70.0 110.0 20.0
TORSION CG OD2 OD1 H3 160.0 200.0 20.0
ANGLE OD1 H3 PSA 70.0 110.0 20.0
TORSION OD2 OD1 H3 PSA 0.0 360.0 20.0
TORSION OD1 H3 PSA C3 160.0 200.0 20.0
Placement: H3 from Aspartate (OD2)
type atom1 atom2 atom3 atom4 min max step
DISTANCE OD2 H3 1.1 1.5 0.2
ANGLE OD1 OD2 H3 70.0 110.0 20.0
TORSION CG OD1 OD2 H3 160.0 200.0 20.0
ANGLE OD2 H3 PSA 70.0 110.0 20.0
TORSION OD1 OD2 H3 PSA 0.0 360.0 20.0
TORSION OD2 H3 PSA C3 160.0 200.0 20.0
Placement: H3 from Glutamate (OE1)
type atom1 atom2 atom3 atom4 min max step
DISTANCE OE1 H3 1.1 1.5 0.2
ANGLE OE2 OE1 H3 70.0 110.0 20.0
TORSION CD OE2 OE1 H3 160.0 200.0 20.0
ANGLE OE1 H3 PSA 70.0 110.0 20.0
TORSION OE2 OE1 H3 PSA 0.0 360.0 20.0
TORSION OE1 H3 PSA C3 160.0 200.0 20.0
Placement: H3 from Glutamate (OE2)
type atom1 atom2 atom3 atom4 min max step
DISTANCE OE2 H3 1.1 1.5 0.2
ANGLE OE1 OE2 H3 70.0 110.0 20.0
TORSION CD OE1 OE2 H3 160.0 200.0 20.0
ANGLE OE2 H3 PSA 70.0 110.0 20.0
TORSION OE1 OE2 H3 PSA 0.0 360.0 20.0
TORSION OE2 H3 PSA C3 160.0 200.0 20.0
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Table 3-3.  Geometric constraints contacts between the active site residues and the 
transition state in the active site search.  Three contacts are required:  Asp/Glu, 
Phe/Trp and Ser/Thr/Tyr.  Distance measurements are given in Ångströms.  Angle, 
torsion, and plane measurements are given in degrees. 
 
Contact: Asp/Glu to H3
residue type atom1 atom2 atom3 atom4 min max
Asp DISTANCE OD1 H3 1.0 1.6
ANGLE OD2 OD1 H3 69.0 111.0
TORSION CG OD2 OD1 H3 159.0 201.0
ANGLE OD1 H3 PSA 69.0 111.0
TORSION OD2 OD1 H3 PSA 0.0 360.0
TORSION OD1 H3 PSA C3 159.0 201.0
Asp DISTANCE OD2 H3 1.0 1.6
ANGLE OD1 OD2 H3 69.0 111.0
TORSION CG OD1 OD2 H3 159.0 201.0
ANGLE OD2 H3 PSA 69.0 111.0
TORSION OD1 OD2 H3 PSA 0.0 360.0
TORSION OD2 H3 PSA C3 159.0 201.0
Glu DISTANCE OE1 H3 1.0 1.6
ANGLE OE2 OE1 H3 69.0 111.0
TORSION CD OE2 OE1 H3 159.0 201.0
ANGLE OE1 H3 PSA 69.0 111.0
TORSION OE2 OE1 H3 PSA 0.0 360.0
TORSION OE1 H3 PSA C3 159.0 201.0
Glu DISTANCE OE2 H3 1.0 1.6
ANGLE OE1 OE2 H3 69.0 111.0
TORSION CD OE1 OE2 H3 159.0 201.0
ANGLE OE2 H3 PSA 69.0 111.0
TORSION OE1 OE2 H3 PSA 0.0 360.0
TORSION OE2 H3 PSA C3 159.0 201.0
Contact: Ser/Thr/Tyr to O1
residue type atom1 atom2 atom3 atom4 min max
Ser DISTANCE OG O1 2.6 4.0
ANGLE OG HG O1 150.0 180.0
ANGLE HG O1 N2 100.0 160.0
TORSION HG O2 N2 C3 120.0 240.0
Thr DISTANCE OG1 O1 2.6 4.0
ANGLE OG1 HG1 O1 150.0 180.0
ANGLE HG1 O1 N2 100.0 160.0
TORSION HG1 O2 N2 C3 120.0 240.0
Tyr DISTANCE OH O1 2.6 4.0
ANGLE OH HH O1 150.0 180.0
ANGLE HH O1 N2 100.0 160.0
TORSION HH O2 N2 C3 120.0 240.0
Contact: Phe/Trp to PS2
residue type atom1 atom2 atom3 atom4 atom5 atom6 min max
Phe PSEUDO_ATOM PS1, equidistant between CE1 and CD2
PSEUDO_ATOM PS2, equidistant between C4 and C9
DISTANCE PS1 PS2 3.0 4.0
PLANE CG CE1 CE2 C5 C8 N2 0.0 40.0
Trp PSEUDO_ATOM PS1, equidistant between CE2 and CD2
PSEUDO_ATOM PS2, equidistant between C4 and C9
DISTANCE PS1 PS2 3.0 4.0
PLANE CD1 CE3 CH2 C5 C8 N2 0.0 40.0  
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Table 3-4.  Geometric constraints for additional base contact.  A single hydrogen 
bond contact was required to one of the carboxylate oxygens of the general base.  
Distances are given in Ångströms.  Angles are given in degrees. 
 
Contact:  His to OD1/OD2
residue type atom1 atom2 atom3 min max
Hie DISTANCE NE2 OD1 2.6 4.0
ANGLE NE2 HE2 OD1 130.0 180.0
ANGLE HE2 OD1 CG 120.0 180.0
Hie DISTANCE NE2 OD2 2.6 4.0
ANGLE NE2 HE2 OD2 130.0 180.0
ANGLE HE2 OD2 CG 120.0 180.0
Hid DISTANCE ND1 OD1 2.6 4.0
ANGLE ND1 HD1 OD1 130.0 180.0
ANGLE HD1 OD1 CG 120.0 180.0
Hid DISTANCE ND1 OD2 2.6 4.0
ANGLE ND1 HD1 OD2 130.0 180.0
ANGLE HD1 OD2 CG 120.0 180.0
Contact:  His to OE1/OE2
residue type atom1 atom2 atom3 min max
Hie DISTANCE NE2 OE1 2.6 4.0
ANGLE NE2 HE2 OE1 130.0 180.0
ANGLE HE2 OE1 CD 120.0 180.0
Hie DISTANCE NE2 OE2 2.6 4.0
ANGLE NE2 HE2 OE2 130.0 180.0
ANGLE HE2 OE2 CD 120.0 180.0
Hid DISTANCE ND1 OE1 2.6 4.0
ANGLE ND1 HD1 OE1 130.0 180.0
ANGLE HD1 OD1 CD 120.0 180.0
Hid DISTANCE ND1 OE2 2.6 4.0
ANGLE ND1 HD1 OE2 130.0 180.0
ANGLE HD1 OE2 CD 120.0 180.0  
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Table 3-5.  Thermocycler temperature programs for gene construction and 
mutagenesis reactions. 
 
 
 
Temp 
(°C)
Time 
(min)
# 
cycles
Temp 
(°C)
Time 
(min)
# 
cycles
Temp 
(°C)
Time 
(min)
 # 
cycles
95 1 95 1 95 1
95 1 95 1 95 1
55 1 55 1 55 1
68 14 68 14 68 14
4 hold 4 hold 4 hold
  30x  25x    23x
gene assembly amplification site-directed mutagenesis
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Table 3-6.  Crystallographic statistics for HG-1. 
 
 
Data collection
Space group P212121
Cell dimensions
     a,b,c (Å) 48.3, 72.5, 74.6
       !,",# (deg) 90.0, 90.0, 90.0
Resolution (Å) * 2.0 (2.1 - 2.0)
Number of reflections 48807
     unique reflections 18096
Rmerge (%) * 2.5 (4.4)
I/$I * 30.7 (21.1)
Completeness (%) * 99.2 (98.2)
Redundancy * 2.7 (2.6)
Refinement
Resolution (Å) 29.5 - 2.0
Number of reflections
     working set 17163
     test set 924
Rwork/Rfree 16.4 / 23.0 %
No. atoms
     protein 2326
     solvent 187
B-factors
     protein 13.9
     water 19.7
R.m.s deviations
     bond lengths (Å) 0.027
     bond angles 1.938
Ramachandran plot
     favored (%) 91.0
     allowed (%) 8.6
     generously allowed (%) 0.4
     disallowed (%) 0
* Last shell is shown in parentheses  
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Figure 3-1.  5-NBX transition state.  (A) 5-NBX atom names.  The bonds being broken 
are shown as dotted lines.  (B) Stick representation of the transition state structure.  The 
pseudoatom is shown as an orange star near H3. 
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Figure 3-2.  Kemp elimination ideal active site.  The enzyme design calculations 
required either an Asp or Glu as a general base, a Ser, Thr, or Tyr as a H-bond donor to 
the phenolic oxygen, and a π-stacking residue above or below the plane of the TS 
structure (blue).  The pseudoatoms that were used to define the π-stacking contact are 
shown in pink. 
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Figure 3-3.  Additional hydrogen bond contact.  An additional contact 
(Hie/Hid/Gln/Asn) was required to the base (shown in blue). 
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Figure 3-4.  Predicted active site structure of HG-1.  (A) Active site 2-1, identified 
through the active site search.  The catalytic residues and TS are shown in green overlaid 
with the wild-type crystal structure in grey.  (B) Repacked active site.  The TS model is 
shown in pink and all seven mutations are identified.  The hydrogen bond network 
supporting the conformation of the base is indicated with green dotted lines. 
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Figure 3-5.  First-order rate constants for KE reaction.  The rate constants for the 
reactions including 200 µM wild-type TAX, HG-1, HG-1a (HG-1/N239D), HG-1b (HG-
1/N239D/ M46A), HG-1c (HG-1/M46A), and the buffer-catalyzed background reaction 
are given.  No significant rate acceleration was seen above that for the scaffold (wild-type 
TAX)-catalyzed reaction for any of the variants assayed under any of the conditions 
tested.  Sodium citrate was used for pH 5.0 and 5.5, sodium phosphate was used for pH 
6.5 and 7.5, and sodium borate was used for pH 8.5. 
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+ wt TAX 
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Figure 3-6.  CD analysis of HG-1.  (A) Far-UV wavelength scan indicating that HG-1 is 
folded.  (B) Thermal denaturation curve indicating that HG-1 is significantly destabilized 
compared to TAX. 
A 
B 
wt TAX 
HG-1 
wt TAX, pH 5.5 
HG-1 pH, 5.5 
HG-1 pH, 7.5 
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Figure 3-7.  Crystal structure of HG-1.  (A) Overlay of backbone structure of HG-1 
(magenta) and wild-type TAX structure 1GOR (grey).  (B) Electron density in active site 
of HG-1. 
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Figure 3-8.  Electron density of HG-1 mutation sites.  (A) A24M/E46M.  (B) 
S89F/Q90Y.  (C) W87G.  (D) W267A. 
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Figure 3-9.  Overlay of HG-1 crystal structure active site with design model.  The 
structure predicted by ORBIT (grey) is very similar to the actual conformations seen 
in the crystal structure (magenta).  Predicted hydrogen bonds are represented as yellow 
dotted lines.  (A) E237 and the supporting hydrogen bond network and Y90.  (B) E237 
and supporting hydrogen bond network including H209, N239, and W275. 
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Figure 3-10.  Ordered water molecules near E237 in the active site.  Residues that 
participate in the hydrogen bond network to E237 are shown in yellow, additional polar 
residues in the active site are shown in pink, and water molecules are shown as red 
spheres.  The modeled TS is shown in grey. 
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Figure 3-11.  MD analysis of HG-1.  (A) Representative structures of HG-1 in state 1 
where the substrate is bound in the active site and in state 2 after the substrate has exited 
the active site.  (B) The substrate-base distance over the course of the simulation.  States 
1 and 2 are indicated. 
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Figure 3-12. Active site of HG-1h.  The active site residues of HG-1h (green) are shown 
overlaid with the HG-1 active site (grey).  Mutations with respect to HG-1 are indicated. 
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Figure 3-13.  MD analysis of HG-1h.  (A)  Representative structures before (green) and 
after the MD simulation (blue).  (B) The substrate-base distance over the course of the 
simulation.  (C) The distribution of the substrate-base distances for the entire simulation.  
The substrate-base distance for the initial configuration is indicated by a green line and 
the substrate-base distance for the final configuration is indicated by a red line. 
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Chapter IV 
 
 
The computational design and molecular dynamics simulation 
analysis of multiple Kemp elimination enzymes 
 
 
All of the experimental work described in this chapter was performed in the Mayo 
laboratory.  Gert Kiss of the Houk lab (UCLA) carried out the molecular dynamics 
simulations. 
 
 
 
Abstract   
Crystallographic and molecular dynamics (MD) simulation analysis of our 
inactive Kemp elimination (KE) design HG-1 suggested that possible reasons for the 
inactivity lay in the flexible, solvent-exposed active site.  In an effort to construct a more 
hydrophobic, rigid active site in the same protein scaffold, we placed the catalytic 
residues farther into the barrel of the protein, resulting in an active KE enzyme.  Using 
similar computational methods, three other active KE designs were also identified in two 
scaffolds that had been previously shown to be amenable to computational design 
procedures for this reaction.  We also show that MD analysis of these designs is able to 
accurately differentiate between active and inactive designs, suggesting a novel in silico 
screening step for the computational enzyme design process. 
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Introduction 
Most of the expense and time associated with computational enzyme design is in 
the experimental evaluation of designs predicted by the software.  After a protein 
sequence is predicted to have activity for a given reaction, the corresponding DNA 
sequence must be ordered from a commercial source or constructed from scratch, the 
heterologous expression of the protein must be optimized and a purification scheme must 
be developed.  Each of these steps has the potential for unforeseen problems unique to the 
system of interest, which may take weeks to overcome.1  Indeed, much work has been 
dedicated to overcoming challenges associated with heterologous protein expression 
including optimizing gene sequences, using cell-free extracts, and employing eukaryotic 
expression systems.1,2 
Before activity assays can be carried out, the substrate must be purchased or 
chemically synthesized and purified.  Only then can the expressed protein can be assayed 
for activity and stability and characterized structurally.  At a minimum, the entire process 
starting from the computationally predicted protein sequence can take a month and cost 
thousands of dollars in synthetic genes, oligonucleotides, and reagents. 
Recent successes in de novo computational enzyme design have relied in part on 
the synthesis and screening of a large number of putative enzymes.3,4  Although these 
methods did result in active enzymes, the time and costs associated with their synthesis 
and screening make the process extremely inefficient and point to inaccuracies in the 
design process.  De novo enzyme design with our protein design software, ORBIT, and 
the recently developed software called Phoenix, has also been challenging (see Chapter 
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III and Appendix A), indicating that we also have undetermined problems in our design 
procedure. 
Two strategies could help us address the inefficiencies in computational enzyme 
design: (1) Use the protein design cycle, mentioned in Chapter I and Chapter III, to 
analyze the inactive or less active designs and modify the design procedure accordingly.  
(2) Identify sequences from the design process that are likely to be inactive so that 
experimental time and money are focused on active enzymes. 
Here, we attempt to use both strategies in the context of the Kemp elimination 
(KE).  First, we use information from the analysis of a previous inactive KE design to 
inform the direction of new designs for the KE in the Thermoascus aurantiacus xylanase 
(TAX) scaffold.  This cyclic design procedure resulted in a highly active KE enzyme that 
appears to accelerate the reaction with a 106-fold rate increase. 
Second, we created a small set of KE enzymes, which were analyzed by a new 
MD simulation procedure to observe dynamics of the transition state (TS) structure, 
explicit solvent, and the catalytic residues within the active site.  These analyses correctly 
predicted the presence or absence of activity in most of the designs.  A method of this 
type could serve as an initial screen to help us eliminate false-positives from the design 
process. 
The inability of our design procedure to reliably predict active sequences and the 
success of the MD simulations in making that distinction point to several limitations of 
our design procedure.  Both ORBIT and Phoenix use fixed backbone structures to 
represent the scaffold and neither can currently model dynamics or explicit solvation.  
However, both of these factors are modeled in MD simulations.  The combination of 
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fixed-backbone computational enzyme design and MD simulation could combine the best 
features of both procedures to improve the accuracy and efficiency of the computational 
enzyme design process. 
 
 
Materials and methods 
Active site placement 
The protein design software Phoenix, which is similar to ORBIT, was used for 
these designs.5,6,7 
For the active site search in design HG-2, all non-Pro positions within 5 Å of 
D127 in 1GOR that point into the barrel of TAX were designated design positions 
(residues 17, 42, 44, 81, 83, 129, 170, 172, 209, 234, 236, 237, 265, and 267).  These 
positions were allowed to sample all conformations of Gly, Phe, Trp, Ser, Thr, and Tyr.  
Position 127 was defined as the only catalytic position and was allowed to sample all 
conformations of Asp.  As in the design of Chapter III, a backbone-independent 
conformer library was used.8  The library of TS poses was generated through the targeted 
ligand placement as discussed in Chapter II and Chapter III using the geometric 
variations in Table 3-2.  The other catalytic contacts were enforced using the geometric 
constraints described in Chapter III (Table 3-3) except that the additional hydrogen bond 
contact to the base (Table 3-4) was not required.  The catalytic contacts identified in this 
design were D127, W44, and S265. 
The active site placement for the designs in scaffolds 1THF and 1A53 were 
carried out in a similar manner.  The design positions and the required contacts for these 
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designs are shown in Table 4-1 along with the actual residues chosen as catalytic contacts 
in the active site search. 
 
Active site repacking 
 For the repacking calculation, the initial TS position was taken from the active 
site chosen after the active site search.  From this initial position, the TS structure was 
translated ± 0.4 Å in x, y, and z in 0.2 Å steps and rotated 10° in each direction in 5° 
steps.  The geometric constraints from Tables 3-3 and 3-4 were applied to enforce the 
contacts between the TS and each of the three catalytic residues identified in the active 
site search. 
 For design HG-2, residues 42, 21, 81, 83, 84, 125, 130, 172, 234, 236, and 267 
were designated design positions and were allowed to sample all conformations of all 
residues except Pro and Cys.  A second shell of float positions was designated around the 
design positions (residues 16, 17, 46, 47, 50, 79, 87, 90, 170, 207, 209, 239, 275, and 
276), which were allowed to sample all conformations of the wild-type residue at that 
position.  Positions 44, 127, and 265 were allowed to sample all rotamers of Trp, Asp, 
and Ser, respectively.  The residues that were designated as design and float residues for 
the calculations in scaffolds 1THF and 1A53 are shown in Table 4-1. 
An occlusion-based solvation potential was applied with scale-factors of 0.05 for 
nonpolar burial, 2.5 for nonpolar exposure, and 1.0 for polar burial.7  Other standard 
parameters were applied as in Lassila et al. and a backbone-independent conformer 
library was used to represent side chain flexibility.8  As in the active site search, 
sidechain-TS interaction energies were biased to favor those contacts that satisfy the 
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geometries in Table 3-3 and Table 3-4.  Sequence optimization was carried out with 
FASTER,9,10 and a Monte Carlo-based algorithm11,12 was used to sample sequences 
around the minimum energy conformation from FASTER (FMEC). 
 
Gene synthesis and cloning 
 Genes for the designed proteins were designed and constructed as described in 
Chapter III.  The DNA sequence for a factor Xa cleavage site and a His6-tag added to the 
C-terminus of all genes.  Closely related sequences (e.g., wild-type TAX, HG-1, and HG-
2) were synthesized from a common oligonucleotide set with new oligonucleotides 
introduced as needed for differences in the gene sequence.  Site-directed mutagenesis of 
the genes to create point mutations is also described in Chapter III. 
 
Protein expression and purification 
 For initial activity screening, 200 µL LB/ampicillin starter cultures were 
inoculated with a single BL-21 (DE3) E. coli colony and grown at 37°C overnight with 
shaking.  The entire starter culture was used to inoculate 5 mL of Overnight Express 
Instant TB media (Novagen) with ampicillin in 24-well culture plates (Whatman).  The 
plates were fitted with Bugstopper Venting Capmats (Whatman) and incubated for 3 
hours at 37°C with shaking.  Expression was continued at 18°C overnight with shaking.  
The cells were harvested by centrifugation and then washed with 1 mL phosphate 
buffered saline.  Cell pellets were frozen on dry ice for 30 min, then thawed at 4°C and 
resuspended in 400 µL lysis buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 
2.5 mM imidazole, 1x CelLytic B (Sigma-Aldrich), 1 mg/mL lysozyme (Sigma-Aldrich), 
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and 1 U Benzonase endonuclease (Merck)).  The lysate was centrifuged at 5000 × g for 
20 min at 4°C and crude protein samples were taken from the supernatant. 
For further purification of 5 mL cultures, His-Select plates (Sigma-Aldrich) were 
equilibrated with 600 µL of equilibration buffer (50 mM NaPO4 pH 8.0, 300 mM NaCl).  
The crude supernatant was applied to the plate wells and the columns were washed with 
600 µL of wash buffer (50 mM NaPO4 pH 8.0, 300 mM NaCl, 5 mM imidazole).  The 
purified protein was eluted in 500 µL elution buffer (50 mM NaPO4 pH 8.0, 300 mM 
NaCl, 250 mM imidazole). 
For larger-scale production, proteins were expressed in 1 L LB/ampicillin cultures 
of BL-21 (DE3) E. coli as described in Chapter III except that the expression was induced 
at 18°C for up to 18 hours.  The proteins were purified using 1 mL of Ni-NTA resin 
(Qiagen) and the elution buffer was exchanged with 50 mM sodium citrate, 150 mM 
NaCl pH 5.5 or 25 mM HEPES, 100 mM NaCl pH 7.25. 
 
Protein concentration determination 
 Protein concentrations were measured by UV absorbance after protein 
denaturation in 8 M guanidinium hydrochloride for 10 min with a dilution of at least 10x.  
The extinction coefficient of each protein at 280 nm was calculated based on the number 
of Trp and Tyr residues in the sequence (Table 4-2). 
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Protein characterization 
Circular dichroism (CD) and mass spectrometry (MS) were carried out as in 
Chapter III.  CD spectra and thermal denaturation curves were obtained with 10 µM 
protein in 25 mM HEPES, 100 mM NaCl pH 7.25 or 25 mM MES, 100 mM NaCl pH 
5.5. 
 
KE activity screening 
5-nitrobenzisoxazole (5-NBZ) was synthesized and purified as described in 
Chapter III.  The reactions were carried out in a total volume of 200 µL in black 96-well 
microtiter plates with clear bottoms (Greiner) at 27°C.  The reaction contained 20 µL of 
the lysate supernatant and 1 mM 5-NBZ diluted in 25 mM HEPES, 100 mM NaCl pH 
7.25.  The acetonitrile concentration was 2% for all reactions.  The production of the 
phenolate product (Figure 1-2) was monitored by an increase in absorbance at 380 nm 
using a Safire2 microplate reader (Tecan). 
 
Kinetic measurements 
 Kinetic parameters were determined by monitoring phenolate production at 380 
nm (ε = 15,800 cm-1M-1 )13 using a Shimadzu UV-1601 spectrophotometer equipped with 
a temperature-controlled cell holder.  A 50 mM stock of 5-nitrobensoxazole was made in 
acetonitrile and stored at −20°C.  Assays were carried out with 5 µM protein in 25 mM 
HEPES, 100 mM NaCl pH 7.25 at 27°C.  Assays contained substrate concentrations 
between 16 µM and 1 mM and the acetonitrile concentration was kept constant at 2% of 
the 1 mL reaction volume.  Initial reaction rates were determined from the linear portion 
  
95 
of the reaction progress curve and were corrected for the initial rate contribution for the 
buffer catalyzed (no protein) reaction. 
Kaleidagraph was used to fit the data to the Michaelis-Menten equation 
(Equation-1) to determine the kinetic parameters kcat and Km: 
 
 
! 
v 0 =
kcat " [E]T " [S]0
Km + [S]0
    Equation-1 
 
where v0 is the initial reaction rate, [E]T is the total enzyme concentration and [S]0 is the 
initial substrate concentration.  In the cases where the enzyme was not saturated because 
of limited substrate solubility, the data were fit to a line to determine kcat/Km. 
 
pH profiles 
 pH profiles were determined in 96-well microtitre plates by monitoring the 
absorbance increase at 380 nm with a Safire2 microplate reader (Tecan).  The final 
concentration of protein was 10 µM in a 200 µL total volume.  Each reaction was carried 
out in 25 mM buffer (pH 5.4: MES, pH 6.6 and 7.0: potassium phosphate, pH 7.25: 
HEPES, pH 8.0 and 9.0: Tris) and 100 mM NaCl.  A dilution series of 5-NBZ stocks was 
made in acetonitrile, resulting in substrate concentrations between 0.39 mM and 50 mM.  
4 µL of each substrate stock was added to each reaction well.  Initial rates were 
calculated from the first 400 sec of measurements.  The initial rates of the buffer-
catalyzed reaction (no protein) were subtracted from the protein-catalyzed initial rates.  A 
pathlength of 0.67 cm was assumed for a volume of 200 µL in the 96-well plates. 
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Crystallography 
 Crystallization screens were set up by the Caltech Molecular Observatory.  
Crystals for HG-2 were obtained in three conditions at 20°C and a protein concentration 
of 9.5 mg/mL: (1) 100 mM MES, pH 6.5, 1.6 M magnesium sulfate (Figure 4-5C); (2) 
100 mM HEPES, pH 7.5, 20 mM magnesium chloride, 22% (w/v) polycrylic acid 510 
sodium salt; (3) 100 mM HEPES, pH 7.5, 1.26 M ammonium sulfate.  Crystals for HG-
2/K50A were obtained at 20°C in 200 mM ammonium sulfate, 30% (w/v) PEG 8000, 9.9 
mg/mL protein. 
 
Molecular dynamics (MD) simulations 
 MD simulations were carried out as described in Chapter III, Materials and 
Methods. 
 
 
Results and Discussion 
Second-generation designs 
 The design calculations for the second-generation designs were carried out using 
Phoenix, a computational protein design software package similar to ORBIT, which has 
also been developed in the Mayo lab.5,6  Like ORBIT, Phoenix utilizes geometric-
constraint-based methods to generate libraries of ligand poses including targeted ligand 
placement and rotation/translation;8 stochastic search methods, including FASTER and 
Monte Carlo, are used for sequence optimization.10 
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The second-generation designs were carried out in the same scaffold as HG-1 (see 
Chapter III) with identical geometric constraints.  A wild-type carboxylate residue in the 
TAX scaffold, D127, was identified as being in a promising position to serve as the 
catalytic base.  This residue is deeply buried inside the core of the protein in an area that 
appeared to have enough room for the TS and other active site residues.  The area 
surrounding D127 is adjacent to the wild-type binding pocket but is located farther into 
the barrel of the (α/β)8 scaffold (Figure 4-1).  One major difficulty associated with using 
an active site that is not located in the natural binding pocket of a scaffold is potential 
destabilization of the protein by disruption of important interactions in the core to make 
room for the TS and catalytic residues. 
The active site chosen in the active site search consisted of D127 as the general 
base, W44 as the π-stacking residue and S265 as the hydrogen bond donor (Figure 4-2A).  
This active site displays good stacking between W44 and the TS, and good hydrogen 
bond geometry between D127 and the TS H3.  In addition, the oxazole ring is pointed 
into the back of the active site pocket and is well shielded from solvent.  The nitro 
substituant on the TS is solvent-exposed and may be in a position to interact favorably 
with the wild-type residue K50. 
Active site repacking resulted in a sequence that is 12 mutations away from wild-
type TAX (Table 4-1, Figure 4-2B).  Overall, the residues surrounding the TS and 
catalytic residues are hydrophobic and are predicted to pack well around the TS structure.  
In addition to the required polar catalytic contacts, the wild-type residue K50 is predicted 
to make a favorable interaction with the TS nitro group.   
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MD analysis of the design, which was done blind to the experimental results, 
indicated that the active site undergoes a conformational rearrangement that results in two 
distinct states with active site RMSD values of 1.85 and 2.28 Å from the initial 
configuration, respectively (Figure 4-3 and Figure 4-4A).  This rearrangement results 
from changes in the secondary structure of the protein due to removal of stabilizing 
interactions (especially between D127 of β-1 and R81 of β-2) to make room for the 
active site.  As a result of this change in secondary structure, D127 is able to make a 
favorable hydrogen bond interaction with the backbone carbonyl of G81 about 10 ns into 
the simulation, drawing it into an alternative conformation that coincides with the 
transition between the two states. 
State 1 is more structurally similar to the original design than state 2 and many of 
the designed contacts are maintained.  In state 2, the substrate has rotated 90° from its 
initial position, losing the stacking contact with W44 and the electrostatic contact with 
K50 (Figure 4-3).  However, the base-substrate contact is maintained in both states as 
well as during the transition (Figure 4-4B), due in part to the flexibility of the 
methionine-rich active site.  The designed hydrogen bond contact with S265 is not 
observed in either state, but the positioning of this residue may force the substrate closer 
to the base in state 1. 
 The simulation also shows that the binding site residues pack well around the 
substrate, preventing the invasion of any explicit solvent molecules into the active site to 
interact with the base.  The lack of water in the active site suggests that the pKa of the 
base may be appropriately elevated to facilitate abstraction of the substrate proton.  In 
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combination with the well-defined base-substrate contact, these analyses suggest that this 
design will be active. 
A single Ni-NTA affinity chromatography purification step was sufficient to 
produce about 10 mg of pure HG-2 from 2 liters of culture (Figure 4-5A) and the mass 
was confirmed with electrospray MS (Figure 4-5B).  CD analysis of HG-2 showed that 
the 12-fold mutant is folded with similar secondary structure to wild-type TAX (Figure 4-
6A).  However, HG-2 is significantly destabilized with respect to the wild-type protein 
(Figure 4-6B). 
As predicted by the MD simulations, kinetic analysis of HG-2 indicates that the 
design is an active catalyst for the KE, far above the rate of the buffer catalyzed reaction 
(Figure 4-7A).  The wild-type TAX scaffold was determined to have no activity for the 
KE.  Substrate saturation was never reached for this design, so the kinetic constants kcat 
and Km could not be determined reliably.  kcat/Km was determined to be 122 M-1s-1 from 
the slope of the initial rate versus initial substrate concentration plot, making the 
efficiency of this enzyme comparable to the best KE enzymes designed by Röthlisberger 
et al.3  Knockout mutations of the base (D127N) and the hydrogen bond donor (S265A) 
show a significant decrease in activity compared to HG-2, with the base knockout losing 
almost all activity (Figure 4-7B).  The loss of activity upon mutation of the putative 
catalytic residues indicates that these residues are, in fact, important for catalysis and 
support the proposed designed mechanism for this enzyme. 
 The pKa of the base was observed to be significantly elevated from the solvent-
exposed pKa of aspartate (~ 7 versus ~ 4) (Figure 4-8A).  The pH profile also showed a 
significant decrease in activity at high pHs, which may indicate the presence of a second 
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ionizable group in the active site with a high pKa or simply the unfolding of the protein at 
high pH.  CD analysis ruled out the latter possibility, showing that the protein remains 
folded at pHs up to 9.0 under the conditions of the assays (25 mM HEPES, 100 mM 
NaCl pH 7.25, 27°C) (Figure 4-8B).  Further investigation into the cause of the decrease 
in activity of HG-2 at high pH will be necessary. 
 
Third-generation designs 
 In an attempt to increase activity of HG-2, point-mutants of HG-2 were selected 
based on the MD simulations.  G81A was chosen to rigidify the local secondary structure 
to prevent the backbone hydrogen bond to D127 (Figure 4-3).  However, MD analysis of 
HG2/G81A indicates that though the secondary structure of the loop may be stabilized 
somewhat, the base can adopt an alternate conformation, preventing interactions with the 
substrate.  Subsequent experimental analysis of this mutant showed that it was less active 
than the original design HG-2 (Figure 4-9, Table 4-1). 
MD analysis of HG-2 suggested that S265 was acting to push the substrate closer 
to the base and prevent water from entering the active site.  The S265T mutation was 
chosen because of the slightly larger volume of Thr, which may provide better packing 
around the substrate.  In addition, this mutation also reverts to the wild-type residue at 
this position.  MD analysis of HG2/S265T predicted that this variant would be more 
active than the original design as the substrate-base interaction is maintained just as well 
as in HG-2, but no active site rearrangement occurs.  Experimental evaluation showed 
that although this design has a slightly lower kcat than HG-2, the Km is also lower, 
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resulting in a kcat/Km that is about three fold higher than HG-2 (Figure 4-9, Table 4-1) or 
any of the KE enzymes from Röthlisberger et al.3 
 
Additional designs 
 With one successful KE design in hand, we tested Phoenix’s ability to recapitulate 
the active sites of enzymes with known activity that had been designed by Röthlisberger 
et al.3  Starting with the scaffolds and base positions for KE07, KE10, and KE59, we 
applied our enzyme design methods to generate active sites within the binding pockets of 
Thermotoga maritima imidazoleglycerolphosphate synthase (PDB: 1THF)14 and 
Sulfolobus solfataricus indole-3-glycerolphosphate synthase (PDB: 1A53)15.  The 
methods used were the same as those described above for HG-2 except that lysine was 
allowed to be the hydrogen bond donor catalytic contact to fully access some of the 
designs. 
 Starting with the scaffold and catalytic base position from KE59 (1A52, E231), 
we used targeted ligand placement to generate ligand poses and required a π-stacking 
residue and a hydroxyl hydrogen bond donor in addition to the base contact as defined in 
Table 3-2.  The sequence containing catalytic residues from KE59 (W110, S131, E231) 
was identified in the top 20 active site sequences from the design calculation.  The 
catalytic residues for this design were predicted to overlay well with the catalytic residues 
of KE59 (Figure 4-10A).  The repacking calculation introduced noncatalytic active site 
residues that differed from those in KE59, resulting in 1A53-1, an 8-fold mutant from 
KE59.  However, this design showed good stacking interactions and an additional 
hydrogen bond donor contact to the base (S210) (Figure 4-10B).  
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 MD analysis predicted that this design would be inactive because the catalytic 
base, E231, rearranges readily to form stable interactions with nearby S210 and S211 
preventing productive interaction with the substrate (Figure 4-13A, B).  In addition, the 
active site was not well packed around the substrate, allowing the substrate to adopt 
alternate binding modes (Figure 4-13C).  The inactivity of this design was confirmed by 
experimental KE activity screening (Figure 4-11). 
 Starting with the scaffold and catalytic base position from KE10 (1A53, E178), 
targeted ligand placement was used to generate ligand poses.  As seen in KE10, the only 
contacts required in the active site search were a π-stacking and base contact.  Phoenix 
identified the catalytic residues of KE10 (E178 and W210) through the active site search.  
In addition, a second π-stacking contact was identified (W110), essentially sandwiching 
the substrate in the active site (Table 4-1, Figure 4-10C).  The active site was repacked 
around the base and double π-stacking contacts, resulting in 1A53-2, a 12-fold mutant 
from the wild-type sequence and a 9-fold mutant from KE10 (Table 4-1, Figure 4-10D). 
The MD analysis of this design showed that the binding pocket contributes to a 
significant reorientation of the substrate over the course of the simulation, at first 
maintaining the base-substrate contact (Figure 4-14A, B, C, E).  Towards the end of the 
simulation, the flexible active site allows water molecules to enter and the substrate 
diffuse away from the base (Figure 4-14D, F).  Because of the sharp distance distribution 
of the substrate-base contact (Figure 4-14E), the design was predicted to have some 
activity.  However, it was not expected to be highly active because of the late intrusion of 
solvent and diffusion of the substrate.  This design was determined to be active by 
experimental KE activity screening (Table 4-3, Figure 4-9). 
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In addition to the active site of 1A53-2 found in the KE10 recapitulation 
calculation, an alternate active site was identified with a base at E157 and π-stacking 
contacts at W110 and W210 (Table 4-1, Figure 4-10E).  Active site repacking resulted in 
the design 1A53-3, which is an 11-fold mutant from the wild-type scaffold (Figure 4-
10F). 
MD analysis predicted 1A53-3 to be active because the active site configuration is 
maintained over the course of the simulation (Figure 4-15).  Soon after the simulation 
begins, substrate rotates slightly from the initial configuration, but the base maintains 
contact with both the substrate and the π-stacking (W209) residue.  In addition, only one 
water molecule is able to enter the active site and interact with the base (Figure 4-15B).  
Experimental evaluation of 1A53-3 confirmed the MD prediction of activity for this 
design (Table 4-3, Figure 4-9). 
Two strategies were implemented in the recapitulation of KE07.  In the first, a 
base, π-stacking residue, and a Lys hydrogen bond donor are required.  However, 
Röthlisberger et al. found that the removal of the Lys hydrogen bond donor from the 
active site of KE07 actually increased activity because this residue may interact directly 
with the base, lowering the pKa.3  Thus, in the second strategy, we required a hydroxyl 
hydrogen bond donor instead of the Lys.  Starting with the base E101 in the scaffold 
1THF, Phoenix identified W50 and K222 as the catalytic residues in the first calculation 
(Figure 4-12A) and W50 and S201 as the catalytic residues in the hydroxyl hydrogen 
bond donor case (Figure 4-12C).  In both of these designs, W128 is identified as an 
additional π-stacking contact.  Repacking of the E101/W50/W128/K222 active site 
resulted in the design 1THF-1, which is a 13-fold mutant from wild type and a 9-fold 
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mutant from KE07.  In this design, the base is anchored by S78 and the substrate is held 
in place by the two Trps (Figure 4-12B).  Repacking the E101/W50/W128/S201 active 
site resulted in the design 1THF-2, which is a 10-fold mutant from the wild type and a 
10-fold mutant from KE07. 
MD analysis of 1THF-1 indicated that the active site maintains its overall 
configuration with respect to the initial structure during the simulation (Figure 4-16A, B).  
The base-substrate contact is less well maintained than the previously described active 
designs (Figure 4-16C) because the base alternates its interactions between the substrate 
and solvent molecules in the pocket.  As in the crystal structure of KE07, K222 appears 
to interact directly with the base, perhaps lowering the pKa.3  Because the base-substrate 
distance seemed appropriate for catalysis, this design was predicted to be active, although 
less active than KE07.  For 1THF-2, the overall configuration is the same as the initial 
structure (Figure 4-17A, B), and it also has an extremely sharp base-substrate distance 
distribution that is characteristic of previous active designs (Figure 4-17C).  The 
simulation indicated that the substrate moved about 2 Å deeper into the pocket than was 
predicted in the design, preventing S201 from maintaining its contact to the substrate.  
However, in multiple KE designs, the hydrogen bond donor contact has been shown not 
to be critical for catalysis.3  As a result, this design was predicted to be more active than 
1THF-1.  Experimental evaluation could not detect any activity in 1THF-1 but substantial 
activity was detected in 1THF-2 (Table 4-3, Figure 4-9), agreeing with the MD 
prediction. 
 We were able to recapitulate the placement of the active site residues in all three 
of the previously designed KE catalysts.  However, the final sequences that were 
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generated by Phoenix were very different from the existing active designs.  The 
sequences of the active enzymes found by Röthlisberger et al. are not necessarily the 
optimal sequences with respect to activity; each is just one of the many possible active 
sequences for a given set of catalytic residues.  Despite our repacked sequences being at 
least eight mutations away from the active design, 3 out of 5 of our designs showed 
significant KE activity.  In some cases, our sequences were more active than the 
corresponding sequence that we were trying to recapitulate and in other cases, our 
sequences were less active, or lacked activity completely.  Starting with the initial 
sequence from computational enzyme design, it has been previously demonstrated that 
KE activity can be significantly improved through many rounds of directed evolution;3 
however, we have shown here that activity can also be optimized by additional rounds of 
design based on structural or MD analysis.  In both cases, computational enzyme design 
served to generate an active starting point for further optimization by arranging critical 
catalytic residues in productive orientations in an environment amenable to the chemical 
reaction.  This initial step is necessary for directed evolution, which generally cannot 
generate enzymatic activity de novo.16 
 
MD analysis versus experiment 
 When compared with experimental results, MD analysis successfully predicted 
activity in HG-2, 1THF-2, 1A53-2, and 1A53-3, as well the inactivity of 1A53-1 (Table 
4-4).  In addition, the MD analysis was able to predict relative levels of activity in point 
mutants of HG-2.  In the case of KE enzymes, the main criteria for prediction of activity 
versus inactivity were solvent inaccessibility of the active site, stable binding of the 
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substrate, and a stable substrate-base contact within hydrogen bonding distance.  The 
success of these criteria in predicting activity agrees with the original work of Kemp et 
al. on the decomposition of benzisoxazoles, which shows that nonpolar solvents enhance 
the rate of the reaction significantly relative to water,13,17 and more recent work, which 
shows that the nonpolar microenvironment of the binding pocket and the positioning of 
the base in the catalytic antibody and serum albumins are important.18,19 
The criteria that are used to predict activity will likely vary for other reaction 
types and will help to elucidate the subtle requirements for a successful catalyst.  
However, determination of the best criteria for MD analysis may not be straightforward, 
especially for reactions that have been less well studied; MD evaluation of positive and 
negative controls for similar reactions will likely be necessary. 
 
Conclusions 
 In this work, we used Phoenix to successfully design four active KE enzymes in 
three different inert scaffolds, demonstrating the applicability of Phoenix to de novo 
computational enzyme design.  Of these enzymes, HG-2/S265T showed a catalytic 
efficiency that was 3 times higher than any other computationally designed KE enzyme. 
The success of the Phoenix KE designs is due, in large part, to iterative analysis and 
redesign of inactive enzymes as a part of the protein design cycle discussed in Chapters I 
and III.  The analysis of inactive designs provides valuable information as to the 
deficiencies of our design procedure, allowing us to correct these problems to produce 
active enzymes. 
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We also show that MD simulations of these enzymes can predict the presence or 
absence of activity and, in the case of point mutants of HG-2, the relative level of activity 
can also be predicted.  Once the MD methods are optimized and fully automated, these 
types of analyses could be used as a pre-screen to help eliminate any false-positives that 
may result from the design process, allowing us to focus our experimental efforts on 
designs that are most likely to be active.  That the results of our computational protein 
design procedure can be assisted by the addition of MD analysis points to three major 
deficiencies in our design procedure: the reliance on a fixed backbone scaffold, discrete 
sidechain rotamers, and implicit solvation, all of which help make our design calculations 
tractable.  The MD analysis of computationally designed enzymes can serve as an 
immediate solution to these problems until new methods that address these deficiencies 
are fully integrated. 
 While the activity of these Phoenix designs is encouraging, the enzymes described 
here still do not demonstrate rate accelerations or efficiencies close to those of natural 
enzymes.  In addition, the Kms of most of the computationally designed enzymes for this 
reaction so far have been above 1 mM, suggesting that the active sites are not optimized 
for substrate binding.  Crystal structures of the designs described here are currently being 
pursued to identify possible improvements in the active site structure for better substrate 
binding in fourth-generation designs.  In addition, directed evolution has previously been 
shown to be an effective supplemental strategy for significantly enhancing both the kcat 
and Km of designs with low-level activity.3   
Even though the complete recapitulation of the active sites of previous KE 
designs was not possible, the redundancy of the active designs with respect to the base 
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position and scaffold demonstrate the ability of computational protein design to provide 
multiple correct answers to de novo enzyme design problems, yielding multiple starting 
points for further optimization by directed evolution.  In vitro evolution studies are 
currently underway in the Hilvert lab at the Swiss Federal Institute of Technology to 
optimize the activity of some of these designs, and the results of these experiments 
should help us to better understand this model system and the limitations of 
computational enzyme design.  
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Table 4-2.  Physical characteristics of protein variants. 
 
 
molecular 
weight (g/mol) ! (M
-1
cm
-1
)
formal 
charge
# amino 
acids
1THF 29185 10360 -8 266
KE07 29350 17120 -5 266
1THF-1 29245 21480 -7 266
1THF-2 29225 21480 -8 266
1A53 30070 16360 0 261
KE59 29969 21920 +1 261
1A53-1 29974 27480 +1 261
1A53-2 29969 27480 +1 261
1A53-3 30071 27480 +1 261
1GOR 34564 55280 -4 318
HG-2 34440 55280 -4 318  
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Table 4-3.  Experimental characterization of designed Kemp elimination enzymes.  
 
 
 
 
 
parent mutation scaffold kcat (s
-1
) Km (mM)
kcat/Km         
(s
-1
 M
-1
)
kcat/kuncat
a Tm (°C)
HG-2 - 1GOR NA NA 130 NA 46.6
HG-2 D127N 1GOR NA NA 2 NA 51.0
HG-2 S265A 1GOR NA NA 54 NA 45.8
HG-2 K50A 1GOR NA NA 37 NA 49.3
HG-2 G81A 1GOR NA NA 17 NA 46.7
HG-2 S265T 1GOR 0.68 ± 0.4 1.6 ± 0.1 430 5.9E+05 47.9
1A53-2 - 1A53 0.012 ± 0.002 0.74 ± 0.2 16 1.0E+04 ND
1A53-3 - 1A53 0.015 ± 0.003 0.90 ± 0.03 17 1.3E+04 ND
1THF-2 - 1THF NA NA 5 NA 73.7
KE07 
b, c - 1THF 0.018 ± 0.001 1.4 ± 0.1 13 1.6E+04 NA
KE07 
b, d - 1THF 0.0089 ± 0.006 0.79 ± 0.09 11 7.7E+04 ND
KE70 
b, c - 1JCL 0.16 ± 0.05 2.1 ± 2 78 1.4E+05 NA
KE70 
b, d - 1JCL 0.070 ± 0.003 0.50 ± 0.06 146 6.0E+04 ND
ND = not determined
NA = not applicable
a
 kuncat under the assay conditions was determined to be 1.16x10
-6
 s
-1
 by Rothlisberger et al.
b
 These enzymes were designed by Rothlisberger et al.
c
 The kinetic constants were determined by Rothlisberger et al.
d
 The kinetic constants were determined as a part of this thesis work.
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Table 4-4.  Design summary of Kemp elimination enzymes.  MD prediction and 
experimental detection of activity are indicated. 
 
 
 
 
name scaffold base !-stack H-bond from wt
from active 
design MD experimental
KE59
a 1A53 L231E K110W L131S 10
1A53-1 1A53 L231E K110W/E159W L131S 9 8 (KE59) no no
KE10
a 1A53 G178E E210W - 11
1A53-2 1A53 G178E K110W/E210W - 12 9 (KE10) yes yes
1A53-3 1A53 L157E K110W/E210W - 11 - yes yes
KE07
a 1THF S101E L50W L222K 13
1THF-1 1THF S101E K50W/A128W L222K 13 9 (KE07) yes no
1THF-2 1THF S101E L50W/A128W S201 10 10 (KE07) yes yes
HG-2 1GOR D126 T44W T265S 12 - yes yes
HG2-S265T 1GOR D126 T44W T265 11 1 (2.2.0) increase higher kcat/Km
HG2-G81A 1GOR D126 T44W T265S 13 1 (2.2.0) decrease decrease
HG2-K50A 1GOR D126 T44W T265S 13 1 (2.2.0) decrease decrease
a
 These KE enzymes were designed by Rothlisberger et al.
# mutations activity
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Figure 4-1.  Active site locations of first- and second-generation designs in TAX.  (A) 
The active site of first generation design 1.2.1 (purple) is in the native binding pocket for 
xylobiose (grey).  (B) The active site of second-generation design HG-2 (yellow) is 
located deeper into the barrel of the scaffold. 
 
 
 
 
 
 
         
 
Figure 4-2.  Active site of HG-2.  (A) Catalytic residues identified through the active 
site search.  (B) Repacked active site (pink) overlaid with the wild-type residues (grey). 
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Figure 4-5.  Expression and purification of HG-2.  (A) SDS-PAGE gel of HG-2 
expression and purification.  Lane 1: MW marker.  Lanes 2 and 3: uninduced cells.  
Lanes 4 and 5: cells 18 hours after IPTG induction.  Lane 6: lysate supernatant.  Lane 7: 
lysate pellet.  Lane 8: Ni-NTA purification elution.  (B) Electrospray mass spec.  
Expected mass:  34308.7, actual mass: 34308.8.  (C) UV image of HG-2 crystals grown 
in 0.1 M MES, pH 6.5, 1.6 M Magnesium Sulfate with 9.5 mg/mL HG-2. 
A 
B 
C
C 
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Figure 4-6.  CD analysis of wild-type TAX and HG-2.  (A) Far-UV wavelength scan.  
(B)  Thermal denaturation.  All experiments were carried out with 10 µM protein in 25 
mM HEPES pH 7.25, 100 mM NaCl.  
A 
B 
wt TAX 
HG-2 
wt TAX 
HG-2 
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Figure 4-7.  Kinetic characterization of second-generation enzymes.  5 µM protein is 
used in 25 mM HEPES pH 7.25, 100 mM NaCl, 27°C.  (A) Michaelis-Menten plots of 
design HG-2 (red), wild-type TAX (blue) and background reaction (black).  (B) 
Michaelis-Menten plots of KE70 (red), HG-2 (blue), and HG-2 knock out mutants HG-2-
S265A (green) and HG-2-D127N (yellow). 
A 
B 
background 
wt TAX 
HG-2 
KE70 
HG2 
HG2-S265A 
HG2-D127N 
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Figure 4-8.  Effect of pH on the activity and structure of HG-2.  (A)  pH-rate profile 
of HG-2.  (B) Far-UV CD wavelength scan of HG-2 at various pHs. 
 
A 
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Figure 4-9. Kinetic characterization of third-generation enzymes. Michaelis-Menten 
plots of KE70 (red), design HG-2 (blue), 220-S265T (green), G81A (yellow), and 220-
K50A (grey).  5 µM protein was used and the reactions were carried out in 25 mM 
HEPES pH 7.25, 100 mM NaCl, 27°C. 
 
KE70 
HG2 
HG2-S265T 
HG2-G81A 
HG2-K50A 
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Figure 4-10.  Active sites of designs in scaffold 1A53.  (A) Catalytic residues of 1A53-1 
(pink) overlaid with those from KE59 (grey).  (B) Repacked active site of 1A53-1.  (C) 
Catalytic residues of 1A53-2.  (D) Repacked active site of 1A53-2.  (E) Catalytic residues 
of 1A53-3.  (F) Repacked active site of 1A53-3. 
E F 
C D 
A B 
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Figure 4-11.  Kinetic characterization of designs in scaffolds 1A53 and 1THF.  
Standard errors are calculated from three measurements. 
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Figure 4-12.  Active sites of designs in scaffold 1THF.  (A) Catalytic residues of 1THF-
1 (blue) overlaid with those from KE07 (grey).  (B) Repacked active site 1THF-1.  (C)  
Catalytic residues of 1THF-2 (yellow) overlaid with those from KE07 (grey).  (D) 
Repacked active site of 1THF-2. 
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Figure 4-13.  MD analysis of 1A53-1.  (A) Initial active site configuration of 1A53-1.  
(B) Representative configuration after MD simulation.  (C) Distance distributions of 
contacts between the substrate and catalytic residues. 
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Figure 4-15.  MD analysis of 1A53-3  (A) Initial active site configuration of 1A53-3.  
(B) Representative configuration after MD simulation.  (C) Distance distributions of 
contacts between the substrate and catalytic residues. 
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Appendix A 
 
 
Toward the computational design of a novel enantioselective 
hydrolase 
 
 
 
 
Abstract 
Enzymes are ideal catalysts of organic reactions because of their high efficiency 
and ability to perform a wide variety of chemical transformations with extreme chemo- 
and enantioselectivity under mild reaction conditions.  The chemical repertoire of natural 
enzymes is not exhaustive, however, and certain reactions of industrial interest are not 
found in nature.  A general method to design and optimize an enzyme for the catalysis of 
a specific reaction, especially difficult enantioselective reactions, would be a powerful 
tool in organic synthesis and would open up a range of reactions not currently accessible 
due to the lack of an appropriate catalyst.  Towards this end, we used the ORBIT 
computational protein design software in an attempt to design an enzymatic catalyst for 
the kinetic resolution of N-benzoyl-L-phenylalanine through the selective hydrolysis of 
(S)-2-benzyl-4-phenyl-oxazolone-5-one (F-FOX) as a model system.  This project did not 
result in an active enzyme.  However, the methods developed here laid the groundwork 
for future active designs using other systems. 
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Introduction 
Enantioselective enzymes 
Enantiomerically pure drugs have become the new standard in the pharmaceutical 
industry.  Chemists have long recognized the influence chiral molecules can have over a 
biological system.  Indeed, many of the common drugs isolated from natural sources, 
such as morphine and quinine, are single enantiomers.1  However, synthetically 
producing the single active enantiomer of a compound has always been challenging, if 
not impossible, and as a result, chiral drugs were historically produced as racemates.2,3  
Since the tragic effects of thalidomide were discovered in 1961, we have come to better 
understand the differing biological activity and pharmacokinetics of the individual 
enantiomers of a drug.  These differences make enantiopure drugs preferable and even 
necessary in many cases.  Fortunately, technology has advanced to make the synthesis of 
many single enantiomer drugs possible.3  
Chemists use four basic methods to enantiomerically enrich a target compound: 
(1) isolation of chiral compounds from nature, (2) chemical asymmetric techniques, (3) 
chiral resolutions, and (4) enzymatic techniques.  In spite of major advances in 
asymmetric synthetic techniques, nature is still arguably the richest source of chiral 
compounds and catalysts.  However, even with this “chiral pool” of compounds, the 
selection, enantiopurity, and extractable quantities of these chiral compounds are limited.4  
Asymmetric strategies to access chiral compounds are far from being fully developed.  
Especially challenging reactions involve the formation of carbon-carbon bonds to a 
stereogenic center.  Chiral resolutions of racemates into individual enantiomers are one of 
the oldest and most industrially important methods for enantio-enrichment.  However, 
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this approach has the inherent drawback of a maximum theoretical yield of 50%, because 
by definition a racemate only has 50% of the desired enantiomer, except in special cases 
described below.5,6 
With an ever-increasing demand for enantiomerically pure, complex, biologically 
active compounds (i.e., drugs), synthetic chemists are necessarily beginning to look 
beyond standard chemical strategies in favor of the high yields, efficiency, and strict 
selectivity of enzymatic reactions.2  Although enzymes are widely used in industry, their 
use is often limited to reactions that are parts of natural metabolic processes.  Exceptions 
include enzymes with natural limited selectivity such as some lipases.7 
 As previously mentioned in Chapter I, both directed evolution and catalytic 
antibodies have drawbacks that prevent their use as general tools for the introduction of 
new chemistries into enzymes.  Here, I describe our initial strategy to introduce 
enantioselective hydrolysis activity into inert scaffolds using our computational protein 
design software, ORBIT. 
 
Selected system: the dynamic kinetic resolution of F-FOX hydrolysis 
Dynamic kinetic resolutions are a powerful method for transforming a racemic 
starting material into an enantiomerically pure product without the theoretical yield 
limitations imposed by standard chiral resolutions.  Under the conditions of a dynamic 
kinetic resolution, the starting material racemizes and an equilibrium is established 
between the stereoisomers.6  Consequently, by continuously removing one enantiomer 
from the mixture, 100% of the starting material can be converted into the desired 
enantiomer of the product compound.  Our goal here was to design a stereoselective 
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enzyme to carry out a dynamic kinetic resolution.  The enantioselective hydrolysis of (S)-
2-benzyl-4-phenyl-oxazolin-5-one (F-FOX) to produce N-benzoyl-L-phenylalanine8 was 
chosen as our model system (Figure A-1). 
Initially, we found F-FOX hydrolysis to be an attractive system for this proof of 
principle because (1) F-FOX has reasonable solubility and stability in water;9 (2) 
oxazolones have a characteristic absorption at around 245 nm that is reduced significantly 
upon hydrolysis, allowing the reaction to be easily monitored (see Materials and 
Methods); (3) F-FOX can be easily synthesized through a single-step reaction from 
commercially available materials;10  (4) F-FOX racemizes quickly under basic conditions 
in aqueous solution (Figure A-3C);11  (5) the benzyl sidechain of F-FOX gives a large 
hydrophobic handle with which to distinguish two enantiomers;  (6) F-FOX is fairly rigid 
for its size, having only three degrees of freedom to model in the transition state; (7) F-
FOX undergoes hydrolysis by a simple base-catalyzed mechanism;9,11  (8) F-FOX is a 
strong fluorophore in aqueous solution providing a possible method for binding analysis 
fluorimetry (see Results);  (9) F-FOX hydrolysis is not performed selectively by a natural 
enzyme.  Some lipases have been shown to hydrolyze oxazolones, but these enzymes are 
nonselective hydrolases, the hydrolysis rates are modest, and the mechanism of 
oxazolone hydrolysis has not been established.12,13  
In a method analogous to the generation of catalytic antibodies, our strategy was 
to first calculate a structure for the F-FOX transition state and then optimize the binding 
pocket of a protein around the structure using ORBIT to maximize the protein’s affinity 
for the transition state. 
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Scaffold selection 
In contrast to directed evolution, the protein design process requires a scaffold 
that is inert with respect to the reaction of interest. Several proteins were tested 
computationally as possible scaffolds to house the F-FOX hydrolase active site and 
transition state including Homo sapien retinol binding protein (PDB: 1BRP),14 E. coli 
ribose binding protein (PDB: 2DRI),15 Thermus thermophilus aspartate amino transferase 
(PDB: 1GCK),16 and E. coli maltose binding protein (pdb: 1ANF).17  As these proteins 
are all enzymes or ligand-binding proteins, they all have well-defined ligand-binding 
pockets, which is where the active site search was targeted.  The periplasmic binding 
protein maltose binding protein (MBP) from E. coli, shown in Figure A-2, was chosen as 
the initial scaffold for the F-FOX hydrolase design because the size and shape of its 
binding pocket can accommodate the necessary catalytic residues and reaction transition 
state.  Another attractive feature of this protein is its large size (41 kDa).  In general, large 
proteins are convenient for enzyme design because the overall stability of the protein 
should not be significantly affected by mutations introduced to the binding pocket.  Also, 
MBP not only binds to maltose with high affinity, but also binds to maltotriose and 
maltotetraose.  The F-FOX transition state is of similar size and shape to maltose and 
maltotriose, suggesting that with some modifications to the residues within the binding 
pocket, MBP should be capable of binding to the F-FOX transition state as well.  Our 
design calculations were based on the MBP crystal structure in complex with maltose at 
1.67 Å resolution (PDB: 1ANF).17 
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Materials and Methods 
Calculation of F-FOX transition state  
Ab initio calculations of the first transition state of (S)-F-FOX hydrolysis (Figure 
A-1) were performed using the hybrid density functional B3LYP as implemented by the 
Jaguar 5.5 program package18 and a 6-31G** basis set.  The implicit solvation effects of 
methanol were calculated using a dielectric constant of 33.62 and a probe radius of 2.00 
Å.  Partial atomic charges were calculated with an electrostatic potential fit. 
 The system under investigation included the (S)-F-FOX structure with the phenyls 
removed to facilitate a faster calculation, a water molecule, and NH3 to deprotonate the 
attacking water (Figure A-3A).  A transition state structure for the hydrolysis of (S)-F-
FOX was calculated using the following steps.  First, a bond length scan was performed  
by varying the distance between the attacking water molecule and the carbonyl carbon of 
F-FOX until a maximum energy was found. The distance that produced the highest 
energy structure was used as the starting point for the transition state calculation. The 
final transition state structure has a water-oxygen to carbonyl-carbon distance of 1.79Å 
(Figure A-3B).  We made 18 conformations of the transition state structure by varying 
the χ1 and χ2 angles of the benzyl group to correspond to the six phenylalanine rotamers 
in the Karplus and Dunbrack library19 and by allowing the phenyl ring attached directly to 
the oxazolone to adopt positions that are ±15° out of the oxazolone plane as shown in 
Figure A-3C.  The partial atomic charges for F-FOX were also calculated with Jaguar 
using an electrostatic potential fit. 
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Defining the design geometric constraints 
To obtain a protein that exhibits high affinity and specificity towards the 
transition state structure, optimal contacts and ranges of contacts were defined between 
the transition state structure and three amino acid side chains based on ideal hydrogen 
bond configurations (Figure A-4).  The geometric constraints shown in Figures 3-5 and 3-
6 describe the activation of water by both the Nδ and Nε atoms of neutral histidine (in the 
Hie form of histidine, Nε is protonated; in Hid, Nδ is protonated) and the protonation of 
the oxazolone nitrogen by either nitrogen of protonated histidine (Hsp).  Each of the 
constraints of these geometry definitions defines a range of allowable distances, angles or 
torsions among the atoms of the transition state and the side chain.  
If the molecules adopt any orientation whose geometry falls within these ranges, 
they will be considered to be making a hydrogen bonding contact.  There are four 
different ways the arginine guanidinium group can make a double hydrogen bonding 
contact to the two oxygens of the transition state (Figure A-6A) and the geometric 
constraints for arginine-transition state contacts are shown in Figure A-6B.  To help 
define the geometries, pseudo-atoms with no volume, mass, or charge were created at the 
midpoint between each pair of nitrogens and between the two oxygens of the transition 
state (shown as pink stars in the figures).  The distance between the pseudo-atom at the 
optimal orientation for the formation of two hydrogen bonds is 2.9 Å. 
 
Design strategy and parameters 
The overall strategy for the enzyme design was: (1) strip the side chains from the 
binding pocket, (2) find locations within the binding pocket that will allow all of the 
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defined contacts between the catalytic side chains and the transition state, (3) choose the 
optimal location for the active site, and (4) repack the rest of the binding pocket side 
chains around the catalytic residues and transition state.  Steps 1-3 are referred to as the 
active site search and step 4 is called active site repacking. 
As described previously, the scoring function is the sum of the van der Waals 
energy, hydrogen bond energy, electrostatics energy, and atomic solvation energy for the 
system.  The atomic radii used to calculate the van der Waal’s energies were scaled by 
0.95.20  Making the atoms appear smaller than their known van der Waal’s radius softens 
all of the interactions and serves to compensate for the rigidity of the fixed backbone and 
discrete rotamers.  We used a hydrogen bond potential function with a well depth of 8 
kcal/mol.21  Hydrogen bonds between two side chains and between a side chain and a 
remote backbone atom were treated equally, but hydrogen bonds between a side chain 
and its own backbone are not considered stabilizing and were scaled by 0.00.  The 
surface area-based solvation terms were all weighted individually:22  the benefit for non-
polar surface area burial was 0.026 kcal/mol/Å2, the penalty for nonpolar surface area 
exposure was scaled by a factor of 1.60, and the penalty for burial of polar atoms was 
0.10 kcal/mol/Å2. 
The side chains were removed from all of the residues of MBP within 4 Å of 
maltose in the wild-type structure, creating a poly-glycine hole in the binding pocket.  
The residues within 8 Å of maltose in the wild-type structure were allowed to change 
conformation but not identity during the active site search.  All other side chains and the 
backbone atoms were kept in the positions determined by the crystal structure.  The 
geometry definitions for the Hie/Hid to transition state contact are special in that they 
  
139 
were also used to define rotamers for the transition state with respect to each neutral 
histidine rotamer.  As these “substrate-target” residues sample positions/rotamers during 
the transition state search, the transition state structure samples all of its rotameric forms 
as it translates and rotates with respect to the neutral histidine rotamer.  These translations 
and rotations were subject to the geometric constraints shown in Figure 4.  Distances 
were sampled in 0.5 Å steps, and angles and torsions were sampled in 15 or 20° steps.  
The two additional catalytic residues also sampled positions within the poly-glycine 
region.  
 
Active site search 
In the active site search, single residue and pair-wise energies were calculated 
without application of solvation potentials.  Any configuration meeting all the geometric 
constraints discussed above received an energy benefit of 100 kcal/mol, biasing the 
resulting configurations towards those that have a desired geometry with respect to the 
transition state.  A penalty of 1000 kcal/mol was applied to any arginine or histidine 
located within the binding pocket that does not make a specified contact to the transition 
state, preventing extra catalytic residues from being selected based on favorable van der 
Waals interactions with the backbone or other residues. Optimization was performed 
using a modification of the FASTER algorithm,23 resulting in a solution that specifies a 
single possible location of the active site. 
A Monte Carlo search24,25 was then performed to explore the “active site space” 
around the FASTER solution.  To surmount the unrealistically deep local minima 
represented by a three-residue active site/transition state configuration within an empty 
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pocket, an increased high annealing temperature of 500,000 K was used.  Even with this 
elevated temperature, only about 50% of the moves were successful.  The Monte Carlo 
search provided a list of sequences that met all of the specified geometric and sequence 
requirements, ranked by energy; these structures were then evaluated individually.  
Evaluation criteria included transition state/catalytic residue geometry, favorable 
interactions of the catalytic residues with the backbone, wild-type residue identity at a 
catalytic residue position, positioning of the catalytic residues within the binding pocket 
and relative to one another, and overlap of the transition state structure with the position 
of the natural ligand within the binding pocket. 
 After the optimal active site location was chosen, the catalytic residue positons 
were fixed and FASTER was used to repack the rest of the binding pocket side chains 
around the catalytic residues and the transition state structure.  Binding pocket residues 
capable of contacting the transition state or the catalytic residues could sample rotamers 
for all the amino acids except proline, methionine, and cysteine.  The transition state was 
allowed to move in small steps according to its allowed geometries with respect to the 
neutral histidine.  All other binding pocket residues and the catalytic residues were 
allowed to sample all conformations but were not allowed to change identity.  Again, a 
Monte Carlo algorithm was used to sample sequence space around the solution provided 
by FASTER.  A high annealing temperature of 4000 K was used.  The top 20 Monte 
Carlo sequences were then subjected to a DEE-based algorithm that finds the lowest 
energy rotamer for each designed residue in the sequence. 
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F-FOX synthesis and characterization 
F-FOX was synthesized as previously described10 and purified via flash 
chromatography.  (230-400 mesh silica gel, 60 Å purchased from Aldrich, 4:7 ethyl 
acetate:hexanes).  N-benzoyl-L-phenylalanine and N-cyclohezyl-N’-2-(N-methyl 
morpholino)-ethylcarbodiimide p-toluenesulfonate were purchased from Aldrich and 
used without further purification.  Evaporation under reduced pressure gave the 
oxazolone as a white solid; yield: 80.0 mg (50%)  m.p. 70-72°C  (Lit.10 m.p. 70-71°C).   
I.R. (CH2Cl2): ν = 1822; 1655; 1496; 1425; 1323; 1082; 1046; 965; 885 cm-1. 
1H-N.M.R. (CDCl3): δ = 3.3 (q, 2H); 4.7 (t, 1H); 7.4 (t, 2H); 7.6 (d, 1H); 7.9 ppm 
(d, 2H). 
NMR was performed on a Varian Mercury 300 MHz machine, and IR spectra were 
recorded using a Perkin-Elmer Spectrum BX spectrometer.  UV-vis spectroscopy was 
performed using a Shimadzu UV-1601 spectrophotometer equipped with a temperature 
controlled cell holder.  Fluorescence measurements were performed on a Photon 
Technology International fluorimeter equipped with a Model 180/814 photomultiplier 
detection system and a Ushio xenon short arc lamp.  Fluorescence polarization 
experiments were carried out with 50 µM to 0.5 nM protein and 500 nM F-FOX.  500 nM 
BSA was used as a control. 
 
Protein expression and purification 
The gene for the F-FOX hydrolase (1ANF-FFH) was optimized for expression, 
synthesized with an N-terminal His6 tag and Gly-Gly-Ser linker (Blue Heron, Bothell, 
WA), and cloned into a pETlla vector (Invitrogen).  The plasmid was transformed into 
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BL-21(DE3) Gold cells (Strategene) by heat shock and protein expression was induced 
for 4 hours at 37°C with 1.0 mM IPTG.  Cells were harvested by centrifugation at 5000 × 
g for 30 min and pellets were resuspended in 10 mM imidazole, 300 mM NaCl, 20 mM 
Tris pH 7.4.  The cells were lysed mechanically and pelleted at 10,000 × g for 45 min.  
The soluble fraction was applied to a Ni-NTA Agarose column  (QIAGEN) and washed 
with 10 column volumes of 10 mM imidazole, 300 mM NaCl, 20 mM Tris pH 7.4 and 10 
column volumes of 20 mM imidazole, 300 mM NaCl, 20 mM Tris pH 7.4.  The protein 
was eluted with 250 mM imidazole, 300 mM NaCl, 20 mM Tris pH 7.4 and the eluate 
was dialyzed exhaustively against 20 mM Tris pH 7.4, 50 mM NaCl and stored at 4°C 
until use.  The overall purity of 1ANF-FFH was > 90% as determined by SDS-PAGE.  
The expected molecular weight of 1ANF-FFH was within 9 units of the weight 
determined by electrospray mass spectrometry.  Expression yields for 1ANF-FFH were 
between 20 and 40 mg per liter of culture. 
 
Circular dichroism 
Circular dichroism (CD) data were recorded with an Aviv DS spectropolarimeter. 
The temperature was controlled with a thermoelectric unit.  Experiments were performed 
on samples containing 16.6 µM protein in buffer containing 20 mM Tris pH 7.4 and 50 
mM NaCl.  Wavelength scans were performed in triplicate in 1nm steps from 250 nm to 
190 nm with an averaging time of 1 sec.  Thermal denaturation was performed in 1°C 
steps from 1 to 99°C with 2 min of equilibration at each new temperature and averaging 
over 30 sec.  Thermal unfolding was monitored at 222 nm.  Apparent melting 
temperatures were determined using the relation of Minor and Kim.26 
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Enzyme activity assays 
 Enzymatic activity was assayed using 3-5 µM 1ANF-FFH in 1 mL total volume 
and buffers of varying composition, salt concentration, pH and temperature.  The assay 
was initiated by the addition of F-FOX in acetonitrile to a final concentration of 20–70 
µM.  If the assay temperature was above 25°C, the protein and the buffer (or the buffer 
and an equivalent amount of the protein storage buffer for controls) were equilibrated at 
that temperature for 10 min before the addition of substrate.  The disappearance of the 
substrate with respect to time was observed by monitoring the absorbance of the sample 
at 245 nm for 10 min at each initial substrate concentration.  Initial substrate 
concentrations were calculated using an extinction coefficient of 13000 cm-1M-1 (see 
Results section).  The initial rates were calculated from the linear portion of the substrate 
concentration versus time curves.  For preliminary enzyme activity assays, all rate 
constants were determined at three different initial substrate concentrations.  
 
Fluorescence polarization 
Fluorescence polarization measurements were performed on a Photon Technology 
International fluorimeter equipped with a Model 180/814 photomultiplier detection 
system, a Ushio xenon short arc lamp, and three polarizers from Photon Technology 
International.  An excitation wavelength of 356 nm and an emission wavelength of 440 
nm were used.  Data were collected for 60 sec with a slit width of 1.25 mm.  Experiments 
were carried out with 50 µM to 0.5 nM protein and 500 nM F-FOX.  BSA was used as a 
positive control. 
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Chiral HPLC 
 A method for the separation of D-benzoyl-phenylalanine and L-benzoyl-
phenylalanine (the products of F-FOX hydrolysis) was developed using chiral high-
pressure liquid chromatography (HPLC).  Good separation was found in 12% ethanol in 
hexanes with 0.1% trifluoroacetic acid on a 4.6 mm × 250 mm Chiracel AD column at a 
flow rate of 1 mL/min. 
  
Site-directed mutagenesis 
 All mutagenesis reactions were carried out using site-directed mutagenesis as 
described in Chapter III, Materials and Methods. 
 
 
Results and Discussion 
F-FOX characterization 
 The UV-vis spectra of F-FOX and N-benzoyl-phenylalanine are shown in Figure 
A-7.  The spectra are substantially different, but both the F-FOX reactant and benzoyl-
phenylalanine product absorb at the same wavelengths.  Because a large difference in the 
two spectra occurs at 245 nm, this wavelength was chosen to follow the reaction kinetics.  
F-FOX and N-benzoyl-phenylalanine were determined experimentally to have extinction 
coefficients of 13000 ± 311 cm-1M-1 and 6600 ± 141 cm-1M-1, Respectively, at 245 nm 
(data not shown). 
 The hydrolysis of F-FOX follows pseudo-first-order kinetics with a large 
dependence on pH.  The background reaction occurs with a first-order rate constant of 
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0.00836 ± 0.000495 min-1 in 0.01 M KPi pH 6.6.  As expected, the rate constant is 
positively correlated with pH (data not shown). 
 An excitation wavelength scan shows that F-FOX fluoresces upon excitation with 
356 nm light with emission occurring at 440 nm.  This fluorescence is strongly pH 
dependent (Figure A-8), suggesting that F-FOX fluoresces most strongly when it is in its 
deprotonated form.  The loss of the acidic α-proton causes aromaticity to extend between 
the oxazolone and the phenyl side chain, facilitating fluorescence. 
Due to the very different character of the two forms of F-FOX, its fluorescence is 
also strongly dependent on the nature of its environment.  The fluorescence of F-FOX is 
completely quenched upon transfer into dichloromethane or acetonitrile, but it regains 
fluorescence with increasing water concentration in a mixture with acetonitrile.  In 
contrast, most fluorescent molecules experience an increase in fluorescence in 
hydrophobic environments because these types of environments tend to shield the 
molecule from quenchers that are present in aqueous solutions.27  Because the 
hydrophobic binding pockets of proteins can mimic the effects seen in nonpolar solvents, 
we attempted to take advantage of this unusual fluorescence property of F-FOX to 
monitor F-FOX-protein binding through a decrease in fluorescence.  However, an assay 
of this type is challenging because many factors other than a change in the environment 
of a fluorophore can contribute to a reduction in fluorescence.  In addition, measurements 
of a reduction in fluorescence are inherently less sensitive than measurements of an 
increase in fluorescence.  
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1ANF-FFH active site  
Of the many possible active site locations, one was ultimately chosen by visual 
inspection.  This site is shown in Figure A-9A. In this active site, all three catalytic 
residues make good hydrogen bonds to the transition state.  Nε of Arg 66 forms an 
electrostatically favorable contact with the carbonyl oxygen of the transition state, which 
at 4.1 Å, is too long to call a true hydrogen bond.  This particular contact may be 
important in stabilizing the oxyanion intermediate of the hydrolysis, and the long contact 
may give the transition state enough room to form the intermediate.  In addition to the 
favorable geometry between the catalytic residues and the transition state, this particular 
active site was chosen because of the similarity of the rotameric forms of the designed 
residues and the wild-type residue (Figure A-9C).  Hid 62 overlays perfectly with the 
indole of the wild-type Trp, and Arg 66 is not only a wild-type residue, but adopts a very 
similar rotamer to that in the crystal structure.  
The similarity of the catalytic residues and wild-type residues is promising, 
suggesting that rotameric strain will not be a large destabilizing factor in the formation of 
this active site.  Some of the catalytic residues of this active site also have additional 
stabilizing interactions.  Hid 64 makes an additional hydrogen bond contact to a main 
chain carbonyl that was not required by the geometry definitions (Figure A-9B).  This 
extra contact may stabilize the catalytic histidine in its appropriate orientation. The final 
design for the F-FOX hydrolase based on scaffold 1ANF (1ANF-FFH) is a seven-fold 
mutant including the two catalytic histidines.  The catalytic arginine at position 66 is wild 
type.  Figure A-10A shows the designed active site overlaid with the wild-type residues.  
Again, all of the designed residues adopt rotamers similar to those in the wild-type 
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protein.  A space-filling representation of the active site and the binding pocket residues 
(Figure A-10B) shows that the benzyl side chain of the transition state is well packed.  
Favorable van der Waals contacts are made with designed residues such as Hid 64 and 
Phe 63 as well as with wild-type residues such as Tyr 155, Trp 230, and Trp 340. 
 
CD analysis of 1ANF-FFH 
 CD analysis of 1ANF-FFH shows that the protein is well folded and has an 
overall secondary structure composition comparable to that of wild-type MBP (Figure A-
11A).  Difference in the curve magnitudes may be due to uncertainties in protein 
concentrations.  The apparent melting temperature of 1ANF-FFH is very close to the 
melting temperature determined for MBP under identical conditions (58.3 ± 0.03°C for 
1ANF-FFH versus 60.2 ± 0.05°C for MBP as determined by thermal denaturation) 
(Figure A-11B).  The similarity in melting temperatures indicates that the seven 
mutations introduced into the binding pocket of MBP have little effect on the overall 
stability of the protein.  
 
Enzyme assays 
The apparent pseudo-first-order rate constants determined for F-FOX hydrolysis 
under various conditions are shown in Table A-1 and Figure A-12.  The addition of 
micromolar quantities of 1ANF-FFH was found to increase the rate of F-FOX hydrolysis 
up to 10% above background at 25°C, which is similar to the rate enhancement seen upon 
addition of wild-type MBP.  A rate increase of this size is not indicative of enzymatic 
activity and a similar effect upon addition of wild-type protein suggests that F-FOX 
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hydrolysis is being affected subtly by nonspecific interactions with the exterior of the 
protein.  Pseudo-first-order rate constants were also established for the background 
hydrolysis of F-FOX in buffer and in buffer with 50 µM imidazole.  The addition of 
imidazole did not enhance F-FOX hydrolysis significantly at any pH.  An increase in 
buffer concentration from 10 mM to 50 mM results in an increase in F-FOX hydrolysis 
consistent with general base catalysis, but the addition of 1ANF-FFH and MBP do not 
increase the rate significantly in either case.  Assays performed at 37°C show an increase 
in the rate of background hydrolysis compared to 25°C, but no significant rate 
enhancement was observed by the addition of 1ANF-FFH (data not shown). 
 
FOX binding assay 
 1ANF-FFH did not show any FOX hydrolysis activity.  However, FOX may have 
still been binding in the active site of 1ANF-FFH.  Taking advantage of FOX 
fluorescence, fluorescence anisotropy was used to assay FOX binding.  MBP has a large, 
irregular shape, so the effective size of FOX should increase dramatically upon being 
bound by the protein, resulting in an increase it its fluorescence anisotropy.  As 
mentioned in the Methods, FOX fluorescence decreases in nonpolar solvents.  The 
binding pocket of the protein is less polar than water, so FOX fluorescence is expected to 
decrease upon entering the binding pocket.  The decrease in FOX fluorescence upon 
protein binding, along with the high background hydrolysis rate of FOX, make this 
measurement more difficult because both result in a decrease in signal.  BSA was used as 
a control because it is known to have the ability to bind nonspecifically to many small 
molecules, especially hydrophobic small molecules.28 
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 The titration of 1ANF-FFH at a constant FOX concentration is shown in Figure 
A-13.  The titration curve shows that 1ANF-FFH binds to FOX much more weakly than 
BSA, which probably exhibits nonspecific binding.  It is unclear if this weak 1ANF-FFH 
binding is specific or nonspecific. 
 
1ANF-FFH modifications 
In our analysis of the model of the inactive design, we identified four potentially 
beneficial mutations for 1ANF-FFH (Figure A-13).  These include a double mutation of 
I239 and A96 to tryptophan at positions located in the hinge region distal to the ligand-
binding site.  Hellinga and coworkers reported that this double mutant induces a 60-fold 
increase in the affinity of wild-type MBP for maltose by shifting the equilibrium of MBP 
to its closed conformation.29  We predicted that the N150D mutation would contribute to 
the stabilization of the protonated catalytic histidine in the desired configuration and 
protonation state.  Two additional mutations, (Y155F) and another double mutant of polar 
residues to tryptophan (N12W and D14W) were not expected to directly influence the 
catalytic residues or transition state, but might contribute to the stabilization of the 
binding pocket itself (Figure A-13).  These mutations were made using site-directed 
mutagenesis (see Materials and Methods) and the activity of the variants was assayed as 
described above.  The N150D mutant and the A96W/I329W double mutant showed no 
significant F-FOX hydrolysis activity (Figure A-14).  The N12W/D14W double mutant 
and the N150D/A96W/I239W triple mutant also showed no significant activity (Figure 
A-15). 
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Lessons learned from F-FOX hydrolase design 
 None of the F-FOX hydrolase designs have significantly catalyzed F-FOX 
hydrolysis under any of the conditions examined so far.  In retrospect, some issues have 
been identified that will help inform our future selection of both the chemical system and 
the scaffold.  First, the protonation state of the catalytic histidines (especially the base) is 
critical to the proposed hydrolysis mechanism.  However, histidine has a pKa near neutral 
and can exist in three protonation states, making it difficult to control the histidine 
species present in the active site.  Second, the F-FOX hydrolysis system has a 
background reaction rate that is relatively high.  This is a benefit in the sense that the 
reaction is easy to carry out.  However, any designed enzyme would have to perform 
better than this high background rate before activity could be detected.  Finally, the 
flexibility of some of the scaffolds selected for these designs (especially MBP) may lead 
to active sites that are too exposed to solvent.  As mentioned above, the catalytic 
histidines must be in their correct protonation states for the reaction to work and the 
presence of water in the active site may cause the protonation state of the histidines to 
shift unpredictably.  In addition, the active site of the MBP designs is not fully formed 
until the hinge that connects the two lobes is closed.  For future designs, it would be 
advantageous to choose scaffolds that always have a fully formed active site rather than 
one that spends at least part of its time in an open state where entropy and desolvation 
costs work against the formation of the active site. 
Because we have no structural data for any of these designs, we can only 
speculate on reasons for their inactivity.  However, the problems listed above combine to 
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form a reasonable argument for abandoning this system in favor of one that has fewer 
practical issues. 
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Table A-1.  Apparent pseudo-first-order rate constants for F-FOX hydrolysis.  
Standard errors were calculated from assays at multiple initial substrate concentrations. 
 
 
pH
50 mM KPi          
50mM NaCl
 + 50 µM         
imidazole
+ 5 µM              
1ANF-FFH
+ 5 µM               
MBP
6.2 0.013 ± 0.0001 0.014 ± 0.001 0.014 ± 0.0006 0.017 ± 0.004 
6.4 0.016 ± 0.0003 0.018 ± 0.001 0.018 ± 0.0003 0.021 ± 0.002
6.6 0.020 ± 0.0003 0.022 ± 0.0008 0.022 ± 0.0004 0.025 ± 0.003
6.8 0.024 ± 0.001 0.026 ± 0.002 0.029 ± 0.0006 0.030 ± 0.0003
7.0 0.031 ± 0.002 0.031 ± 0.003 0.034 ± 0.0011 0.035 ± 0.0005
7.2 0.035 ± 0.002 0.037 ± 0.001 0.040 ± 0.0004 0.042 ± 0.0018
7.4 0.041 ± 0.002 0.044 ± 0.001 0.047 ± 0.0018 0.050 ± 0.002
7.6 0.047 ± 0.002 0.05 ± 0.002 0.052 ± 0.0016 0.054 ± 0.002
pH
10 mM KPi          
50mM NaCl
 + 50 µM             
imidazole
+ 5 µM                  
1ANF-FFH
+ 5 µM                  
MBP
6.6 0.010 ± 0.0009 0.010 ± 0.002 0.011 ± 0.001 0.012 ± 0.0007
6.8 0.012 ± 0.0009 0.012 ± 0.0009 0.015 ± 0.001 0.015 ± 0.001
7.0 0.015 ± 0.0012 0.016 ± 0.0006 0.016 ± 0.0006 0.017 ± 0.001
7.2 0.017 ± 0.0036 0.017 ± 0.0002 0.018 ± 0.001 0.020 ± 0.002
7.4 0.021 ± 0.0011 0.021 ± 0.001 0.023 ± 0.002 0.024 ± 0.001
k, min
-1
k, min
-1
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Figure A-1.  Model system for dynamic kinetic resolution. Enantioselective hydrolysis 
of S-2-benzyl-4-phenyl-oxazolone-5-one ((S)-F-FOX).8 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-2.  Maltose binding protein structure. The scaffold for the design, maltose 
binding protein, in complex with maltose (pdb code: 1ANF).17 
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Figure A-3.  (S)-F-FOX transition state structure. (A) The system for the ab initio 
calculation of the reaction transition state included a simplified (S)-F-FOX and a water 
molecule.  NH3 was added to activate the water. (B) Final transition state structure. (C) 
Rotamers of the transition state.  The phenyl side chain can rotate 15° out of the plane of 
the oxazolone.  The benzyl sidechain rotamers are based on the canonical backbone 
independent rotamers for phenylalanine. 
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Figure A-4.  Ideal active site contacts.  Ideal hydrogen bond contacts between the 
desired catalytic residues and (S)-F-FOX hydrolysis transition state. 
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Figure A-5.  Geometric constraints for the contacts between the catalytic residues 
and the (S)-F-FOX transition state (TS).  Distance constraints are shown in blue, angle 
constraints are shown in red, and torsion constraints are shown in green.  The transition 
state side chains were removed for clarity. 
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Figure A-6.  Arginine–(S)-F-FOX geometric constraints. (A) Arginine can make four 
different double hydrogen bonding contacts to the transition state: NH1/oxazolone O and 
NH2/O; NH1/O and NH2/oxazolone O; NH1/oxazolone O and NE/O; NH1/O and 
NE/oxazolone O.  Pseudo-atoms represented by pink stars. (B) Geometric constraints for 
the contacts between arginine and the transition state oxygens.  Distance constraints are 
shown in blue, angle constraints are shown in red, and torsional constraints are shown in 
green.  Pseudo-atoms are represented by pink stars. 
A B 
  
159 
 
 
 
Figure A-7.  UV-vis spectra of F-FOX and N-benzoyl-phenylalanine.  λmax for F-FOX 
is 244.5 nm. 
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Figure A-9. Active site structure.  (A) Chosen active site location and configuration. 
Hydrogen bonds are represented by dotted green lines.  (B) Additional stabilization of 
Hid 64. (C)  Designed active site residues (pink) overlaid with wild-type residues at those 
positions (red). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-10.  Repacked active site.  (A) The designed active site is shown in light pink 
and is overlaid with the wild-type binding pocket (magenta).  The transition state 
structure is shown in yellow.  (B) Space-filling representation of the active site.  The 
benzyl side chain of the transition state is shown in yellow. 
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Figure A-11. 1ANF-FFH CD analysis.  (A) CD wavelength scans of 1ANF-FFH 
compared to a scan for wild type MBP under identical conditions.  (B) Thermal 
denaturation curve of 1ANF-FFH measured at 222 nm.  All samples include 16.1µM 
1ANF-FFH, 20 mM KPi 50 mM NaCl, pH 7.4. 
A 
B 
Tm = 58.3 ± 0.03 °C  
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Figure A-13.  Additional potential beneficial mutations to 1ANF-FFH.  The transition 
state is shown in yellow.  Wild-type residues are shown in pink and mutations are shown 
in green. 
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Appendix B 
 
 
Using computational library design to alter the specificity of a 
xylanase 
 
 
 
The work described here was carried out in the Mayo lab.  All TAX activity screening 
and kinetic assays were carried out by Dr. Roberto Chica. 
 
 
 
Abstract   
 Computational library design allows us to explore additional highly ranked 
sequences in the energy landscape near the minimum energy conformation that was 
predicted by a protein design calculation.  Here, our goal was to use computational 
library design to adjust the specificity of a xylanase that exhibits a broad specificity for 
monosaccharide and disaccharide substrates.  So far, none of our designs have exhibited 
an increase in specificity for the two substrates tested.  However, this project is ongoing 
and calculations are currently being carried out on additional substrates.   
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Introduction 
Computational library design is a special application of computational protein 
design discussed in Chapter I.  Instead of identifying a single best sequence, the goal of 
computational library design is to specify a library of sequences that represents a group of 
top-scoring sequences from the computational design calculation and can be encoded by 
a single degenerate codon at each design position.  This protein design procedure called 
Combinatorial Libraries Emphasizing and Reflecting Scored Sequences (CLEARSS) was 
developed in the Mayo lab and is advantageous over existing computational library 
design software because it ranks possible libraries via energy calculations of every 
member of each library and allows direct control over the size of the library.1,2 
The relationship between protein structure and function is not completely 
understood.  Consequently, many approximations are used in the protein design 
algorithm, including a fixed backbone structure, discrete sidechain rotamers, an energy 
function optimized for the stabilization of small proteins, and heuristic models of protein 
function that are necessary for incorporation into the force field.  The screening of a large 
number of highly ranked protein sequences identified by computational library design 
can compensate for these limitations by allowing us to examine a larger portion of 
sequence space instead of a single sequence, improving our chances of finding a 
sequence that incorporates the function of interest into the protein.3 
The xylanase from the thermophilic fungus Thermoascus aurantiacus (TAX) is a 
convenient system for testing computational library design procedures because it has 
been well studied with established mechanism, specificities, and kinetics (Table B-1, 
Figure B-1).4,5  Glycosidase activity can be readily monitored using commercial 
  
169 
fluorogenic or chromogenic substrate analogs (Figure B-2).  TAX has been 
recombinantly expressed in high yield in Escherichia coli and can be purified to 
homogeneity with a single affinity chromatography step (see Appendix D).  Also, a high-
resolution crystal structure of TAX bound to xylobiose is available at 1.7 Å resolution 
(PDB: 1GOR).5 
The specificity of TAX is highly stringent in some respects and broad in others.  
TAX can hydrolyze para-nitrophenol (pNP)-derivatives of many pentose and hexose 
mono- and disaccharides, such as glucose and xylose; however it is inactive on others, 
such as mannose and maltose (Table B-1).5  Upon modeling these inactive sugars into the 
active site of TAX, it is evident that steric clashes are the usual cause of the inactivity 
(Figure B-3).  For example, glucopyranoside may be less active than xylopyranoside 
because the hydroxymethyl on C5 of glucose is expected to clash with W275.  
Mannopyranoside may be less active than glucopyranoside because the inverted 
stereochemistry at C2 causes the hydroxyl to clash with W84, N126, and E127.  Maltose 
appears to be inactive because the α(14) bond causes the second glucose to adopt a 
conformation that is almost perpendicular to the binding pocket.  In general, 
disaccharides are more active than monosaccharides because they have an increased 
number of binding interactions to compensate for distortion in the transition state (TS). 
 In the work described here, we used CLEARSS to modify the specificity of TAX.  
In addition to evaluating the effectiveness of the library design calculation methods, these 
experiments were designed to elucidate the exact requirements for specificity in the TAX 
active site, especially the primary binding interactions that are critical for substrate 
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binding.  None of the designs to increase the specificity for xylose or glucose have been 
successful so far; however, this project is ongoing. 
 
 
Materials and Methods 
Carbohydrate structures 
The structures of the carbohydrate substrates were generated using the molecular 
modeling program BIOGRAF6 to modify the xylobiose structure found in the crystal 
structure from Lo Leggio et al. (PDB: 1GOR).5  The xylobiose structure was 
appropriately modified, hydrogen atoms were added, and the resulting structure was 
minimized for 50 steps.  Charges were calculated using an electrostatic potential fit, 
methanol solvation including a dielectric constant of 33.62, and a hybrid density 
functional B3LYP as implemented by the Jaguar 5.5 software package and a 6-31G** 
basis set.7  Rotamers were created using canonical torsions (60°, 180°, and 300°) for each 
rotatable bond in the region of carbohydrate that differs from xylobiose (e.g., the C5 
hydroxymethyl group on glucose).  The initial position of each carbohydrate structure 
within the TAX active site was determined by overlaying with the crystallographic 
xylobiose. 
 
Phoenix calculations 
Protein design calculations were carried out with Phoenix1,2,8 using xylose- or 
glucose-based intermediates.  For the xylose calculations, only Trp and Phe were allowed 
at position 275 to account for the results of the site-saturation mutagenesis, which showed 
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that only these two active residues at this position result in an active enzyme.  Other 
design positions were 90 and 276.  These positions were allowed to sample all rotamers 
of all amino acids except Pro.  Residues in the immediate area of the design residues 
were allowed to change conformation but not identity (46, 47, 50, 83, 84, 87, 89, 130, 
172, 207, 209, 239, and 267).  The nucleophile of the reaction, E237, was required to be 
Ala to prevent steric clashes that could result from the close proximity of the nucleophile 
and the TS in the active site in the absence of a covalent bond. 
An occlusion-based solvation potential was applied with scale factors of 0.05 for 
nonpolar burial, 2.5 for nonpolar exposure, and 1.0 for polar burial.8 Other standard 
parameters were applied as in Lassila et al., and a backbone-independent conformer 
library was used to represent side-chain flexibility.9  The ligand was allowed to translate 
± 0.2 Å in every direction in 0.2 Å steps and rotate ± 5° in every direction in 5° steps.  As 
in the enzyme design calculations (Chapters II, III, IV, and Appendix A), geometric 
constraints were imposed to preserve important contacts between the intermediate and the 
active site sidechains.  In this case, these contacts are wild-type ligand-binding contacts 
that are found in the crystal structure of TAX and are described in terms of distance only 
(Figure B-4).   
To preserve the contact between xylose and K50, the Nζ of a Lys residue was 
required to be between 3.0 and 3.5 Å from O4 of xylose and between 2.5 and 3.0 Å from 
O3 of xylose.  For the contact between H83 and xylose, the Nε of a Hid residue was 
required to be between 2.5 and 3.5 Å from O2 and O3 of xylose.  Finally, the Nδ of Asn 
was required to be between 2.5 and 3.0 Å from O2 of xylose to preserve the contact 
between xylose and N172. 
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As in previous enzyme design calculations, sidechain-ligand interaction energies 
were biased to favor those contacts that satisfy the geometries.  Sequence optimization 
was carried out with FASTER,10,11 and a Monte Carlo-based algorithm12,13 was used to 
sample sequences around the minimum energy conformation from FASTER (FMEC). 
For the glucose calculations, hydrophobic residues (Ala, Ile, Leu, Val, Phe, Tyr, 
and Trp) were allowed at position 275 and nine internal rotamers of glucose were used to 
represent flexibility in the hydroxymethyl group.  Otherwise, the glucose calculations 
were carried out in the same manner as the xylose calculations. 
 
Library design calculations 
Library design calculations were also carried out in Phoenix.  The size of the 
libraries was set to 120 and the wild-type residue was required to be a member of the 
library at each design position. 
 
Library construction 
Construction of the libraries was carried out using splicing by overlap extension 
(SOE) mutagenesis to introduce degenerate codons at the design positions.14  The site-
saturation mutagenesis primers that were used are listed in Table B-2 (Integrated DNA 
Technologies).  These primers were designed with the same rules as those for site-
directed mutagenesis described in Chapter III, Materials and Methods.  Mutagenesis 
primers for the xylose and glucose libraries were identical except for the replacement of 
the NNS site-saturation codon with the degenerate codon from the library design 
calculation (Table B-3).  The mutagenesis fragments were constructed by combining 170 
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ng of template DNA (TAX-pET11a, described in Appendix D), 10x Thermopol buffer 
(New England Biolabs), 1 U Vent DNA polymerase (New England Biolabs), 0.5 mM 
dNTP mixture, 25 µmol forward or reverse mutagenesis primer, and 25 µmol forward or 
reverse flanking primer (TAX_NdeI_forward or TAX_BamHI_reverse) in a total reaction 
volume of 100 µL.  The reactions were carried out on Mastercycler Personal 
Thermocycler (Eppendorf) using the temperature program described in Table B-4.  The 
gene fragments were run on a 1% agarose gel and the bands were extracted and purified 
using a QIAquik Gel Extraction Kit (Qiagen).   
Assembly reactions were carried out using an equimolar mixture of the forward 
and reverse fragments (200 ng total) and 10x Thermopol buffer (New England Biolabs), 
0.5 mM dNTP mixture, 25 µmol forward and reverse flanking primers. and 1 U Vent 
DNA polmerase (New England Biolabs) in a total of 100 µL.  The temperature program 
used for the PCR is described in Table B-4. 
After amplification, the reactions were purified with a QIAquik PCR Purification 
Kit (Qiagen) then digested with BamHI and NdeI (New England Biolabs).  The digested 
genes were then run on a 1% agarose gel and the bands were extracted and purified using 
a QIAquik Gel Extraction Kit (Qiagen).  The digested genes were then ligated into a 
similarly digested pET11a vector (Novagen).  The libraries were transformed into E. coli 
BL-21 Gold (DE3) ultracompetent cells (Stratagene) and individual colonies were 
sequenced to confirm an adequate distribution of amino acids at each site (Agencourt). 
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TAX expression 
Colonies were picked into 250 µL LB/ampicillin supplemented with 10% glycerol 
in 96-well plates and grown overnight at 37°C with shaking.  These pre-cultures were 
used to inoculate 300 µL cultures in Overnight Express Instant TB media (Merck 
Biosciences), which were grown overnight at 37°C with shaking.  The cells were 
pelleted, washed with phosphate buffered saline (PBS), and frozen on dry ice.  The 
pellets were thawed at 30°C and resuspended with lysis buffer (1x CelLytic B (Sigma-
Aldrich), PBS pH 7.4, 1 mg/mL hen egg white lysozyme (Sigma-Aldrich)).  Lysis was 
carried out at 30°C for 30 min with shaking and the lysate was centrifuged for 15 min at 
4°C at 3000 × g. 
 
TAX activity assays 
200 mM stocks of 4-methylumbelliferyl-β-D-glucopyranoside (MUG) and 4- 
methylumbelliferyl-β-D-xylopyranoside (MUX) were made in N,N-dimethylformamide 
(DMF).  For the assays, the stocks were diluted to 10 mM MUG or MUX in citrate-
phosphate buffer, pH 5.0 with a total DMF concentration of 5%.  For end-point screening 
assays, 20 µL of cell lysate supernatant was added to 80 µL of the buffer with substrate in 
black 96-well microtiter plates with clear bottoms (Greiner).  The plates were incubated 
for 30 to 60 min at 40°C and the fluorescence intensity was measured at λem = 445 nm 
(λex = 360 nm) using a Safire2 microplate reader (Tecan).  Variants that exhibited end-
point fluorescence intensity at least 1.5 times that of the median fluorescence value of the 
plate were considered to be active. 
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 For kinetic analysis of selected variants, protein expression, purification, and 
concentration determination were carried out as for the TAX-based designs described in 
Chapter IV, Materials and Methods.  Dilution series of MUX and MUG were made by 
serial two fold dilutions into DMF starting with a 250 mM stock solution in DMF.  Final 
substrate concentrations ranged from 98 µM to 12.5 mM.  In a clear bottom 96-well 
plate, 180 µL 50 mM citrate-phosphate buffer, pH 5.0 was combined with 10 µL 
substrate stock in DMF.  The reaction was initiated by the addition of 10 µL TAX to a 
final concentration 30 µM.  The release of 4-methylumbelliferone was monitored by an 
increase in fluorescence intensity at 445 nm with a λex of 360 nm.  The conversion factor 
for arbitrary fluorescence units (AFU) to concentration of 4-methylumbelliferone was 
determined to be 120 ± 23 AFU/µM by a standard curve. 
 
 
Results and Discussion 
 The goal of our calculations here was to increase the specificity of TAX for both 
xylose and glucose individually.  The design positions for these calculations were 
determined based on an overlay of the xylobiose and cellobiose-bound crystal structures 
of two xylanases (Figure B-5).5,15  The positions with the most deviation in their 
conformations were identified as Q90, W275, and R276.  To determine the tolerance of 
TAX for mutations in the active site, site-saturation mutagenesis was performed at these 
three sites.  TAX activity assays on MUX indicated that in the case of xylose, only Phe 
and Trp are tolerated at position 275.  At position 90, Gln (wild-type), Ser, and Arg are 
the residues that confer the most activity, but most other residues are also tolerated.  
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Position 276 shows a high tolerance for mutation with the greatest activity resulting from 
Arg (wild-type), Val, Leu, and Gly. 
The results of the site-saturation mutagenesis suggest that our xylose libraries 
should be limited to Phe and Trp at position 275, and all residues should be sampled at 
the other two positions.  Because no degenerate codon encodes just Phe and Trp, two 
separate calculations were carried out: one with Phe only at position 275 (Xyl1-Phe) and 
another with Trp only at 275 (Xyl2-Trp).  In the library design calculations, the size of 
these two libraries was reduced to 60 so that the total size of the combined xylose 
libraries would be 120.  Unfortunately, the signal for the assays of the MUG substrates 
was too low to get any meaningful site-saturation data.  For the glucose calculations, we 
allowed only hydrophobic residues at position 275 to allow room for the C5 
hydroxymethyl group and to help shield the active site from the solvent. 
The results of the library design calculations are shown in Table B-3.  In each of 
the libraries, a majority of the library members have calculated energies that are 
favorable.  The two xylose libraries are identical except for the residue at position 275.  
Thus, the combination of these two libraries results in a full-sized library with 50% Trp 
and 50% Phe at position 275.  It is evident from these results that because of the genetic 
code, the degenerate codon that is selected after the library design can encode for more 
amino acids than were represented in the initial design calculation.  These cases test our 
assumptions about the restrictions on the identity of a given position and allow us to 
determine if, for example, it was reasonable to require only hydrophobic residues at 
position 275 in the glucose calculation. 
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The diversity in the xylose libraries at position 90 includes Arg, Asn, and Gln, 
which were found to be highly active from site-saturation mutagenesis.  In all of the 
libraries, the high level of diversity at position 276 agrees with the tolerance of this site as 
seen during the site-saturation mutagenesis. 
 The designed combinatorial libraries were screened in crude cell lysate in 96-well 
plates, and the initial rates of the hydrolysis of MUG and MUX were compared.  Some 
trends were observed from the results of this initial screening: (1) the W275F mutation 
eliminates MUG hydrolysis activity in variants with this mutation.  This mutation also 
tends to decrease the activity for MUX somewhat, resulting in an increase in specificity 
for MUX.  (2) Mutants with the R276V mutation (without the W275F mutation), show 
decreased activity for both substrates, but the overall specificity for MUG is increased.  
(3) The R276L mutation in the absence of W275F decreases the glucose hydrolysis rate 
while maintaining a high xylose hydrolysis rate, resulting in an increase in specificity for 
MUX. 
Based on initial screening results, three point mutants were chosen for further 
kinetic characterization: W275F, R276V, and R276L. The kinetic constants resulting 
from these assays are shown in Table B-5.  Specificity was determined by the ratio of 
kcat/Km of MUX and MUG.  For wild-type TAX, the ratio of kcat/Km values of MUX to 
those for MUG is about 9.  The R276V mutation decreased kcat/Km for both MUX and 
MUG.  The R276V and R276L mutants were expected to increase the specificity of TAX 
for xylose over glucose.  Instead, a slight decrease in MUX specificity was observed (2.9 
and 2.2, respectively), but these changes in specificity are not large enough to be 
considered significant.  In contrast, the W275F mutation, which was expected to decrease 
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the specificity for MUX over MUG, caused a slight increase in the specificity for xylose 
to about 10.  The observed changes in specificity were not large enough to be considered 
significant.  The flexibility of the TAX active site near positions 275 and 276 may have 
contributed to the inability to design a Kemp elimination enzyme in the natural binding 
pocket, as described in Chapter III.  The inherent flexibility at these positions may allow 
the binding pocket to adjust to fit a variety of substrates regardless of the identity at these 
positions, making it impossible to change the specificity for glucose and xylose by solely 
manipulating the residues here. 
 
 
Conclusions 
 So far, we have not been able to significantly alter the specificity of TAX using 
computational library design; however, xylose and glucose are the only substrates for 
which TAX has been redesigned.  The variation in the structures of xylose and glucose 
may be too subtle and correspond to a region of the protein that is inherently flexible, 
allowing rearrangement upon binding an alternate substrate.  Additional substrates with 
more substantial differences in structure from xylobiose (e.g., maltose or mannose) may 
prove to be better substrates for a specificity switch.  Cellobiose may make a better 
substrate for a change in TAX specificity because it has an additional glucose molecule 
with a hydroxymethyl group that must also be accommodated.  In addition, the higher 
specific activity that TAX shows for many disaccharides should make screening with 
these substrates more consistent than with monosaccharides, which exhibit low signal-to-
noise ratios. 
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 Other protein design strategies may also be employed to change the specificity of 
TAX.  “Negative design” is one such strategy, where in addition to designing for 
increased binding to one specific substrate to shift specificity, a separate calculation is 
carried out with the goal of decreasing binding to another, alternate substrate.  The best 
sequence in this type of calculation would have a low energy when bound to the target 
substrate and a high energy when bound to the alternate substrate. 
 Because of the limited number of substrates tested up to this point, we cannot 
draw any conclusions about our computational library design procedure.  However, we 
are encouraged by the correlation between the site-saturation mutagenesis results and the 
sequences predicted in the library design calculation.  As a larger number of substrates 
with more diverse structures are used to design combinatorial TAX libraries, we will be 
better able to assess the effectiveness of our library design methods. 
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Table B-1.  Specific activity of TAX on 2.5 mM pNP-glycosides.  A dash indicates that 
no activity was detected.  The data in this table were taken from Lo Leggio et al.5 
 
 
 
 
 
 
 
 
 
Table B-2.  Mutagenesis primers for site-saturation mutagenesis libraries.  The 
degenerate codon is indicated in red.  TAX_NdeI_forward and TAX_BamHI_reverse are 
the flanking primers used for the mutagenesis. 
 
 
 
 
 
 
substrate
activity 
(U/mg)
pNP-!-D-xylopyranoside 60
pNP-!-D-glucopyranoside 12.7
pNP-!-D-mannopyranoside -
pNP-!-D-cellobioside 1290
pNP-!-D-lactoside 281
pNP-!-D-maltoside -
name sequence
Q90X_forward 5'-CTGGTTTGGCACAGCNNSCTGCCGTCTTGGGTG-3'
Q90X_reverse 5'-CACCCAAGACGGCAGSNNGCTGTGCCAAACCAG-3'
W275X_forward 5’- GCCGATCCTGATTCTNNSCGCGCATCCACTACCC-3’
W275X_reverse 5’-GGGTAGTGGATGCGCGSNNAGAATCAGGATCGGC-3’
R276X_forward 5’- CGATCCTGATTCTTGGNNSGCATCCACTACCCCG-3’
R276X_reverse 5’- CGGGGTAGTGGATGCSNNCCAAGAATCAGGATCG-3’
TAX_NdeI_forward 5’-GAAGGAGATATACATATGGCAGAAGCG-3’
TAX_BamHI_reverse 5’- GTTAGCAGCCGGATCCCTAATGGTG-3’
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Table B-3.  Designed TAX libraries.  The non-standard bases in the degenerate codons 
represent equimolar mixtures of bases: R = A, G; M = A, C; K = G, T; S = G, C; D = G, 
A, T; B = G, T, C; N = A, T, G, C. 
 
 
 
 
 
 
 
 
 
 
Table B-4.  Thermocycler temperature programs for mutagenesis reactions. 
 
 
 
 
 
 
library residue #
wild-
type
sampled amino acids amino acids in library
degenerate 
codon
Xyl1-Phe 90 Q ACDEFGHIKLMNQRSTVWY HKNQRS MRM
275 W F F TTC
276 R ACDEFGHIKLMNQRSTVWY CFGILMRSVW NKS
Xyl2-Trp 90 Q ACDEFGHIKLMNQRSTVWY HKNQRS MRM
275 W W W TGG
276 R ACDEFGHIKLMNQRSTVWY CFGILMRSVW NKS
Glc 90 Q ACDEFGHIKLMNQRSTVWY HIKLMNQRS MDS
275 W AFILVWVY ACFGILMPSTVW NBK
276 R ACDEFGHIKLMNQRSTWVY ACFGILMPRSTVW NBS
Temp (°C) Time (min) # cycles
94 5
94 1
55 1
72 1
72 2
4 hold
SOE mutagenesis
  15x
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Table B-5.  Kinetic constants for TAX variants with MUX or MUG. 
 
 
 
 
 
 
 
TAX 
variant
kcat (s
-1
) Km (mM)
kcat/Km            
(s
-1
M
-1
)
kcat (s
-1
) Km (mM)
kcat/Km            
(s
-1
M
-1
)
MUX/MUG  
kcat/Km
MUG/MUX 
kcat/Km
wild-type 7.5E-03 3.3 2.26 1.4E-03 0.26 8.77 8.8 0.11
W275F 4.7E-03 2.6 1.8 1.6E-03 0.62 2.88 2.9 0.35
R276V 9.9E-03 2.6 3.82 9.1E-03 1.7 2.19 2.2 0.46
R276L 2.6E-03 2.0 1.28 3.5E-04 0.13 10.02 10.0 0.10
MUX MUG
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Figure B-1.  Mechanism of retaining glycosidases. 
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Figure B-2.  Xylanase activity assays.  (A) The hydrolysis of p-NP-glucopyranoside 
releases pNP, which absorbs with a λmax of 410 nm.  (B) The hydrolysis of 4-
methylumbelliferyl-glucopyranoside releases 4-methylumbelliferyl, which is fluorescent 
with a λex = 360 nm and a λem = 445 nm. 
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Figure B-3.  Predicted clashes of mannose in the TAX active site.  The modeled 
mannose-acyl intermediate structure is shown in green.  Steric clashes are indicated with 
dotted lines. 
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Figure B-4.  Wild-type hydrogen bonds preserved in TAX calculations.  The 
hydrogen bonds between K50, H83, N172, and the ligand are indicated with yellow 
dotted lines.   
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Figure B-5.  Site-saturation mutagenesis positions in TAX.  The Cellulomonas fimi 
xylanase is shown in cyan with the cellobiose shown in blue.15  The TAX structure and 
xylobiose are shown in green.5  Sites of site-saturation mutagenesis are indicated. 
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Appendix C 
 
 
Altering the specificity of an androgen receptor 
 
 
 
This project was carried out in collaboration with Prof. Robert Fletterick’s lab at the 
University of California, San Francisco.  The computational components of the project 
described here were carried out in the Mayo lab.  All experimental work was carried out 
by Leslie Cruz in the Fletterick lab. 
 
 
 
Abstract 
 Androgen receptors (AR) are nuclear hormone receptors that play a major role in 
sexual development.  To study the role of AR on sexually stereotyped behavior, a mutant 
AR/ligand pair is needed that is orthogonal to the wild-type AR/androgen system.  This 
variant AR could then be selectively activated in the presence of the wild-type AR and 
wild-type ligands.  Here, we attempted to use our computational protein design methods 
to design an AR that can be activated by the nonnatural ligand 19PT.  Our results so far 
indicate that none of our designed ARs are activated by 19PT. 
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Introduction 
Some behavioral differences between the two sexes of a species are controlled on 
the molecular level.  Male mice, for example, demonstrate aggressiveness towards other 
mice and are territorial, whereas female mice do not exhibit these behaviors.1  These 
sexually dimorphic behaviors have prompted investigations into biochemical differences 
in the brains of male and female mice.  However, few examples of molecular differences 
have been identified so far.  One major difference has been observed in the distribution of 
androgen receptors (AR) in the hypothalamus of mice; male mice tend to have a larger 
number of highly localized neurons expressing AR, whereas females have fewer, more 
disperse neurons expressing AR.1 
AR is a 110 kD nuclear hormone receptor, that is sequestered by a heat shock 
protein (HSP) in the cytoplasm.  Upon binding dihydrotestosterone (DHT), a metabolic 
derivative of testosterone (TES), AR undergoes a conformational change that allows its 
translocation into the nucleus.  Once in the nucleus, it homodimerizes and acts as a DNA 
transcription activator for genes that control sexual development and the maintenance of 
skeletal and muscular systems (Figure C-1).2,3  While these roles of AR are widely 
accepted, less is known about the role of AR in the brain and its effect on sexually 
stereotypical behavior.1 
Our goal here was to create a system that can facilitate the study of the role of AR 
in sex-differentiated behavior in a mouse model.  To this end, we attempted to design an 
AR that can be activated by the nonnatural TES-analog 19PT (Figure C-2).  The design 
of a novel AR-ligand pair is the first step to the design of a “magic pair” that is 
orthogonal to the wild-type AR-DHT system.  The expression of this mutant AR in the 
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brains of mice would allow manipulation of mutant AR activity in a site-specific manner 
without affecting the endocrine system in the rest of the animal. 
The strategy for redesigning the AR active site to accommodate 19PT is similar to 
that for designing enzyme active sites described in Chapters I-IV.  As before, we used the 
computational protein design software ORBIT.4  However, instead of designing around a 
reaction transition state (TS), we optimize the active site residues for binding to the 
ground-state ligand structure.  Important binding contacts, such as hydrogen bonds, can 
be enforced using geometric constraints as in the enzyme design calculations.  In 
addition, some rotational and translational freedom is given to the ligand during the 
design calculation and the internal flexibility of the ligand is modeled with canonical 
torsions of rotatable bonds, as in Appendix A.   
 
 
Methods 
Scaffold selection 
 Because it had been used for past analyses by the Fletterick lab, the 1.7 Å 
structure of AR from Pan troglodytes bound to DHT was chosen as the scaffold for the 
design.5 
 
19PT structure and rotamer design 
 The DHT structure found in the crystal structure from Hur et al.5 (PDB: 1T7T) 
was modified to produce the structure of 19PT using the molecular modeling program 
BIOGRAF.6  Starting with the DHT structure, hydrogens and the 19-butyl group were 
added and the entire structure was minimized for 50 steps.  Charges were calculated 
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using an electrostatic potential fit, methanol solvation, and the hybrid density functional 
B3LYP as implemented by the Jaguar 5.5 software package and a 6-31G** basis set.7  
Rotamers were created using canonical torsions (60°, 180°, and 300°) for each of the four 
rotatable bonds, resulting in 81 rotamers, which were then minimized for 250 steps using 
BIOGRAF (Figure C-3).6 
 
Androgen receptor design for 19PT binding 
 The initial position of the 19PT ligand was determined by overlaying with the 
DHT structure in the 1T7T crystal structure.5  The ligand was allowed to rotate ± 5° in x, 
y, and z in 5° steps and translate ± 0.2 Å in x, y, and z in 0.2 Å steps.  Three positions 
(W741, M742 and M745) were chosen as design positions because of their proximity to 
the expected position of the 19PT butyl group based on its initial position (Figure C-4).  
All residues within 6 Å of DHT in the 1T7T structure (701, 704, 705, 707, 746, 749, 752, 
746 768, 780, 784, 787, 873, 876, 877, 880, 889, 891, 895, 899) were allowed to change 
conformation but not identity.  
As in Chapter III, Lazaridis-Karplus occlusion-based solvation was applied with 
scale factors of 1.0 for nonpolar burial and nonpolar exposure and a scale factor of 0.6 for 
polar burial (see Materials and Methods).8  Other standard ORBIT parameters were 
applied as in Lassila et al. and a backbone-independent conformer library was used to 
represent sidechain flexibility9.  Loose geometric constraints were applied to preserve 
hydrogen bonds that are present in the wild-type crystal structure.  An Asp and Thr 
residue was required to be between 2.5 and 3.2 Å of one of the 19PT hydroxyls and an 
arginine contact was required between 4.0 and 5.0 Å of the other hydroxyl (Figure C-5). 
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Transcriptional activation assay 
 The activation of AR variants was monitored using a luciferase reporter assay in 
HeLa cells as described by Bohl et al.10  In these experiments, the AR ligand binding 
domain is fused to the transcriptional activator Gal4 (Gal4-AR).  Ligands were added to 
the culture after a day of expression and chemiluminescence was used to determine AR 
activation.  Assays were carried out with 10 µM 19PT and 100 nM DHT.  Percent 
activity was calculated based on DHT activity in Gal4-AR set at 100%. 
 
 
Results and Discussion 
 The designs from the ORBIT calculations are summarized in Table C-1.  In 
general, the sequences are hydrophobic and relocate the bulk in the active site from 
position 745 to position 715 to make room for the 19PT butyl group.  The sequences 
resulting from the calculations fall into five groups, which can be separated based on the 
residue chosen at position 741.  Groups 1-4 each contain 3 sequences that all have an 
alanine at position 745.  All three sequences in each of these groups are structurally 
identical except for the residue at 715, which is either leucine, methionine, or isoleucine.  
These four groups are distinguished by the residue at position 741.   
Group 1 has a tyrosine at position 741, whose hydrogen bond contact is 
unfulfilled.  The 19PT structure in these designs does not have an extended butyl group.  
Group 2 designs are identical in structure to group 1, except that a phenylalanine is 
substituted for tyrosine at position 741 (Figure C-6A).  Again, the butyl group of 19PT is 
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in a kinked conformation that may not be energetically favorable.  Group 3 designs have 
a W715H mutation.  In these designs, the histidine overlays well with the indole of the 
tryptophan in the wild-type crystal structure and the butyl of 19PT is in a fully extended 
conformation (Figure C-6B).  Group 4 has a leucine at position 741, which causes the 
butyl group to adopt the same kinked conformation seen in group 2 (Figure C-6C).  In 
contrast to the other sequences, group 5 has only a single sequence with a single W741A 
mutation and the 19PT butyl group is in a fully extended conformation (Figure C-6D). 
  These five groups of designs were submitted to the Fletterick lab for testing and a 
large number of variants were made.  Only one of the variants (W741A) shows wild type-
like DHT activation (Gal-AR) in the transcription activation assay and none of the AR 
variants that we designed so far shows significant activation by 19PT (Figure C-8).  The 
loss of DHT activation in most of the designs indicates some kind of perturbation in the 
active site or a prevention of the conformational change necessary for activation.  One of 
the limitations of computational protein design is that we can only design for ligand 
binding and not for AR activation.  Unfortunately, in the case of AR, ligand binding is 
necessary but not sufficient for activation.  To evaluate the success of the computational 
protein design process in this case, we would need to assay for binding directly.  
Currently, no binding assay exists for AR beyond crystallography, which is extremely 
low-throughput and not a reliable assay for binding due to the high potential for false 
negatives. 
In addition, conformational changes of the backbone upon mutation of the binding 
pocket residues cannot be ruled out.  In the crystal structure of AR/M745A, the backbone 
of the binding pocket is observed to shift slightly, changing the conformation of some of 
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the residues significantly, including W741 and N705 (Figure C-7).11  Future design 
calculations could account for this backbone flexibility by using molecular dynamics or  
by including multiple backbone conformations during the design calculation.12,13 
 
 
Conclusions 
So far, we have not been able to use our computational protein design methods to 
design a mutant AR that can be selectively activated by the nonnatural ligand 19PT.  
However, without specific structural or ligand-binding data, it remains unclear if our 
methods failed or if this system is simply not amenable to computational design due to 
subtleties in the receptor structure-function relationship.  This project is ongoing with 
experimental work in the Fletterick lab.  Future computational studies of this system with 
molecular dynamics simulations may help us understand the effect of mutations on the 
activity of the receptor, and the incorporation of this information into future designs using 
multi-state design may aid us in creating active AR variants. 
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Table C-1.  AR-19PT design summary.  The designs were separated into five groups 
based on their mutations at positions 741 and 745.  Group 1 (blue) has W741Y and 
M745A mutations.  Group 2 (orange) has W741F and M745A mutations.  Group 3 
(white) has W741H and M745A mutations.  Group 4 (purple) has W741L and M745A 
mutations.  Group 5 (yellow) has only a W741 mutation. 
 
 
 
 
 
 
 
 
 
name 715 741 745
ORBIT 
energy 
(kcal/mol)
comments
wt V W M
1 L Y A -216.9
2 M Y A -216.8
3 I Y A -216.8
4 L F A -216.0
5 M F A -215.9
6 I F A -215.9
7 L H A -215.5
8 M H A -215.4
9 I H A -215.4
11 L L A -215.1
12 M L A -215.1
13 I L A -215.1
14 V A M -212.6 single mutation
His overlays well with indole of W741
W241L has been made previously and does not preturb 
structure
Y742 makes no H-bond, butyl not fully extended
butyl not fully extended, but takes up most of empty 
space
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Figure C-1.  Activation mechanism of AR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-2.  Chemical structures of androgens of interest. 
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Figure C-3.  Rotamers of 19PT.  (A) Chemical structure of 19PT with red arrows 
indicating the positions of rotatable bonds.  (B) Overlay of the 81 minimized 19PT 
rotamers used in the calculations. 
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Figure C-4.  Design positions in the active site of AR.  Sidechains that were designed 
are indicated and a model of the 19PT ligand is shown in purple. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-5.  Wild-type hydrogen bonds to 19PT.  These hydrogen bond contacts were 
enforced through a simple geometry pruning step.  The 19PT model is shown in purple. 
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Figure C-6.  ORBIT designs for AR binding of 19PT.  Each design is shown overlaid 
with the wild-type AR crystal structure, shown in pink.5  (A) AR/V215I/W241F/M245A 
design is shown in green.  (B) AR/V215I/W241H/M245A is shown in magenta.  (C) 
AR/V215I/W241L/M245A is shown in cyan.  (D) W241A is shown in green. 
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Figure C-7.  Structural differences in the AR crystal structure caused by M745A.  
The structure of wild-type AR5 is shown in blue and the structure of AR/M745A11 is 
shown in green.  DHT was bound in both structures.  (A) Structural differences of W741 
and M742.  (B) Structural differences of N705. 
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Figure C-8.  Transcriptional activation assay.  Percent activity is calculated based on 
the DHT activity in Gal-AR being 100%. 
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Appendix D 
 
 
Recombinant expression and purification of a xylanase from the 
thermophilic fungus T. aurantiacus 
 
 
 
 
Abstract 
 The Thermoascus aurantiacus xylanase 10A (TAX) is of interest for industrial 
and enzyme engineering purposes because of its ability to hydrolyze polymers of xylose 
at elevated temperatures.  Previous expression of this xylanase has relied on natural 
production from fungal cell cultures, limiting the quantities that can be produced and 
hindering genetic manipulation that could be used to optimize existing activity or 
engineer novel activities.  Here, we optimize the gene sequence of TAX for expression in 
E. coli and successfully express the protein in quantities up to 150 mg per liter of culture.  
In addition, a quick single-step purification protocol is developed that results in highly 
pure protein. 
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Introduction 
Endo-β-1,4-xylanases are of industrial interest because of their hydrolytic activity 
against the internal glycosidic bonds of xylan, which is the major polysaccharide 
component of plant cell walls.  The optimization of the stability and catalytic activity of 
such enzymes has potential applications in paper bleaching as well as in food and animal 
feed processing.  Thus, thermostable xylanases such as xylanase 10A from the 
thermophilic fungus Thermoascus aurantiacus (TAX) are particularly well suited for 
industrial applications at elevated temperatures.  Previously, TAX had only been obtained 
from the endogenous expression in T. aurantiacus found in samples of Indian soil.1  
Although natural expression gave sufficient quantities for crystallization studies, 
cultivation of fungal cells was necessary, requiring between 3 and 13 days of incubation 
to produce the protein.2 
Our interest in TAX focused on its potential use as a scaffold for computational 
enzyme design.  Three features of TAX make it attractive for these purposes: (1) The 
protein is thermostable, which generally indicates a robust scaffold more amenable to 
multiple mutations than its mesophilic homologs.3  (2) TAX has a large natural binding 
pocket that could accommodate large substrates and multiple catalytic residues.  (3) A 
high-resolution crystal structure is available at 1.7 Å with the natural ligand bound in the 
active site.4 
The engineering of any protein requires an expression system amenable to genetic 
manipulation, thus the natural fungal system is not appropriate for the expression of 
designed TAX variants.  Here, we present an efficient, recombinant E. coli expression 
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and purification protocol that yields up to 150 mg of active enzyme per liter of culture 
and is readily transferable to a high-throughput format.  
 
 
Materials and Methods 
Optimization of the TAX-His6 gene 
The protein sequence for TAX was taken from the FASTA sequence of the crystal 
structure of TAX (PDB:1GOR).4  A hexahistidine purification tag was added to the 
C-terminus of the protein sequence preceded by a Factor Xa cleavage site resulting in the 
C-terminal sequence: GSIEGRGHHHHHH.  The gene for TAX-His6 was designed from 
the protein sequence using DNA 2.0 Gene Designer and optimized for expression in E. 
coli.5  A unique NdeI restriction site was incorporated at the 5′ end of the gene, and a stop 
codon (TAG) along with a unique BamHI restriction site were incorporated immediately 
following the 3′ end of the gene.  The gene and protein sequences for TAX-His6 are 
shown in Figure D-1. 
 
Design of the oligonucleotides 
Forty-eight overlapping oligonucleotides for the construction of the TAX-His6 
gene were designed using Assembly PCR Oligo Maker.6  The overlapping 
oligonucleotides spanned the length of the gene and were less than 40 base pairs long 
with 16 to 20 base-pair overlapping regions (Table D-1).  All oligonucleotides were 
synthesized by Integrated DNA Technologies at a 20 mmol scale with no additional 
purification. 
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Gene construction 
The full-length TAX-His6 gene was constructed by recursive PCR based on the 
method of Stemmer et al.7  The protocol for gene construction is outlined in Chapter III, 
Materials and Methods.  After construction, the gene was amplified using the primers 
TAX_forward 5′-(TAAGAAGGAGATATACATATGG)-3′ and TAX_reverse              
5′-(AACTCAGCTTCCTTTCGGG)-3′, which were calculated to have melting 
temperatures of 63.9 and 67.6°C, respectively.  The purified gene fragment was digested 
using BamHI/NdeI (New England Biolabs) and was then ligated into a similarly digested 
pET11a plasmid (Novagen) yielding the TAX-His6-pET11a plasmid.  The plasmid was 
then transformed into E. coli XL-1 Blue cells (Stratagene) and the gene sequence was 
confirmed by DNA sequencing. 
 
Overexpression of TAX-His6 
TAX-His6-pET11a was transformed into E. coli BL-21(DE3) cells for expression.  
A single colony was then used to inoculate 50 mL of LB containing 100 µg/mL 
ampicillin, which was then grown overnight at 37°C with shaking.  30 mL of the pre-
culture was used to innoculate 1 L LB/ampicillin.  The culture was grown at 37°C with 
shaking to an OD600 of approximately 0.3.  The temperature was then reduced to 25°C 
and expression was induced at an OD600 of 0.6 with the addition of 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG).  The culture was grown 18 hours and the cells were 
harvested by centrifugation. 
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Purification of TAX-His6 
The harvested cells were resuspended in lysis buffer (10 mM imidazole, 100 mM 
Tris pH 7.4, 300 mM NaCl), lysed mechanically with an Emulsiflex-C5 (Avestin), and 
then clarified by centrifugation at 10,000 × g for 40 min.  The supernatant was then 
applied to 3 mL of Ni-NTA resin (Qiagen), which had been equilibrated with lysis buffer.  
The column was washed with 10 column volumes of lysis buffer and 10 column volumes 
of wash buffer (20 mM imidazole, 100 mM Tris pH 7.4, 300 mM NaCl).  The protein 
was eluted with 3 column volumes of elution buffer (200 mM imidazole, 100 mM Tris 
pH 7.4, 300 mM NaCl).  The eluate was dialyzed exhaustively against 50 mM sodium 
citrate, 50 mM NaCl, pH 5.5 and then concentrated using Amicon 10,000 MWCO 
centrifugal concentrators (Millipore). 
 
Protein concentration determination 
Protein concentrations were determined by UV absorbance after protein 
denaturation in 8 M guanidinium hydrochloride for 10 min with a dilution of at least 10×.  
An extinction coefficient at 280 nm of 55,280 M-1cm-1 was used. 
 
Protein characterization 
 CD and MS were carried out as in Chapter III, Materials and Methods.  CD 
spectra and thermal denaturation curves were obtained using 10 µM protein in 50 mM 
MES, pH 5.5, 100 mM NaCl.  
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Xylanase activity assays 
 The specific activity of TAX-His6 was assayed using pNP-β-D-glucopyranoside 
as in Lo Leggio et al.4  2.5 mM substrate in 50 mM sodium citrate, pH 5.3 was incubated 
at 50°C for 5 min.  The reaction was initiated with the addition of purified TAX-His6 to a 
final volume of 300 µL.  Protein concentrations between 170 µM and 1.7 µM were used.  
The reactions were mixed and incubated at 50°C for 15 min.  The reaction was quenched 
with the addition of 400 uL of 20% Na2CO3 and the amount of liberated pNP was 
determined by measuring the absorbance at 410 nm.  An extinction coefficient at 410 nm 
of 18,400 M-1cm-1 was used for pNP at pH 10.0. 
 
 
Results and Discussion 
 We observed very high levels of TAX-His6 expression in the BL-21 (DE3) E. coli  
cells (Figure D-2, lane 2) and were able to obtain 150 mg of highly pure protein per liter 
of culture after a single Ni-NTA affinity chromatography purification step (Figure D-2, 
lane 6).  A majority of TAX-His6 was expressed into the soluble fraction (Figure D-2, 
lane 3), but a significant amount of protein was found in the insoluble fraction, perhaps a 
result of the very high total amount of expressed protein.  The mass was confirmed with 
electrospray mass spectrometry (Figure D-3), and is within 2 amu of the expected mass 
(34,433 kDa). 
 CD analysis shows that TAX-His6 is folded and has a Tm of 75.2°C (Figure D-4).  
Unfortunately, no CD data is available for direct comparison with fungally expressed 
TAX.  One source reports that TAX retains 40% of its activity at temperatures as high as 
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80°C for 1 hour.  In the recombinant TAX-His6, the protein is fully and irreversibly 
unfolded at this temperature.  One subtle difference between TAX from fungal sources 
and from E. coli is the pyroglutamic acid modification of the N-terminal glutamate that is 
seen in the crystal structure of fungal TAX that is probably not present in the 
recombinant protein.4  However, it is not clear that this small modification is enough to 
cause significant destabilization.  The hexahistidine tag and Factor Xa cleavage site that 
were added to the protein sequence in TAX-His6 may also contribute to the differences in 
stability, although we did not attempt to cleave the tag to determine if this was the cause 
of the destabilization.  In addition, the strain of T. aurantiacus that was used to produce 
the xylanase in the crystal structure, which was the source of our protein sequence, is not 
explicitly stated.  If the xylanase produced by the strain used in the temperature studies 
(C436) differed from the one that was used to produce the protein for the crystal 
structure, the protein sequences could be different, perhaps resulting in variations in 
thermal stability. 
TAX-His6 has a specific activity for pNP-β-D-glucopyranoside of 13.6 ± 3.9 
U/mg.  This is similar to the reported value from the natural expression system (12.7 
U/mg), indicating that the enzyme is functionally unchanged when expressed in E. coli.4 
 
Conclusions 
 We were able to express TAX-His6 recombinantly, and because of our 
optimization of the gene for expression in E. coli, we obtained up to 150 mg of highly 
pure protein per liter of culture.  The recombinantly expressed TAX-His6 is folded, 
stable, and functionally indistinguishable from the protein obtained from the fungal 
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expression system.  The high bacterial expression levels, ease of purification, and 
thermostability of TAX-His6 make it an ideal scaffold for de novo computational enzyme 
design and other enzyme engineering studies.  In addition, the method of constructing the 
TAX-His6 gene through recursive PCR of overlapping 40-mer oligonucleotides facilitates 
future enzyme engineering projects on this scaffold.  Multiple mutations can easily be 
introduced by simply substituting a subset of oligos that encode the mutations and 
carrying out the gene assembly and cloning steps to create the gene for the modified 
protein. 
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Table D-1.  Assembly oligonucleotides for the construction of the TAX-His6 gene.  
Overlapping regions are indicated with bold text and same-colored sections of adjacent 
oligonucleotides are complementary.  All oligonucleotides are written from 5′ to 3′. 
 
 
 
name sequence length
TAX-1t TAAGAAGGAGATATACATATGGCAGAAGCGG 31
TAX-1b TCAGTTGGTCAACGGATTGAGCCGCTTCTGCCATATGTAT 40
TAX-2t CAATCCGTTGACCAACTGATTAAAGCTCGTGGTAAAGTGT 40
TAX-2b GTCGGTTGCAACACCGAAATACACTTTACCACGAGCTTTA 40
TAX-3t TTCGGTGTTGCAACCGACCAGAACCGCCTGACCACTGGC 39
TAX-3b CTGAATGATCGCCGCGTTCTTGCCAGTGGTCAGGCGGT 38
TAX-4t AACGCGGCGATCATTCAGGCAGATTTCGGTCAGGTTACCC 40
TAX-4b CCCATTTCATGGAGTTCTCTGGGGTAACCTGACCGAAATC 40
TAX-5t GAGAACTCCATGAAATGGGACGCGACCGAGCCTTCTCAA 39
TAX-5b CGCCAGCGAAGTTGAAGTTGCCTTGAGAAGGCTCGGTCGC 40
TAX-6t AACTTCAACTTCGCTGGCGCAGACTACCTGGTGAACTGG 39
TAX-6b CAGCTTACCGTTCTGCTGCGCCCAGTTCACCAGGTAGTC 39
TAX-7t CAGCAGAACGGTAAGCTGATCCGCGGTCATACGCTGGTT 39
TAX-7b AGACGGCAGCTGGCTGTGCCAAACCAGCGTATGACCGCG 39
TAX-8t ACAGCCAGCTGCCGTCTTGGGTGTCTTCCATCACCGATA 39
TAX-8b TCACGTTGGTCAGAGTGTTTTTATCGGTGATGGAAGACAC 40
TAX-9t AACACTCTGACCAACGTGATGAAGAACCATATCACTACCC 40
TAX-9b TGCCTTTATAACGGGTCATCAGGGTAGTGATATGGTTCTTC 41
TAX-10t GATGACCCGTTATAAAGGCAAAATCCGCGCGTGGGATGTT 40
TAX-10b CCTCGTTGAATGCTTCATTCACAACATCCCACGCGCGGA 39
TAX-11t GAATGAAGCATTCAACGAGGACGGCAGCCTGCGCCAGAC 39
TAX-11b CACCGATCACATTCAGAAAAACGGTCTGGCGCAGGCTGC 39
TAX-12t TTTTCTGAATGTGATCGGTGAAGATTACATCCCGATCGCAT 41
TAX-12b GCAGCACGGGCGGTCTGGAATGCGATCGGGATGTAATC 38
TAX-13t AGACCGCCCGTGCTGCAGATCCAAACGCTAAGCTGTACA 39
TAX-13b AGTCCAGGTTGTAATCGTTAATGTACAGCTTAGCGTTTGG 40
TAX-14t TAACGATTACAACCTGGACTCTGCGTCTTATCCGAAAACCC 41
TAX-14b AACACGGTTCACGATGGCCTGGGTTTTCGGATAAGACGC 39
TAX-15t GCCATCGTGAACCGTGTTAAACAGTGGCGTGCGGCTGG 38
TAX-15b GCCGATGCCGTCGATCGGAACGCCAGCCGCACGCCACT 38
TAX-16t CGATCGACGGCATCGGCTCCCAGACGCATCTGTCTGCA 38
TAX-16b AGCACGCCAGCGCCCTGGCCTGCAGACAGATGCGTCTG 38
TAX-17t AGGGCGCTGGCGTGCTGCAGGCCCTGCCGCTGCTGGC 37
TAX-17b ACCTCCGGAGTGCCGGCGCTTGCCAGCAGCGGCAGGG 37
TAX-18t CCGGCACTCCGGAGGTTGCAATCACCGAGCTGGATGTAG 39
TAX-18b ATCAGTCGGGCTTGCGCCCGCTACATCCAGCTCGGTGAT 39
TAX-19t GCGCAAGCCCGACTGATTATGTCAACGTCGTGAACGCG 38
TAX-19b CACAAGACTGCACATTCAGGCACGCGTTCACGACGTTGAC 40
TAX-20t CTGAATGTGCAGTCTTGTGTGGGCATTACCGTATGGGGT 39
TAX-20b CCAAGAATCAGGATCGGCAACACCCCATACGGTAATGCC 39
TAX-21t GCCGATCCTGATTCTTGGCGCGCATCCACTACCCCGCTG 39
TAX-21b GGTTGAAATTACCGTCGAACAGCAGCGGGGTAGTGGATG 39
TAX-22t GTTCGACGGTAATTTCAACCCGAAACCAGCTTACAACGCTA 41
TAX-22b CTGTTGCAGGTCCTGAACGATAGCGTTGTAAGCTGGTTTC 40
TAX-23t GTTCAGGACCTGCAACAGGGCAGCATCGAGGGTCGTGGT 39
TAX-23b CCTAATGGTGGTGGTGATGGTGACCACGACCCTCGATGC 39
TAX-24t CATCACCACCACCATTAGGGATCCGGCTGCTAACAAAGC 39
TAX-24b AACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGA 36
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T. aruantiacus xylanase (TAX-His6) 
 
 
    TAA GAA GGA GAT ATA CAT ATG GCA 
       NdeI    A  
  
  1 GAA GCG GCT CAA TCC GTT GAC CAA CTG ATT AAA GCT CGT GGT AAA GTG TAT TTC GGT GTT 
  1  E   A   A   Q   S   V   D   Q   L   I   K   A   R   G   K   V   Y   F   G   V  
 
 61 GCA ACC GAC CAG AAC CGC CTG ACC ACT GGC AAG AAC GCG GCG ATC ATT CAG GCA GAT TTC 
 21  A   T   D   Q   N   R   L   T   T   G   K   N   A   A   I   I   Q   A   D   F  
 
121 GGT CAG GTT ACC CCA GAG AAC TCC ATG AAA TGG GAC GCG ACC GAG CCT TCT CAA GGC AAC 
 41  G   Q   V   T   P   E   N   S   M   K   W   D   A   T   E   P   S   Q   G   N  
 
181 TTC AAC TTC GCT GGC GCA GAC TAC CTG GTG AAC TGG GCG CAG CAG AAC GGT AAG CTG ATC 
 61  F   N   F   A   G   A   D   Y   L   V   N   W   A   Q   Q   N   G   K   L   I  
 
241 CGC GGT CAT ACG CTG GTT TGG CAC AGC CAG CTG CCG TCT TGG GTG TCT TCC ATC ACC GAT 
 81  R   G   H   T   L   V   W   H   S   Q   L   P   S   W   V   S   S   I   T   D  
 
301 AAA AAC ACT CTG ACC AAC GTG ATG AAG AAC CAT ATC ACT ACC CTG ATG ACC CGT TAT AAA 
101  K   N   T   L   T   N   V   M   K   N   H   I   T   T   L   M   T   R   Y   K  
 
361 GGC AAA ATC CGC GCG TGG GAT GTT GTG AAT GAA GCA TTC AAC GAG GAC GGC AGC CTG CGC 
121  G   K   I   R   A   W   D   V   V   N   E   A   F   N   E   D   G   S   L   R  
 
421 CAG ACC GTT TTT CTG AAT GTG ATC GGT GAA GAT TAC ATC CCG ATC GCA TTC CAG ACC GCC 
141  Q   T   V   F   L   N   V   I   G   E   D   Y   I   P   I   A   F   Q   T   A  
 
481 CGT GCT GCA GAT CCA AAC GCT AAG CTG TAC ATT AAC GAT TAC AAC CTG GAC TCT GCG TCT 
161  R   A   A   D   P   N   A   K   L   Y   I   N   D   Y   N   L   D   S   A   S  
 
541 TAT CCG AAA ACC CAG GCC ATC GTG AAC CGT GTT AAA CAG TGG CGT GCG GCT GGC GTT CCG 
181  Y   P   K   T   Q   A   I   V   N   R   V   K   Q   W   R   A   A   G   V   P  
 
601 ATC GAC GGC ATC GGC TCC CAG ACG CAT CTG TCT GCA GGC CAG GGC GCT GGC GTG CTG CAG 
201  I   D   G   I   G   S   Q   T   H   L   S   A   G   Q   G   A   G   V   L   Q  
 
661 GCC CTG CCG CTG CTG GCA AGC GCC GGC ACT CCG GAG GTT GCA ATC ACC GAG CTG GAT GTA 
221  A   L   P   L   L   A   S   A   G   T   P   E   V   A   I   T   E   L   D   V  
 
721 GCG GGC GCA AGC CCG ACT GAT TAT GTC AAC GTC GTG AAC GCG TGC CTG AAT GTG CAG TCT 
241  A   G   A   S   P   T   D   Y   V   N   V   V   N   A   C   L   N   V   Q   S  
 
781 TGT GTG GGC ATT ACC GTA TGG GGT GTT GCC GAT CCT GAT TCT TGG CGC GCA TCC ACT ACC 
261  C   V   G   I   T   V   W   G   V   A   D   P   D   S   W   R   A   S   T   T  
 
841 CCG CTG CTG TTC GAC GGT AAT TTC AAC CCG AAA CCA GCT TAC AAC GCT ATC GTT CAG GAC 
281  P   L   L   F   D   G   N   F   N   P   K   P   A   Y   N   A   I   V   Q   D  
 
901 CTG CAA CAG GGC AGC ATC GAG GGT CGT GGT CAC CAT CAC CAC CAC CAT TAG  
301  L   Q   Q   G   S   I   E   G   R   G   H   H   H   H   H   H 
 
    GGA TCC GGC TGC TAA CAA AGC CCG AAA GGA AGC TGA GTT 
     BamHI 
 
 
 
Figure D-1.  Protein and DNA sequences for TAX-His6.  The hexahistidine tag is 
shown in pink, the Factor Xa cleavage site is in red, and the restriction endonuclease 
cleavage sites are in green. 
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Figure D-2.  SDS-PAGE analysis of TAX-His6 expression and purification.  
Approximate molecular weights are indicated.  Lane 1: Molecular weight marker. Lane 2: 
uninduced cells.  Lane 3: cells after 18 hours of induction.  Lane 4: lysate supernatant.  
Lane 5: lysate pellet.  Lane 6: Ni-NTA affinity column eluate. 
 
 
 
 
 
 
 
 
 
 
 
Figure D-3.  Mass spectrometry analysis of TAX-His6.  The actual mass (34431.2) is 
within 2 amu of the expected mass (34433 amu). 
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Figure D-4.  CD analysis of TAX-His6.  (A) Far-UV wavelength scan, 25°C.  (B) 
Thermal denaturation monitored at 222 nm.  All experiments were carried out with 10 
µM protein in 50 mM MES, pH 5.5, 50 mM NaCl. 
A 
B 
